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Abstract 
 Pyrimidines are essential components of nucleic acids. In biology, they undergo 
a number of redox reactions catalyzed by flavin-dependent enzymes. This thesis 
investigates the mechanism of substrate recognition and activation of two flavin-
dependent enzymes with pyrimidine-containing substrates: flavin-dependent thymidylate 
synthase (FDTS) and tRNA-dihydrouridine synthase (DUS). FDTS catalyzes the 
reductive methylation of the uracil moiety of 2’-deoxyuridine-5’-monophosphate (dUMP) 
into thymine, whereas DUS reduces specific uracils in tRNA to dihydrouracil.  
 NMR data indicate that FDTS ionizes N3 of the uracil in dUMP using an active-
site arginine, which is proposed to initiate catalysis by enhancing the nucleophilicity of 
C5 of the uracil. Biochemical data on dUMP analogs suggests that the phosphate of 
dUMP acts as the base that removes the proton from C5 of dUMP during the FDTS-
catalyzed reaction. Notably, both ionization of N3 and acid-base catalysis by the 
phosphate of dUMP are not implicated in the mechanism used by human thymidylate 
synthase. 
 Several equilibrium and kinetic methods were used to study the mechanism of 
deoxynucleotide recognition by Thermotoga maritima FDTS. FDTS binds 
deoxynucleotides with ~200-fold weaker affinity when the flavin is reduced relative to 
when it is oxidized, and the differences in affinity are largely due to differences in the 
dissociation rate constant. There is also a temperature-dependent effect on the 
xvii 
 
mechanism by which FDTS binds deoxynucleotides – below 45°C the FDTS 
homotetramer behaves as a dimer-of-dimers with deoxynucleotide binding while at 
temperatures above 45°C the four subunits of FDTS bind deoxynucleotides identically. 
T. maritima normally lives at 80°C, so this behavior likely results from studying the 
enzyme at non-physiological temperatures.  
 tRNAs contain a number of nucleobase and ribose modifications – including 
dihydrouracil – at different positions of the tRNA. Previous work has shown that yeast 
tRNALeu-CAA reacts poorly with yeast DUS2 unless it contains other modifications, 
suggesting that tRNA modifications are ordered. The reactivity of yeast DUS2 with other 
unmodified tRNAs was investigated; unmodified yeast tRNAAsp, tRNAAla, and tRNAHis2 
all reacted rapidly with yeast DUS2, indicating that not all tRNAs require prior 
modifications to react rapidly with yeast DUS2. Native gel electrophoresis showed that 
unmodified tRNALeu-CAA misfolds, explaining its poor reactivity with yeast DUS2. 
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Chapter 1 
Introduction 
Background 
 Pyrimidines are important biological molecules. They are major components of 
DNA and RNA – three three types of nucleobases are derived from pyrimidines 
(cytosine, uracil, and thymine), which are crucial components that constitute the 
alphabet of the genetic code. Pyrimidines are also precursors of activated sugars and 
activated lipids that are critical for synthesizing glycoproteins and cell membranes.1 
 Pyrimidines are subjected to a variety of redox reactions during cellular 
metabolism that are catalyzed by flavin-dependent enzymes. Flavins are derived from 
vitamin B2 (riboflavin), which contains the redox-active isoalloxazine moiety (Figure 1 - 
1). Two derivatives of riboflavin are typically used by flavin-dependent enzymes: flavin 
mononucleotide (FMN), which has a phosphate at the end of the ribityl tail of riboflavin, 
and flavin adenine dinucleotide (FAD), which has an adenosine diphosphate group at 
the end of the ribityl tail. Flavoenzymes usually use FMN or FAD as a prosthetic group 
through extensive noncovalent interactions with the non-isoalloxazine portion of the 
flavin. 
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Flavins are capable of performing a wide range of chemistry, which is tightly 
controlled by the active sites of flavoenzymes.2 One of the most common reactions is 
hydride transfer to or from N5 of the isoalloxazine. The two enzymes studied in this 
thesis are proposed to use flavin-dependent hydride transfers as part of their 
mechanisms. Flavoenzymes can also stabilize flavin semiquinones, allowing flavins to 
perform 1-electron transfers. In addition, flavins can undergo nucleophilic or electrophilic 
attack at N5 or C4a of the isoalloxazine, depending on the redox state of the flavin. 
Reduced flavin can react with molecular oxygen at the C4a position to make a flavin 
hydroperoxide intermediate – the hydroperoxide intermediate can then either eliminate 
hydrogen peroxide or be used to oxygenate other substrates. 
 Flavoenzymes often use ping-pong kinetic mechanisms, where one substrate 
donates electrons to oxidized flavin and a second substrate takes the electrons from 
reduced flavin. As a result, the catalytic cycle of most flavoenzymes can be broken up 
into half-reactions (Figure 1 - 2). In the reductive half-reaction, an electron-rich substrate 
Figure 1 - 1. Flavin structures. 
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donates its electrons to oxidized flavin, making reduced flavin. In the oxidative half-
reaction, the reduced flavin donates the electrons to an electron-poor substrate. The 
reductive and oxidative half-reactions can be studied independently, simplifying the 
number of steps being investigated and avoiding the complications of turnover. 
 
 
 
 
 
 
 The flavin prosthetic group is also a chromophore/fluorophore with unique 
spectra for each redox state of the flavin (Figure 1 - 3). Oxidized flavin is bright yellow, 
with absorbance peaks around 450 and 370 nm, and is usually fluorescent. 2-electron 
reduced flavin is pale yellow, with a relatively featureless absorbance spectrum, and is 
usually non-fluorescent. The flavin semiquinone has a distinct absorbance spectrum 
that depends on the protonation state of the semiquinone – anionic semiquinone has a 
high-extinction peak around 370 nm and a second peak around 480 nm whereas the 
neutral semiquinone has a broad absorbance spectrum that extends past 650 nm. The 
Figure 1 - 2. General catalytic cycle of most flavoenzymes. In the reductive half-reaction, the reducing 
substrate donates its electrons to oxidized flavin. The now-reduced flavin donates the electrons to the 
oxidizing substrate in the oxidative half-reaction. 
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various flavin adducts also have characteristic absorbance spectra that aid their 
identification. The different spectral signals enable the monitoring of electron transfer to 
and from the flavin during each half-reaction, so that detailed information on the number 
and nature of chemical steps can be determined. The oxidized and reduced flavin 
chromophores/fluorophores are also often sensitive to changes in the local environment 
of the flavin. As a result, ligand binding can often be monitored through perturbations to 
the absorbance/fluorescence spectrum of the flavin. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 - 3. UV/visible absorbance spectra and structures of the different flavin redox states. 
5 
 
Figure 1 - 4. Reaction catalyzed by dihydropyrimidine dehydrogenase. 
 This thesis focuses on the mechanism of substrate recognition and activation by 
two flavoenzymes with pyrimidine-containing substrates – flavin-dependent thymidylate 
synthase and tRNA-dihydrouridine synthase. The following provides an overview of five 
enzymes that catalyze flavin-dependent hydride transfers to pyrimidine moieties, with 
greater emphasis placed on flavin-dependent thymidylate synthase and tRNA-
dihydrouridine synthase. 
Dihydropyrimidine Dehydrogenase 
 Dihydropyrimidine dehydrogenase (DPDH) catalyzes the NADPH-dependent 
conversion of uracil or thymine to the corresponding 5, 6-dihydropyrimidine, which is the 
first step in the degradation of pyrimidines (Figure 1 - 4).3 One of the final products in 
the degradation pathway for pyrimidines is β-alanine, which is a neurotransmitter.4 
Accordingly, defects in DPDH activity in humans are associated with a number of 
neurological pathologies.5,6 
 
 
 
 
 The pyrimidine degradation pathway initiated by DPDH is also the primary 
mechanism by which the cancer therapeutic, 5-fluorouracil (5FU), is degraded in cancer 
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patients.7 This necessitates very high doses of 5FU in order for the drug to be an 
effective treatment option. In addition, the degradation of 5FU leads to fluorinated 
products that cause a number of side effects to the nervous system.8 Therefore, 
inhibition of DPDH could be used to increase the efficiency of 5FU as a cancer 
treatment while also decreasing side effects of 5FU treatment. 
Structures 
 The only DPDH structure solved to date is of the enzyme from pig liver.9 The 
enzyme is a homodimer, with each dimer containing one FMN, one FAD, and four iron 
sulfur (Fe-S) clusters (Figure 1 - 5). Each monomer is composed of five domains – an 
FAD-containing domain, an FMN/pyrimidine-binding TIM-barrel domain, an NADPH-
binding domain, an N-terminal Fe-S cluster domain, and a C-terminal Fe-S cluster 
domain. The two flavins are located on opposite ends of the protein, and are connected 
by four Fe-S clusters. The chain of Fe-S clusters connecting the FMN and FAD of the 
homodimer are arranged such that the Fe-S clusters in the C-terminal domain of one 
monomer are used to connect the FMN and FAD/N-terminal Fe-S clusters of the other 
monomer, indicating that DPDH is only active as a dimer. 
 Structures of DPDH with pyrimidine analogs bound in the FMN/pyrimidine-
binding domain have also been determined.9,10 A comparison of the ligand-free and 
pyrimidine-bound structures shows that an active site loop closes over the pyrimidine 
binding site when a pyrimidine binds to the enzyme. The pyrimidine binds on the si-face 
of the flavin, parallel to the isoalloxazine of the FMN. Several conserved asparagines 
and a threonine hydrogen bond to the pyrimidine. A conserved active-site cysteine is 
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positioned perpendicular to the plane of the pyrimidine, on the opposite face of the 
pyrimidine from the flavin. The cysteine is proposed to protonate C5 of the pyrimidine 
upon hydride transfer from reduced FMN to C6 of the pyrimidine.3 
 The FAD binding domain is positioned adjacent to the NADPH-binding domain, 
on the opposite end of the protein from the FMN/pyrimidine binding domain. NADPH 
binds in an extended conformation in the NADPH-binding domain, with the reactive 
nicotinamide stacked against the re-face of the isoalloxazine of the FAD, poised for 
hydride transfer.10 Only small, local rearrangements accompany NADPH binding to the 
NADPH-binding domain. 
 
Figure 1 - 5. Structure of pig liver DPDH. (A) Cartoon structure of the DPDH homodimer (PDB code 
1GTH). Monomer A is depicted in blue and monomer B is depicted in red. (B) The redox centers 
and substrates in the DPDH homodimer. The C-terminal Fe-S cluster of one monomer is used to 
connect the redox centers of the other monomer. The subscripts denote which monomer the redox 
centers belong to. Figure based on ref. 3. 
A B 
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Mechanism 
 The catalytic cycle of DPDH can be broken up into half-reactions (Figure 1 - 6). 
In the reductive half-reaction, NADPH binds to the NADPH-binding domain and reduces 
the FAD of the FAD-binding domain. Using stereospecifically deuterated NADPH, it was 
shown that the pro-S hydrogen of NADPH is transferred to N5 of the isoalloxazine of the 
FAD, consistent with the structure of the NADPH-DPDH complex.11 The electrons must 
then be transferred to the FMN on the opposite end of the protein, presumably using the 
Fe-S clusters. However, titrations of DPDH with NADPH only reduced one of the flavins 
of each DPDH monomer – reduction of the Fe-S clusters or transfer of electrons to the 
second flavin of the monomer was not observed in NADPH titrations.12 In addition, the 
reduction potentials of two of the four Fe-S clusters has been estimated as ~-400 mV,13 
which is far lower than the reduction potential of the NADP/NADPH couple (-320 mV at 
pH 7, 25°C) and the potential of free flavins (-207 mV at pH 7, 25°C). Regardless, 
electrons must be transferred between the two flavins of DPDH for catalysis to occur. 
 
 
Figure 1 - 6. Catalytic cycle of dihydropyrimidine dehydrogenase. 
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 In the oxidative half-reaction, DPDH transfers the hydride from reduced FMN in 
the FMN/pyrimidine-binding domain to C6 of the pyrimidine, and C5 of the pyrimidine is 
protonated by an active site acid. The structures showed that a conserved cysteine is 
properly positioned to act as the acid that protonates C5 of the pyrimidine. Mutation of 
this cysteine to alanine in the pig liver DPDH caused a dramatic loss of activity, with the 
mutant enzyme having ~1% of the activity of the wild-type enzyme.12 5-iodouracil is also 
a mechanism-based inhibitor of DPDH that acts by alkylating the active site cysteine.14 
Secondary tritium and solvent deuterium isotope effects have also suggested that 
hydride transfer to C6 and protonation of C5 of the pyrimidine occurs in a stepwise 
manner, as opposed to the concerted manner used by some other enzymes.15 
tRNA-Dihydrouridine Synthase 
 tRNAs contain numerous modifications to the four RNA nucleobases.16 One of 
the most abundant tRNA modifications is dihydrouridine, which is found primarily in the 
D-loop of tRNAs (for which the D-loop gets its name).17 It is formed by the reduction of 
the carbon-carbon double bond of specific uracils by tRNA-dihydrouridine synthases 
(DUSs) (Figure 1 - 7).18 The biological role of dihydrouridine is currently unknown. NMR 
studies have shown that dihydrouridine increases the conformational flexibility of 
tRNA,19 suggesting that dihydrouridine might facilitate the conformational changes of 
tRNAs required when interacting with the ribosome or other binding partners. 
Supporting this idea, cold-loving organisms in general have more dihydrouridine 
whereas thermophilic organisms have less.20 Other studies have shown that tRNA 
lacking dihydrouridine is more susceptible to degradation in vivo.21 Dihydrouridine might 
therefore help protect tRNAs from degradation. 
10 
 
 
 
 
 
 
Increased levels of dihydrouridine are found in a number of cancers.22 Human 
DUS2 has been shown to be responsible for the increased dihydrouridine levels in 
pulmonary carcinogenesis23 and repression of DUS2 inhibited the growth of the 
cancerous tissues. Inhibition of DUS2 activity therefore might be useful in the treatment 
of cancer. 
Generally, several isoforms of DUS are present in most organisms, which 
selectively reduce uracils at different positions in tRNAs. In the budding yeast, 
Saccharomyces cerevisiae, there are four isoforms of DUS.24 DUS1 modifies U16 and 
U17, DUS2 modifies U20, DUS3 modifies U47, and DUS4 modifies U20A and U20B 
(Figure 1 - 8). A sequence alignment of the four yeast DUS isoforms indicates that 
DUS1, DUS2, and DUS4 are similar in size and have a similar fold, whereas DUS3 is 
much larger and has additional motifs beyond those found in DUSs 1, 2 and 4. It is 
unclear how the different isoforms of DUS recognize their appropriate sites, especially 
considering that yeast DUS2 and DUS4 recognize neighboring sites in tRNA. However, 
for DUS1, 2 and 4, when a uracil is present at a recognized site it gets converted into 
dihydrouridine.17 DUS3, on the other hand, does not modify all tRNA uracils at position 
Figure 1 - 7. The reaction catalyzed by tRNA-dihydrouridine synthase. 
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47, suggesting that it has a more complex method of recognizing tRNAs than the other 
yeast DUSs. 
Structures 
 Three structures of DUSs have been solved to date.25,26 All show similar 
architecture and domain organization. DUS has a TIM-barrel domain where the active-
site containing the redox-active FMN is located. In addition to the TIM-barrel is a C-
terminal helix bundle that might aid in tRNA recognition. 
Figure 1 - 8. Sites of tRNA modification by the four yeast dihydrouridine synthases. 
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Figure 1 - 9. Structure of T. thermophilus DUS in complex with tRNA (PDB 3B0U). Left panel, overall 
structure; right panel, active site. The TIM-barrel domain is shown in blue, the helix-bundle domain is 
shown in pink, the FMN is shown in yellow, the substrate uracil of the tRNA is shown in red, and the 
cysteine is shown in gray. 
 The co-crystal structure of DUS from Thermus thermophilus in complex with 
tRNA was recently solved.26 In the structure, the tRNA largely retains its L-shape and 
binds in the positively charged groove between the TIM-barrel and helix-bundle 
domains (Figure 1 - 9). DUS forms multiple contacts with the D- T- and anticodon arms 
of the tRNA. The reactive uracil is flipped ~180° into the active site of the enzyme, 
stacking against the isoalloxazine of the FMN. Surprisingly, an active-site cysteine was 
covalently attached to C6 of the substrate uracil in the structure. This was proposed to 
be an artifact due to heterologous expression of the enzyme under non-native 
conditions in Escherichia coli – the environment inside E. coli is much different than T. 
thermophilus from which the enzyme originated. The covalent attachment between DUS 
and the tRNA likely facilitated the determination of the structure. 
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 Curiously, some well-defined electron-density of unknown origin was present in 
the DUS-tRNA structure in the space between the substrate uracil and the inner wall of 
the active site. Yu, et al. attributed this density to an unknown cofactor that originated 
from E. coli.26 The cofactor appears to be important for activity – mutation of the 
residues interacting with the cofactor abolished the activity of the enzyme.26 
Mechanism 
Yeast DUS2 is the only enzyme whose mechanism has been studied in detail.27 
The catalytic cycle of yeast DUS2 can be broken up into half-reactions (Figure 1 - 10). 
In the reductive half-reaction, NADPH – which has been reported to be the reducing 
substrate for DUSs – binds to the enzyme and reduces the flavin. The reductive half-
reaction of yeast DUS2 is complex, with multiple phases – the largest of which 
corresponding to hydride transfer from NADPH to the flavin. A transient charge-transfer 
band developed with reduction of the flavin, indicating that the product, NADP+, does 
not immediately dissociate from the enzyme. Using stereospecifically-deuterated 
NADPH, it was shown that yeast DUS2 transfers the pro-R hydrogen of NADPH.27 
Reductive half-reactions with pro-R-deuterated NADPH exhibited a kinetic isotope effect 
of 3.5, indicating that hydride transfer from NADPH to the flavin is at least partially rate-
limiting. 
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In the oxidative half-reaction, reduced DUS2 reacts with tRNA, reducing the 
carbon-carbon double bond of the tRNA uracil. A single phase has been observed when 
tRNA reacts with reduced DUS2 in the oxidative half-reaction.27 Interestingly, yeast 
DUS2 reacts poorly in oxidative half-reactions with in vitro-transcribed tRNALeu-CAA. 
However, when tRNALeu-CAA isolated from a yeast DUS2 knockout strain was used 
instead, the rate constant was ~600-fold faster. This indicates that other, prior tRNA 
modifications are important for tRNALeu-CAA to adopt the correct structure to react 
rapidly with DUS2, and suggests that tRNA modifications might be ordered. 
Subsequent to, or accompanying hydride transfer from reduced FMN to C6 of the 
uracil, C5 of the uracil needs to be protonated to form dihydrouridine. An active-site 
cysteine has been proposed to be the general acid that performs this role. Mutation of 
the active-site cysteine to alanine in yeast DUS2 resulted in a massive decrease in the 
reactivity of yeast DUS2 with tRNAs.27 
 
Figure 1 - 10. The catalytic cycle of tRNA-dihydrouridine synthase. 
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Dihydroorotate Dehydrogenase 
 Dihydroorotate dehydrogenases (DHODs) are FMN-dependent enzymes that 
catalyze the oxidation of dihydroorotate (DHO) to orotate (OA) in the only redox step in 
the de novo biosynthesis of pyrimidines (Figure 1 - 11).1 DHODs can be grouped into 
two classes based on sequence similarity. Class 1 enzymes are cytosolic, and have 
been further divided into two subsclasses: Class 1A DHODs are homodimers that are 
oxidized by fumarate;28 Class 1B DHODs are α2β2 heterotetramers that contain a 2-iron-
2-sulfur cluster (2Fe-2S) and an FAD in addition to FMN, which are reoxidized by 
NAD+.29 Class 2 DHODs are membrane-associated monomeric enzymes that are re-
oxidized by membrane-bound ubiquinone.30  
 
 
 
 
 
 
 
 
 
Figure 1 - 11. The catalytic cycle of dihydroorotate dehydrogenases. 
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Figure 1 - 12. Structure of the homodimeric Class 1A DHOD from Trypanosoma cruzi (PDB 2E68). Left 
panel, overall structure of the homodimer; right panel, the active site. The FMN is shown in yellow and 
DHO is shown in magenta. 
Structures 
 Structures of all DHOD classes/subclasses have been solved. All DHODs 
contain a TIM-barrel domain where the FMN is located. Class 1A enzymes are 
homodimeric, with the TIM-barrel domains of each monomer associated through 
conserved salt bridges (Figure 1 - 12).31–36 In Class 1A enzymes, an active site cysteine 
is used as the active site base, and is positioned above C5 of orotate in the orotate-
bound complex. Co-crystal structures with fumarate indicate that the oxidizing substrate 
binds in the same pocket as DHO, with the unsaturated carbons of fumarate in close 
proximity to N5 of the flavin.  
Class 1B enzymes are α2β2 heterotretrameric enzymes. Each heterodimer of the 
α2β2 heterotetramer is composed of a PyrDb subunit and a PyrK subunit (Figure 1 - 
13).37 The PyrDb subunit is a TIM-barrel and contains the FMN used to oxidize DHO. 
An active site cysteine is used as the active site base to remove the C5 proton of DHO. 
The PyrK subunit contains a 2Fe-2S cluster and an FAD. The 2Fe-2S cluster is 
17 
 
positioned between the FMN and FAD of the heterodimer. NAD+ is believed to bind with 
the nicotinamide near the isoalloxazine of the FAD to allow reduction of NAD+ to NADH. 
The 2Fe-2S cluster is assumed to play a role in electron transfer between the two 
flavins.  
 
Figure 1 - 13. Structure of one heterodimer of the Class 1B DHOD from Lactococcus lactis (PDB 1EP2). 
Top panel, the overall structure of one heterodimer; bottom panel, the redox centers and OA in the 
heterodimer. The PyrDb subunit is shown in green; the PyrK subunit is shown in cyan; FMN is shown in 
yellow; OA is shown in magenta; FAD is shown in gray; the 2Fe-2S cluster is shown in orange. 
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Figure 1 - 14. Structure of human Class 2 DHOD (PDB 1D3G). The TIM-barrel domain is shown in green; 
the N-terminal extension that associates with the membrane is shown in cyan; FMN is shown in yellow; OA 
is shown in magenta. 
Class 2 DHODs contain, in addition to the TIM-barrel, an N-terminal extension 
that is responsible for associating the protein with the membrane (Figure 1 - 14).38–43 
The N-terminal domain sits on top of the TIM-barrel domain and helps form a tunnel 
leading to the isoalloxazine of the flavin. This tunnel is proposed to be the ubiquinone 
binding site (ubiquinones are embedded in the membrane). An active site serine sits 
above the pyrimidine binding site, well-positioned to serve as the active site base. A 
hydrogen bonding network connects the active site serine to bulk solvent, which has 
been proposed to help activate the serine as a base.44 
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Mechanism 
 The catalytic cycle of DHODs can be broken up into half-reaction (Figure 1 - 11). 
In the reductive half-reaction, DHO reduces the FMN, with OA being made in the 
process. In the oxidative half-reaction, the electrons obtained from DHO are transferred 
to fumarate in Class 1A DHODs, NAD+ in Class 1B DHODs, and ubiquinone in Class 2 
DHODs. 
 Most of the mechanistic work on DHODs has focused on the reductive half-
reaction. In the reductive half-reaction, two things must ultimately be accomplished – 
hydride transfer from C6 of DHO to N5 of oxidized FMN and removal of the proton from 
C5 of DHO. These two events can occur simultaneously (a concerted mechanism) or in 
a stepwise manner. Kinetic isotope effects have been used to probe the two possible 
mechanisms in the different classes of enzymes. Isotope effects on steady-state assays 
indicated that the Class 2 DHOD from bovine liver45 and the Class 1B DHOD from 
Clostridium oroticum46 use a concerted mechanism, while the Class 1A DHOD from 
Crithidia fasciculata47 uses a stepwise mechanism. However, isotope effects on the 
reductive half-reaction indicated that a concerted mechanism is used by the Class 1A 
DHOD from Lactococcus lactis48 and the Class 2 enzyme from humans and Escherichia 
coli49 use either a stepwise mechanism or a concerted mechanism with tunneling. It is 
unclear why the conclusions from steady state and oxidative half-reaction experiments 
produced contradictory mechanisms. However, it could suggest that the mechanism of 
DHO oxidation by DHODs is not identical amongst enzymes of the same Class. 
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 Little is known about the mechanism of the oxidative half-reaction of DHODs. 
The Class 1A DHODs use fumarate as the oxidizing substrate. A study on the Class 1A 
enzyme from Enterococcus faecalis showed that fumarate binds weakly to the reduced 
form of the enzyme, and flavin oxidation by fumarate is rate-determining for the entire 
catalytic cycle.50 The Class 1B enzymes use NAD+ as the oxidizing substrate. The 
oxidative half-reaction of Class 1B DHOD has not been studied in detail. Presumably, 
the electrons obtained from DHO get transferred to the FAD through the 2Fe-2S cluster, 
and then get transferred to NAD+. The oxidative half-reaction of Class 2 DHODs is 
difficult to study due to the low solubility of ubiquinone. However, short-chain ubiquinone 
analogs have been shown to rapidly oxidize the reduced FMN of Class 2 DHODs.51,52 
Flavin-Dependent Thymidylate Synthase 
 All organisms must replicate and maintain their DNA to survive. Thymidylate − an 
essential precursor for the biosynthesis of DNA − is formed by the reductive methylation 
of 2’-deoxyuridine-5’-monophosphate (dUMP) to form 2’-deoxythymidine-5’-
monophosphate (dTMP) by thymidylate synthases. For decades, de novo biosynthesis 
of dTMP was thought to be catalyzed solely by the classical thymidylate synthases 
which do not use a prosthetic group. Classical thymidylate synthases are arguably one 
of the most thoroughly understood enzymes.53 
 Analysis of genomic databases showed that many organisms lacked the genes 
for classical thymidylate synthase, but were still capable of growing on dTMP-depleted 
media.54,55 In 2002, a new class of enzymes was discovered in these organisms which 
synthesized dTMP with the help of a flavin adenine dinucleotide (FAD) prosthetic group; 
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these enzymes are called the flavin-dependent thymidylate synthases (FDTSs).54,56 
FDTSs are encoded by the thyX gene. 
 Since the discovery of FDTS, numerous studies have shown that FDTSs have a 
novel sequence, structure, and mechanism that is unrelated to classical thymidylate 
synthases. Classical thymidylate synthases are homodimers that use (R)-N5,N10-
methylene-5,6,7,8-tetrahydrofolate (CH2THF) as both the methylene donor and 
reductant in the conversion of dUMP to dTMP, making dihydrofolate (DHF) in the 
process (Figure 1 - 15).57 The DHF is then converted back into CH2THF by the enzymes 
dihydrofolate reductase and serine hydroxymethyltransferase. In contrast, FDTSs use 
CH2THF only as the methylene donor and use reducing equivalents from an external 
reductant – widely assumed to be NADPH – to synthesize dTMP from dUMP, leaving 
the folate as tetrahydrofolate (THF).57,58 The FAD prosthetic group of FDTS is used to 
shuttle electrons from the reductant to dTMP, cycling between oxidized (FAD) and 
reduced hydroquinone (FADH2) redox states. Usually, organisms that rely on FDTS for 
dTMP biosynthesis also lack the gene for dihydrofolate reductase. DHF is generated 
only in dTMP biosynthesis, so the reductase is only needed in organisms that use the 
classical thymidylate synthase.59 
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  Classical thymidylate synthase and FDTS are generally mutually exclusive 
throughout nature; however some organisms contain genes for both enzymes.60 It is 
unclear why some organisms contain genes for both thymidylate synthases. FDTS is 
only found in microorganisms and is overrepresented in hyperthermophilic, 
microaerophilic, and anaerobic microorganisms.60 This could be due to the high 
NADPH-oxidase activity of FDTS,61,62 which would wastefully consume NADPH in an 
aerobic environment. However, FDTS is present in several mesophilic and aerobic 
microorganisms as well, indicating that environmental factors alone do not explain the 
phylogenetic distribution of classical thymidylate synthase and FDTS. Escartin et al. 
showed that the use of FDTS limits the genome size of organisms compared to 
organisms that use classical thymidylate synthase due to the relatively low catalytic 
efficiency of FDTS,63 suggesting an evolutionary need for the more prolific classical 
thymidylate synthase in higher organisms. Notably, a number of human pathogens 
(e.g., Mycobacterium tuberculosis and Helicobacter pylori) use FDTS to synthesize 
dTMP whereas humans use classical thymidylate synthase. Since dTMP biosynthesis is 
Figure 1 - 15. Overall reactions catalyzed by classical thymidylate synthase and flavin-dependent 
thymidylate synthase. 
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essential for DNA replication, the unrelated structure and mechanism of FDTS relative 
to classical thymidylate synthase makes FDTS a promising candidate for the 
development of novel antibiotics. However, a thorough understanding of the mechanism 
and structure of FDTS is essential for the rational design of FDTS inhibitors.  
Structures 
The first structure of FDTS was solved by a structural genomics group about the 
same time its function was discovered.56,64,65 FDTS is a tetramer with a unique fold, 
unrelated to classical thymidylate synthase or any other protein (Figure 1 - 16). The 
tetramer binds four FAD prosthetic groups that are oriented with the AMP moieties in 
the core of the protein and the isoalloxazines in solvent-exposed cavities near the 
surface of the tetramer. There are four active sites per tetramer, each of which consists 
of side chains provided by three of the four subunits as well as the isoalloxazine of an 
FAD. In the structure without bound ligands the positions of the isoalloxazines are not 
well defined and loop 86-97 (T. maritima FDTS numbering) is disordered. The active 
site becomes more ordered with dUMP (or one of its analogs) bound in an enclosed 
pocket partially composed of loop 86-97, with the uracil of dUMP stacked against the re-
face of the isoalloxazine of FAD (Figure 1 - 17). Time-resolved fluorescence of FDTS 
from T. maritima showed that the isoalloxazine environment is much more dynamic 
when dUMP is not bound in the active site.66 
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Figure 1 - 16. Quaternary structure of the FDTS homotetramer (PDB 1O26). Four FADs (yellow) lie in the 
groove between the four subunits. 
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 An outstanding question from the available structural information is how the 
methylene gets transferred from CH2THF to dUMP given how the isoalloxazine is 
stacked directly against the uracil of dUMP with no access for CH2THF. Recently, 
several structures of T. maritima FDTS in complex with dUMP and CH2THF or its 
analogues were solved.67 In these structures the folates are bound on the si-face of the 
isoalloxazine, sandwiched between the isoalloxazine and a conserved active-site 
histidine (H53 in T. maritima) (Figure 1 - 18A) while the positions of dUMP and FAD are 
unperturbed compared to the structures without folates. Mutagenesis has confirmed the 
importance of this conserved histidine for FDTS activity.67–69 The position of CH2THF 
and its analogues in these structures conflicts with the required chemistry since dUMP 
and CH2THF must come into contact with each other for methylene transfer, which 
Figure 1 - 17. dUMP binding site of FDTS (PDB 1O26). dUMP is shown in cyan and the flavin is shown 
in yellow. In the mechanism proposed in Figure 1 - 20D, R90, R174, and the phosphate of dUMP 
stabilize the enolate resonance form of the uracil of dUMP. 
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would be impossible because the isoalloxazine is in between the two substrates. A 
recent report on an enzyme catalyzing apparently related chemistry, FAD/Folate-
dependent tRNA methyltransferase, indicated that the flavin of that enzyme transfers 
the methylene from CH2THF to dUMP through an adduct with N5 of the reduced 
flavin.70 It is unlikely that the flavin plays a similar role in FDTS, though, because 
enzyme containing 5-carba-5-deaza FAD is still active.71 The structures of E144R and 
R174K T. maritima FDTS mutants and the structure of Paramecium bursaria chorella 
virus-1 (PBCV-1) FDTS72 show the isoalloxazine in an alternate conformation, where 
the isoalloxazine is rotated and stacked against H53 (Figure 1 - 18B). Koehn and 
coworkers argued that this alternate conformation of the isoalloxazine would allow 
CH2THF to bind in the crevice between the isoalloxazine and dUMP, facilitating 
methylene transfer from CH2THF to dUMP.
67 They were able to model the iminium form 
of CH2THF into the position vacated by the isoalloxazine when it moves to the alternate 
conformation. The iminium was then well-positioned to react with C5 of dUMP. 
However, to date no structures have been solved with CH2THF productively bound on 
the si-face of the isoalloxazine, between the isoalloxazine and dUMP.  
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Figure 1 - 18. CH2THF binding site and an alternative FAD conformation in T. maritima FDTS. (A) 
CH2THF (salmon) has been shown to bind in the pocket between the isoalloxazine of FAD (yellow) and a 
conserved histidine (orange) (PDB 4GT9). This cannot be a reactive conformation since the isoalloxazine 
is between CH2THF and dUMP (cyan). (B) In two mutant enzyme structures – E144R (PDB 4GTD) and 
R174K (PDB 4GTL) – the isoalloxazine (yellow) is in a different conformation, stacked against the 
conserved histidine (orange). In this conformation, CH2THF could bind next to dUMP to allow methylene 
transfer. 
A 
B 
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Interestingly, a structure of PBCV-1 FDTS with a bound inhibitor, 2-hydroxy-3-(4-
methoxybenzyl)-1,4-napthoquinone (C8-C1), has been solved where the inhibitor is 
bound on the si-face of the isoalloxazine.73 The 1,4-napthoquinone moiety stacks 
against the isoalloxazine, partially overlapping with the putative dUMP binding pocket 
while the 4-methoxybenzyl moiety exits towards the surface of the protein. It is tempting 
to speculate that CH2THF might bind in a similar orientation in the Michaelis complex 
since the pteridine and para-aminobenzoyl moieties of CH2THF share structural 
similarities with the 1,4-napthoquinone and para-methoxybenzyl moieties of C8-C1, 
respectively. 
 The binding site for pyridine nucleotides is still unknown. The only structure with 
a pyridine nucleotide bound is an artifact – in the structure with NADP+ bound to M. 
tuberculosis FDTS, NADP+ displaced the FAD prosthetic group.74 However, the 
nonproductive folate binding site may very well be the site for pyridine nucleotide 
binding. Kinetic studies have shown that NADPH and folates compete for the same 
binding site.67 Pyridine nucleotides can also be easily accommodated in the folate 
binding site. 
Chemical Mechanism 
Like most flavoenzymes, the catalytic cycle of FDTS can be divided into half-
reactions (Figure 1 - 19). In the reductive half-reaction, NADPH (or another reductant) 
reacts with the oxidized FAD of FDTS to reduce the flavin to the hydroquinone. In the 
oxidative half-reaction, the FADH2 of FDTS reacts with dUMP and CH2THF – flavin 
oxidation requires both substrates.75 The methylene is transferred from CH2THF to 
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dUMP and electrons are transferred from FADH2 to make dTMP, THF, and oxidized 
FAD.  
 
 
 
 
 
 
 
 
Reductive Half-Reaction with NADPH 
 Reduced flavin is required to synthesize dTMP by FDTS.54,64,75 When FDTSs 
were first discovered, it was shown that they strictly required NADPH/NADH for 
catalysis but had only a slight preference for NADPH over NADH.54,64 Still, NADPH is 
widely assumed to be the physiological reductant that reduces the flavin. However, 
there are certain features of the reaction of NADPH with oxidized FDTS that are 
unusual, raising questions about its role as the physiological reductant. For one, the 
reaction of NADPH with Campylobacter jejuni FDTS under anaerobic conditions is 
extremely slow, taking nearly an hour to complete.62 While the equivalent reaction of 
NADPH with Thermotoga maritima FDTS occurs quickly, taking seconds to complete, T. 
Figure 1 - 19. Catalytic cycle of FDTS. The catalytic cycle can be divided into half-reactions. In the 
reductive half-reaction, NADPH reduces the FAD prosthetic group of FDTS. In the oxidative half-reaction, 
the reduced FAD of FDTS reacts with dUMP and CH2THF to make dTMP and THF. 
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maritima FDTS shows little preference for NADPH or NADH, which is unusual for 
flavoenzymes that use pyridine nucleotides as their physiological reductant.62 Also, the 
Kd determined for NADPH binding to oxidized FDTS is ~1 mM − unusually weak binding 
for flavoenzymes that use pyridine nucleotides as reductants. T. maritima FDTS 
surprisingly exhibits lax stereochemistry in the hydride transfer from NADPH, 
abstracting 68% of the proR hydride when using [4R-2H]NADPH and 8% of the proS 
hydride when using [4S-2H]NADPH in the reductive half-reaction.62 The hydride transfer 
reactions of pyridine nucleotides are always extremely stereospecific; there are no 
reports of other enzymes with lax stereochemistry in hydride transfer. Taking these 
points into consideration, it is conceivable that pyridine nucleotides are not the 
physiological reductant for FDTSs, but a better reductant has yet to be identified.  
Oxidative Half-Reaction with dUMP and CH2THF 
 Much of the work on FDTS has focused on the chemical mechanism for the 
formation of dTMP in the oxidative half-reaction. A number of mechanisms have been 
proposed (Figure 1 - 20). This section reviews the evidence supporting and 
contradicting each of these mechanisms. 
Classical Thymidylate Synthase 
When FDTSs were first discovered it was considered that they use a mechanism 
similar to classical thymidylate synthases, except that the reducing equivalents came 
from NADPH (via the flavin) instead of THF.54 In classical thymidylate synthase, a 
conserved active-site cysteine covalently activates the uracil of dUMP by a Michael-like 
addition to C6 of the uracil ring (Figure 1 - 20A). The resulting enolate allows C5 of the 
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uracil to act as a nucleophile, which attacks the iminium form of CH2THF, forming an 
adduct between the enzyme, dUMP, and CH2THF. Upon deprotonation of C5, THF is 
eliminated, leaving an exocyclic methylene deoxynucleotide intermediate still covalently 
bound to the enzymatic cysteine. Finally, a hydride is transferred from THF to C7 of the 
intermediate, making DHF and eliminating the active-site cysteine, completing the 
catalytic cycle. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 - 20. Thymidylate synthase chemical mechanisms. (A) The chemical mechanism of classical 
thymidylate synthase.
53
 (B) A proposed mechanism for FDTS involving an active-site serine nucleophile.
68
 (C) A 
proposed mechanism for FDTS where dUMP is activated by hydride transfer from reduced FAD.
71
 (D) A 
proposed mechanism for FDTS where dUMP is activated by the electrostatically polarizing active site.
78
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Serine as the Activating Nucleophile? 
 The structure of FDTS showed that there is no active-site cysteine available to 
activate dUMP.65 However, a conserved active-site serine was proposed to serve as the 
enzymatic nucleophile in place of cysteine. Mutagenesis studies on the FDTS from H. 
pylori showed that when the conserved active-site serine (S84; S88 in T. maritima) was 
mutated to alanine the enzymatic activity was diminished, but still present.68 The 
authors argued that a neighboring serine (S85) was able to rescue the S84A mutant by 
serving as an alternative nucleophile to activate dUMP. Indeed, when a double-mutant 
S84A/S85A was used all activity was lost. In addition, they also detected a covalent 
adduct between dTMP and FDTS when an S84C mutant was used. Unlike in classical 
thymidylate synthase, this adduct did not contain the folate of CH2THF. The authors 
claimed that these results suggest that FDTS uses a mechanism (Figure 1 - 20B) 
analogous to that of classical thymidylate synthase where an active-site serine 
covalently activates dUMP through Michael addition at C6. At the end, hydride transfer 
from reduced FAD instead of THF would make dTMP and eliminate the serine adduct, 
completing the catalytic cycle. 
 The use of a conserved active-site serine as the activating nucleophile was met 
with some skepticism since the proposed serine is poorly positioned for nucleophilic 
attack of dUMP in the crystal structures of FDTS – the serine is 4 Å away from C6 of 
dUMP and is parallel to the ring instead of perpendicular to it, which would be required 
for Michael-like addition. Also, no covalent complexes between 5-fluoro-dUMP and wild-
type FDTS have been detected when using 5-fluoro-dUMP in place of dUMP during 
catalysis. A covalent adduct between 5-fluoro-dUMP, CH2THF, and an active site 
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cysteine in classical thymidylate synthase was strong evidence supporting covalent 
activation.76  
Koehn et al. performed mutagenesis studies on the FDTS from T. maritima 
similar to those done on the enzyme from H. pylori.71 Surprisingly, the S88A mutant 
(S88 is the homologous putative nucleophile in T. maritima FDTS) retained significant 
activity and unlike in H. pylori FDTS, T. maritima FDTS does not have an adjacent 
serine, indicating that S88 does not activate dUMP.  
Activation by Other Nucleophiles? 
Since the active-site serine of FDTS was ruled out as a nucleophile, other groups 
have been considered. N5 of FAD is proposed to act as a nucleophile in the 
flavoenzymes UDP-galactopyranose mutase77 and FAD/folate-dependent tRNA 
methyltransferase.70 In the crystal structures of FDTS, N5 of FAD is positioned 3.5 Å 
away from C6 of dUMP, perpendicular to the plane of the uracil. Therefore, N5 of FAD 
could conceivably act as a nucleophile in FDTS. However, FDTS containing 5-carba-5-
deaza FAD where the N5 nitrogen is replaced by a methylene was still oxidized by 
dUMP and CH2THF, indicating that N5 of FAD cannot be the nucleophile.
71  
The only other potential nucleophiles in the crystal structure of FDTS are the 
phosphate oxygens of dUMP. dUMP is in an unusual conformation where the 
phosphate of dUMP is curled back towards the uracil moiety of dUMP (Fig. 1 - 17). This 
was also ruled out in stopped-flow studies showing that 2’-deoxyuridine 5’-
monoposphorothioate (dUMP-S) reacts ~10-fold slower with FDTS than dUMP.78  Since 
sulfur is more nucleophilic than oxygen, dUMP-S should be a better substrate than 
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dUMP if the phosphate oxygen serves as the nucleophile towards C6. Excluding the 
possibility of large conformational changes, no other groups in the active site could 
serve as a covalent activator of dUMP – indicating that there is no nucleophile in FDTS 
catalysis.  
Activation by Hydride Transfer? 
 To probe the mechanism further, Koehn et al. followed the flow of hydrogens by 
monitoring the position of label incorporation using 1H and 2H NMR in multiple-turnover 
reactions in D2O.
71 Since N5 of reduced FAD can exchange with solvent in FDTS, D2O 
could be used to label dTMP.58 dTMP was deuterated exclusively at position C7 when 
the reaction was carried out at 65°C (close to the physiological temperature of T. 
maritima). Surprisingly, when the reaction was performed at 37°C, deuterium was 
incorporated at both C6 (60%) and C7 (40%) of dTMP. The authors argued that the only 
way deuterium could be found at C6 would be from direct hydride transfer from reduced 
FAD to dUMP. These findings led them to suggest the mechanism shown in Figure 1 - 
20C. In this mechanism, dUMP is initially activated by direct hydride transfer from 
reduced FAD. The resulting enolate attacks the iminium form of CH2THF, forming an 
adduct between dUMP and CH2THF. Upon deprotonation of C5, the adduct eliminates 
THF forming an exocyclic methylene tautomer of dTMP. This intermediate would then 
undergo an enzyme-catalyzed 1, 3-hydride shift where a hydride is transferred from C6 
to C7, forming dTMP and explaining the distribution of deuterium between C6 and C7.  
 Several experiments show that hydride transfer does not occur until after 
activation of dUMP and transfer of the methylene from CH2THF. 5-fluoro-dUMP and 
35 
 
CH2THF do not oxidize reduced FDTS.
75 The fluoro substituent would not prevent 
hydride transfer from reduced flavin, but would prevent the breakdown of a nucleotide-
folate adduct. The uncleavable C-F bond therefore must block the reaction sequence 
before redox chemistry takes place. Recent work directly monitoring the flavin 
chromophore in anaerobic stopped-flow experiments has shown that multiple steps 
occur prior to hydride transfer.78 Also, chemical quenching experiments showed that 
dUMP is consumed prior to flavin oxidation and dTMP is formed concomitantly with the 
redox step. These results indicate that the reaction sequence of FDTS is not initiated by 
hydride transfer from reduced FAD to C6 of dUMP, so yet another mechanism was 
needed. 
Activation by Polarization? 
 A mechanism was proposed that does not use a nucleophile to activate C6 of 
dUMP towards attacking CH2THF.
78 Instead, dUMP is activated by an electrostatically 
polarizing active site that stabilizes a polarized resonance form of the uracil moiety 
(Figure 1 - 20D). A number of FDTS crystal structures with dUMP show that dUMP 
binds in a pocket where two conserved arginines are positioned in close proximity to O4 
of dUMP (Figure 1 - 17). dUMP is also bound in an unusual curled conformation where 
two of the phosphate oxygens are positioned ~4.5 Å from N1 of dUMP. The positively 
charged arginines near O4 and the negatively charged phosphate oxygens near N1 
favor the uracil pi electrons into the polarized resonance form (Figure 1 - 19D), 
increasing the nucleophilicity at C5. The now-nucleophilic C5 then attacks the iminium 
form of CH2THF, forming an adduct. After deprotonation of C5 the adduct would 
eliminate THF, transferring the methylene to dUMP. A hydride would then be transferred 
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from reduced FAD to C6 of the intermediate. Finally, this intermediate would then 
undergo the 1,3-hydride shift to make dTMP. 
 The mechanism involving activation by polarization is consistent with most 
available data. It is additionally supported by mutagenesis studies. The reaction of 
dUMP and CH2THF with reduced R90A and R174A FDTS mutants in anaerobic 
stopped-flow experiments is ~100-fold and ~400,000-fold slower than WT, 
respectively.78 Also, deoxyuridine – which lacks the phosphate, but still binds to FDTS – 
cannot be processed by FDTS into deoxythymidine, indicating the importance of the 
phosphate in promoting catalysis by FDTS (Chapter 2). Indeed, the lower reactivity of 
dUMP-S relative to dUMP supports the role of phosphate as a polarizer since sulfur is 
less electronegative than oxygen and would, therefore, be less effective at polarizing 
dUMP. The activation of dUMP by polarization has never been proposed in pyrimidine 
enzymology. However, catalytically important polarization has been observed in 
unrelated enzymes using substrates containing α,β-unsaturated carbonyl moieties.79 
 Stopped-flow and acid quenching experiments indicated the presence of two 
transient intermediates during the reaction of reduced FDTS with dUMP and CH2THF.
78 
A separate set of acid quenching experiments using radioisotope labeling detected the 
presence of a single intermediate during the oxidative half-reaction. 5-hydroxymethyl-
dUMP, identified by mass spectrometry, was recovered from the acid-quenched 
reaction mixtures.80 This intermediate accumulated as dUMP was consumed and 
decayed with dTMP formation. The actual intermediate quenched by acid was proposed 
to be the exocyclic methylene tautomer in Figure 1 - 20C after step 3 of the hydride 
activation mechanism, which after an acid-catalyzed reaction with water and oxidation 
37 
 
by O2, would make 5-hydroxymethyl-dUMP, the recovered product. More likely, the 
intermediate would be the one depicted in Figure 1 - 20D after step 3 which has not yet 
been reduced by FADH2. This intermediate could undergo an acid-catalyzed reaction 
with water that would directly yield 5-hydroxymethyl-dUMP. Curiously, the timing of 
dUMP loss has different kinetics in the two sets of quenching experiments. Conrad et al. 
found that dUMP decayed after the first spectral intermediate formed while Mishanina et 
al. observed that dUMP decayed at the same time as the first detectable intermediate 
was formed.78,80 It is unclear what caused this discrepancy since both experiments used 
1 M HCl as the chemical quencher. Interestingly, the timing of 5-hydroxymethyl-dUMP 
detection observed by Mishanina et al. is consistent with the sum of the first and second 
intermediates detected by Conrad et al. The 5-hydroxymethyl-dUMP might therefore 
represent the acid-rearranged product of both the first and second intermediates 
detected by stopped-flow. 
 All mechanisms shown in Figure 1 - 20 predict that 5-fluoro-dUMP should form a 
covalent adduct with CH2THF and perhaps an enzymatic side chain. However, such an 
adduct has never been detected. It is unclear why this is so. One possibility is that the 
adduct between 5-fluoro-dUMP and CH2THF depicted in any of the mechanisms in 
Figure 1 - 20 is unstable when removed from the active-site environment of FDTS. It is 
also conceivable that the electronegative fluoro-substituent at C5 destabilizes the build-
up of electron density at C5 in the polarized resonance form of dUMP, preventing a 5-
fluoro-dUMP-CH2THF adduct from occurring in the first place.  
 The mechanisms shown in Figure 1 - 20 all invoke a general base to remove the 
proton from C5 of the dUMP-CH2THF adduct to facilitate methylene transfer and 
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eliminate THF. Deprotonation of C5 is clearly essential since C5 must be deprotonated 
in order to make dTMP. However, the identity of this general base is unknown. From the 
structures of dUMP complexes, the only potential base close enough is a phosphate 
oxygen of dUMP, which is 3.4 Å away from C5 (Figure 1 - 17). The phosphate oxygen is 
also on the correct face of the uracil moiety for deprotonation of C5 – opposite from the 
putative CH2THF binding site. The phosphate oxygens could therefore conceivably 
serve a dual role in stabilizing the polarized resonance form of the uracil and in 
deprotonating C5 of the dUMP-CH2THF adduct. Other active site groups cannot be 
ruled out, though, since conformational changes likely take place during dUMP-CH2THF 
adduct formation that could bring other groups in close proximity to C5.  
Kinetic Mechanism 
While progress has been made on the chemical mechanism of FDTS, there are 
still many questions about the order of substrate binding and product release during the 
catalytic cycle. Several studies have attempted to elucidate the kinetic mechanism of 
FDTSs and have found different kinetic mechanisms for enzymes from different 
organisms – most of which use a ping-pong mechanism (Figure 1 - 21).58,72,81–84 T. 
maritima FDTS has been shown to use a ping-pong mechanism and under multiple-
turnover conditions the FAD remains oxidized, indicating that reduction of the flavin is 
rate-limiting.58,61,83 PBCV-1 FDTS also uses a ping-pong mechanism for its substrates, 
with NADPH and CH2THF competing for the same binding site.
72,82 Likely, NADPH first 
binds and reduces the flavin followed by NADP+ dissociation and CH2THF binding. A 
notable deviation from the sequential binding order seen in most FDTSs is the enzyme 
from Chlamidya trachomatis which exhibits ping-pong kinetics between dUMP and 
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CH2THF.
81 Consistent with a ping-pong mechanism, THF was produced in reactions 
omitting dUMP. An active-site arginine (R477) was implicated in covalently transferring 
the methylene from CH2THF to dUMP, producing the ping-pong kinetic patterns. 
However, this result could not be replicated by other groups.67,85  A problem plaguing 
much of the published work on FDTS is the presence of O2. The reduced flavin of 
FDTS, like most flavoenzymes, reacts with O2 in a competing non-physiological side 
reaction, and the reaction of O2 with FDTS is rapid enough to compete with thymidylate 
synthesis.61,62,82,86 Unfortunately, the findings from a number of kinetic studies did not 
take into account the oxidase activity of FDTS, raising concerns about the validity of 
their findings. 
 Several studies have shown that the NADPH oxidase activity of FDTS is 
enhanced by the presence of dUMP, suggesting that dUMP binding enhances the 
hydride transfer step from NADPH to oxidized FAD 82,85,87. This could be due to the 
ordering of the active-site observed in the dUMP-bound structures compared to the 
dUMP-free structures. Since dUMP stimulates the oxidation of NADPH by FDTS, it is 
likely that dUMP binds to the oxidized enzyme prior to FAD reduction by NADPH. 
Indeed, the binding affinity of FDTS for dUMP is ~200-fold higher for the oxidized 
enzyme compared to reduced enzyme (Chapter 3). Mason and co-workers originally 
argued that the enhanced NADPH oxidase activity by dUMP binding was due to an 
initial lag-phase in the reductive half-reaction of oxidized FDTS with NADPH that 
became shorter in duration with increasing dUMP concentration.85 However, it was later 
shown that this initial lag phase was due to oxygen contamination which eventually 
became consumed in the original experiment.83 
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Figure 1 - 21. Proposed kinetic mechanisms for FDTS. Proposed kinetic mechanisms for FDTS from 
PBCV-1
72
 (A), C. trachomatis
81
 (B), T. maritima
58
 (C), and T. maritima
83
 (D). 
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 Attempts have also been made to exploit the oxidase activity of FDTS to probe 
the kinetics of substrate binding and product release for some of the ligands involved in 
the FDTS-catalyzed reaction. In reductive half-reaction experiments, Wang and co-
workers observed absorbance that developed upon FAD reduction which they attributed 
to a FADH2-NADP
+ charge-transfer complex.61 This complex decayed very slowly – with 
a rate constant of 0.00135 s-1 – which would indicate that NADP+ does not dissociate 
from FDTS prior to reacting with dUMP and CH2THF. However, the putative charge-
transfer band is not consistent with typical reduced flavin-NADP+ charge-transfer bands 
88,89, and a charge transfer complex between reduced FDTS and NADP+ has not been 
observed in reductive half-reactions or binding experiments.90 More likely, the 
absorbance from 500-800 nm attributed to a charge-transfer complex was due to minor 
protein aggregation which settled out of solution over time. Indeed, given the crowded 
active-site seen in all FDTS structures to date, it is unlikely that FAD, NADP+, dUMP, 
and CH2THF could all be in the active-site at the same time. They also found that 
CH2THF competitively inhibits the NADPH-oxidase activity of FDTS, which, they argued, 
meant CH2THF and O2 compete for the same site. More likely, CH2THF competes with 
the NADPH used in their experiments which would cause the decreased the oxidase 
activity of FDTS in the presence of CH2THF. Indeed, CH2THF and NADPH have been 
shown to compete for the same binding site.67 
Folate/FAD-Dependent tRNA Methyltransferase 
 In most tRNAs, the uracil at position 54 (U54) in the T-loop is methylated to make 
ribothymidine (T54). T54 interacts with another post-transcriptional modification, m
1A58, to 
help stabilize the L-shape of tRNAs.17 In most Gram-positive and some Gram-negative 
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bacteria, U54 is methylated by the recently discovered folate/FAD-dependent tRNA 
methyltransferase (TrmFO).91 Unlike most RNA methyltransferases, which use S-
adenosylmethionine as the methyl donor, TrmFO uses CH2THF and 2-electron reduced 
FAD (FADH¯) to methylate U54 (Figure 1 - 22). The reducing equivalents required to 
reduce the flavin are believed to come from NADPH.  
 
 
 
 
 
 
 
Structures 
 The crystal structure of Thermus thermophilus TrmFO (TrmFOTT) has been 
solved in the ligand-free form and in complex with THF (the folate product of the TrmFO 
reaction) or glutathione (Figure 1 - 23).92 TrmFOTT is composed of two domains – an 
FAD-binding domain and an insertion domain. The FAD prosthetic group is bound with 
the adenosine moiety of the FAD buried deep in the FAD-binding domain and the 
isoalloxazine in a positively-charged cleft on the surface of the protein. THF binds next 
to the isoalloxazine of the FAD in the positively-charged cleft, with the pteridin moiety 
Figure 1 - 22. The reaction catalyzed by TrmFO. 
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sandwiched between the isoalloxazine and the imidazole of a conserved histidine 
residue. tRNA docking models with a tRNA T-arm analog indicated that tRNA can fit 
along the positively-charged cleft, with the substrate uracil near the isoalloxazine of the 
flavin. In the glutathione-bound structure, glutathione forms a disulfide bond with a 
conserved cysteine (C221 in TrmFOTT) located on the opposite end of the protein from 
the flavin. It is unclear if glutathione plays a role in catalysis by TrmFO. However, 
biochemical data using a fluorouracil tRNA minihelix has suggested that the cysteine 
that forms a disulfide with glutathione is the nucleophile that initiates catalysis by 
attacking C6 of the reactive uracil moiety.93  
 
FAD 
THF 
C221 
Figure 1 - 23. Structure of TrmFOTT (PDB 3G5R). Left panel, overall structure of TrmFOTT; right panel, 
active site of TrmFOTT. The FAD-binding domain is shown in red; the insertion domain is shown in blue; 
FAD is shown in yellow; THF is shown in orange; C221, which has been proposed to be the nucleophile that 
initiates catalysis with tRNA, is shown in gray. 
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Mechanism 
 Nearly all of the mechanistic work on TrmFO has focused on deciphering the 
chemical mechanism of the enzyme, and the majority of the biochemical work has been 
done on the Bacillus subtilis enzyme (TrmFOBS). Reduced FAD is required for TrmFO to 
methylate U54 of tRNA. The physiological reductant has not been rigorously verified, 
but NADPH is at least capable of serving as the reductant.91 Studies using tRNA 
containing 5-fluorouracil (5FU tRNA), a mechanism-based inhibitor of TrmFOBS, found 
that C226 forms a covalent adduct with 5FU tRNA, suggesting that C226 is the 
nucleophile that initiates catalysis by forming a covalent adduct with C6 of the reactive 
uracil.93 C226 (C221 in TrmFOTT) is ~20 Å away from the isoalloxazine of the FAD, 
suggesting that large conformational changes must take place during TrmFO catalysis. 
Alternatively, TrmFO could dimerize when bound to tRNA, placing C226 of one 
monomer near the flavin of the other monomer. Curiously, recombinant TrmFOBS 
purifies with an air-stable flavin semiquinone.94 TrmFOBS containing the air-stable flavin 
semiquinone was able to methylate ~1 mol equivalent of tRNA in the absence of 
CH2THF and reductant, indicating that as-purified TrmFOBS co-purifies with the 
methylene and reducing equivalents as part of the enzyme. It was later shown that as-
purified TrmFOBS contained an adduct between the flavin and the conserved C53, 
bridged  by a methylene.70 Mutation of C53 to alanine completely abolished activity of 
TrmFOBS and eliminated the air-stable semiquinone, indicating the importance of this 
residue in TrmFO activity. Based on the identification of a flavin-methylene-cysteine 
adduct, Hamdane et. al. proposed a chemical mechanism where the methylene of 
CH2THF is first transferred to N5 of reduced flavin (Figure 1 - 24).
70 The thiol of C53 
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prevents the flavin-methylene intermediate from reacting with water until the tRNA uracil 
moiety is in the active site (Figure 1 - 24A). Once U54 is properly positioned in the active 
site, C53 can release the flavin-methylene intermediate to allow methylene and hydride 
transfer from FADH- to U54 to occur (Figure 1 - 24B). 
 
 
 
 
 
 
 
 
 
 
Figure 1 - 24. The chemical mechanism for tRNA methylation by TrmFOBS proposed in ref. 69. (A) The 
mechanism for the formation of the reduced FAD-methylene-cysteine adduct. (B) The mechanism for methylene 
and hydride transfer to U54 of tRNA. 
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Thesis Overview 
 The purpose of this thesis is to examine the mechanisms of substrate recognition 
and activation for flavin-dependent thymidylate synthase and tRNA-dihydrouridine 
synthase – two enzymes involving flavin-dependent hydride transfer to pyrimidines.  In 
Chapter 2, I tested a recently proposed mechanism where dUMP is activated in FDTS 
by an electrostatically polarizing active site using 13C-NMR. I find that FDTS does not 
merely stabilize a polarized resonance form of dUMP; instead, the enzyme ionizes N3 
of dUMP using an active site arginine. A modified mechanism for dUMP activation is 
proposed based on this finding. In addition, I present evidence using substrate analogs 
that suggests that the phosphate of dUMP acts as the base that deprotonates C5 of the 
dUMP-CH2THF adduct in the reaction catalyzed by FDTS. Chapter 3 looks at the 
binding of substrate and product nucleotides (dUMP and dTMP) to FDTS through a 
variety of equilibrium and kinetic methods. I show that FDTS binds nucleotides with 
~200-fold weaker affinity when the flavin is reduced relative to when it is oxidized, and 
that the differences in affinity are largely due to differences in the dissociation rate 
constant for nucleotide binding. This finding suggests that the exchange between dTMP 
and dUMP occurs when the flavin of FDTS is reduced. I also find that there is a 
temperature-dependent effect on the mechanism by which FDTS binds nucleotides – 
below 45°C the FDTS homotetramer behaves as a dimer-of-dimers with nucleotide 
binding while at temperatures above 45°C the four subunits of FDTS bind nucleotides 
identically. Chapter 4 focuses on probing the mode of tRNA recognition by yeast tRNA-
dihydrouridine synthase. In contrast with previous work on tRNALeu-CAA, I find that 
tRNAAsp, tRNAAla, and tRNAHis2 from yeast react quickly with DUS2 in the absence of 
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other tRNA modifications. Native gel electrophoresis shows that unmodified tRNALeu-
CAA oligomerizes upon refolding while the other tRNAs (unmodified tRNAAsp, tRNAAla, 
tRNAHis2, and modified tRNALeu-CAA) exist as monomers upon refolding, suggesting 
that tRNALeu-CAA requires other modifications to fold properly to react rapidly with 
DUS2. 
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Chapter 2  
Deprotonations in the Reaction of Flavin-Dependent Thymidylate Synthase‡ 
‡
The NMR spectra presented in this chapter were collected in collaboration with Erik Zuiderweg and the 
x-ray data collection and structure determination of the active site variants were performed by Steffen 
Bernard in the lab of Janet Smith. 
2’-Deoxythymidine-5’-monophosphate (dTMP) − an essential precursor for the 
biosynthesis of DNA − is formed by the reductive methylation of 2’-deoxyuridine-5’-
monophosphate (dUMP) to form dTMP by thymidylate synthases (TSs). There are 
currently two known classes of TSs. Classic TSs are homodimeric enzymes that use 
5,10-methylenetetrahydrofolate (CH2THF) as both the carbon-donor and reductant to 
form dTMP from dUMP without the use of a prosthetic group.1 Flavin-dependent 
thymidylate synthases (FDTSs), on the other hand, are tetrameric enzymes that use a 
flavin adenine dinucleotide (FAD) prosthetic group to synthesize dTMP from dUMP, 
CH2THF and NADPH.
2 Whereas the folate becomes dihydrofolate (DHF) in the classic 
TS reaction, the folate remains in the fully-reduced tetrahydrofolate (THF) state in the 
reaction catalyzed by FDTSs. The electrons required to form dTMP come from NADPH 
by way of the FAD prosthetic group in FDTSs instead of coming from the folate as in 
classic TSs. 
Classic TS has been studied for decades and its chemical mechanism is well-
understood (Figure 2 - 1A).1 Classic TS first activates dUMP through a Michael-like 
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addition of an active-site cysteine to C6 of dUMP (step 1). The resulting enolate then 
attacks the iminium form of CH2THF, forming a bridged intermediate between the 
cysteine, dUMP, and CH2THF (step 2). Upon deprotonation at C5 of the pyrimidine, the 
adduct breaks down into THF and an exocyclic methylene intermediate still covalently 
attached to the active-site cysteine (step 3). Finally, a hydride is transferred from THF to 
the methylene of the intermediate to eliminate the cysteine, forming dTMP (step 4). 
 
 
 
 
 
 
 
In contrast, the chemical mechanism of FDTS has not been fully determined. A 
major question is the mechanism of dUMP activation. Unlike classic TS, FDTS does not 
contain an active-site cysteine to activate dUMP through a Michael-like addition, and 
mutagenesis has ruled out all other potential enzymatic nucleophiles.3 Hydride transfer 
from reduced FAD has been proposed to activate dUMP;3 however, this is unlikely since 
5-fluoro-2’-deoxyuridine-5’-monophosphate (5F-dUMP) cannot oxidize reduced FDTS in 
the presence of CH2THF,
4 and stopped-flow experiments on the oxidative half-reaction 
Figure 2 - 1. Thymidylate synthase chemical mechanisms. (A) the mechanism for classic TS using an 
enzymatic cysteine nucleophile.
1
 (B) a proposed mechanism for FDTS using an electrostatically polarizing 
active site to activate dUMP.
5
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indicate multiple intermediates prior to flavin oxidation.5 The electrostatically polarizing 
active site was recently proposed to activate dUMP.5,6 In this mechanism, the 
arrangement of two arginines (R90 and R174 in Thermotoga maritima FDTS) near O4 
of dUMP and the phosphate of dUMP near N1 stabilizes the resonance form of dUMP 
shown in Figure 2 - 1B (step 1). This resonance form contains an enolate with 
nucleophilicity at C5, which attacks CH2THF, forming a bridged intermediate between 
dUMP and CH2THF (step 2). Upon deprotonation at C5 by an unidentified base, the 
bridged intermediate breaks down into THF and an exocyclic methylene intermediate 
(step 3). A hydride is then transferred from reduced FAD to C6 of the intermediate (step 
4).3 The exocyclic methylene tautomer of dTMP then undergoes a 1, 3-hydride shift to 
form dTMP (step 5). 
While the mechanism for dUMP activation presented in Figure 2 - 1B is 
consistent with most published data, it has not been completely verified. Here we used 
13C-NMR to test the hypothesis that dUMP is activated by an electrostatically polarizing 
active site. We show that polarization is more extreme than previously proposed (Figure 
1B); the enzyme actually ionizes N3 of dUMP using an active site arginine. In addition, 
we present evidence suggesting that the phosphate of dUMP acts as the general base 
that deprotonates C5 of the dUMP-CH2THF adduct in the reaction catalyzed by FDTS. 
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Experimental Procedures 
Protein Preparations  
Recombinant WT and mutant FDTSs from T. maritima were purified as 
previously reported,5 followed by formation of apo-protein by treatment with 
concentrated sodium chloride7 and reincorporation of exogenous FAD.   
Synthesis of 13C/15N-labeled dUMP and dU  
5 mg commercially obtained 13C/15N-labeled dCMP was deaminated by 
incubation with 1 M sodium nitrite in 1 mL aqueous 3 M ammonium acetate, pH 4 for 24 
hours at 37 °C. Conversion of dCMP to dUMP was confirmed by a shift in the UV/Vis 
λmax from 271 nm to 261 nm.  The 
13C/15N-labeled dUMP was purified on a Shimadzu 
HPLC with a UV/Vis diode array detector at room temperature on a 5 µm, 25 cm x 4.6 
mm Supelcosil LC-18-DB column using isocratic aqueous 10 mM ammonium acetate, 
pH 5 at 1 mL/min. The purified 13C/15N-labeled dUMP was then lyophilized three times 
to remove the ammonium acetate. When needed, 13C/15N-labeled dUMP was converted 
to dU using alkaline phosphatase and 13C/15N-labeled dU was purified using the same 
HPLC method used for dUMP. 
Synthesis of dUMS  
The protocol for dUMS synthesis was adapted from a procedure for making 
sulfated guanosine.8 134 mg sulfur trioxide-dimethylformamide complex (0.88 mmol) 
was added to a solution of 200 mg deoxyuridine (0.88 mmol) in 10 mL dry 
dimethylformamide under argon at -10 °C with stirring. After two minutes, the reaction 
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was allowed to warm to room temperature where it remained for two hours with stirring 
under argon. The reaction was then placed on ice and 1 mL saturated aqueous 
potassium bicarbonate was added with stirring. After removing the solvent by 
lyophilization, the powder was dissolved in 1 mL water and dUMS was purified from dU-
disulfate, dU-3’-monosulfate, and unreacted dU on a preparative 5 µm 250 mm x 21 mm 
NUCLEODUR®C18 Gravity HPLC column using isocratic 0.2 M ammonium acetate, pH 
5 at 5 mL/min. The ammonium acetate was then removed from purified dUMS by five 
rounds of lyophilization. 1H-NMR (400 MHz, D2O, 298 K): δ 7.67 (d, 1H), 6.12 (t, 1H), 
5.71 (d, 1H), 4.37 (m, 1H), 4.06 (m, 3H), 2,19 (m, 2H) ppm. 13C-NMR (101 MHz, D2O, 
298 K): δ 166.1, 151.4, 141.5, 102.1, 85.5, 84.4, 70.7, 67.5, 38.8 ppm. MS (ESI, neg. 
mode): [M-H]- 307. Product ion scan fragments of 307[1-]: 195, 111, 97.  dUMS was 
also observed in the crystal structure of the FDTS-dUMS complex. 
Spectrophotometric Titrations  
Spectrophotometric titrations were performed on a Shimadzu UV-2501PC 
scanning spectrophotometer at 25 °C. ~16 µM enzyme in 0.1 M Tris-HCl pH 8 was 
titrated with ligand in the same buffer. Absorbance spectra were recorded after each 
addition. The change in flavin absorbance due to ligand binding was plotted against 
ligand concentration. For weak or moderate binding the data were fit to a square 
hyperbola in KaleidaGraph to determine the Kd. When binding was tight, data were fit to 
Eq. 1, where Δεmax is the maximum change in extinction coefficient, E0 is the initial 
enzyme concentration, and L0 is the ligand concentration. 
        [
          √(        )       
 
]      
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Reactions of dU and dUMS with FDTS  
Experiments testing the reactivity of dU and dUMS with FDTS were performed in 
anaerobic cuvettes9 and monitored in a scanning spectrophotometer. Cuvettes were 
made anaerobic by repeated cycles of vacuum and equilibration with anaerobic argon. 
~80 µM FDTS in 0.1 M Tris-HCl pH 8 at 25 °C was anaerobically titrated with ~30 mM 
dithionite in the same buffer until the flavin was completely reduced. 200 µM CH2THF 
(after mixing) was added, followed by addition of either 10 mM dU or 200 µM dUMS 
(after mixing). No oxidation of the flavin occurred over four hours with either dU or 
dUMS. The flavin could then be reoxidized by exposure to air. 
After air exposure, the reduced FDTS-dUMS-CH2THF sample was treated with 1 
M HCl to denature the protein. The precipitated protein was removed by centrifugation 
and the pH of the supernatant was raised to ~5 by adding 10 mM ammonium acetate 
and titrating with 10 M NaOH. The supernatant was then analyzed by HPLC using a 5 
µM, 25 cm x 4.6 mm Supelcosil LC-18-DB column with 1 mL/min flow rate. A 0 to 10 
minute, 0 to 50% methanol gradient was used in 10 mM ammonium acetate, pH 5, 
followed by 15 minutes of isocratic 50% methanol in the same buffer. No new 
compounds were detected in the sample (i.e., only reactant or flavin-derived peaks were 
detected). 
13C-NMR Spectroscopy  
All 13C-NMR spectra of enzyme complexes were acquired on a Varian/Agilent 
600 MHz NMR spectrometer equipped with a 1H-15N-13C triple resosance cryo-probe 
and cryogenic 13C preamplifier in 50 mM Tris-HCl, pH 8, 0.2 % sodium azide, 10 % 
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D2O, at 45 °C using 5 mm NMR tubes. Protons were decoupled during data acquisition. 
Peak assignments were obtained from 13C-1H, 1H-1H 13C-13C and 15N-13C-1H chemical 
shift correlation spectra of the unbound nucleotide. 500 µM 13C/15N-labeled dUMP or dU 
and 1.5 mM enzyme were used for the WT and mutant FDTS-ligand complexes. Data 
were processed using MestReNova. The 13C-NMR spectrum of the 12C dUMP-FDTS 
complex was subtracted from the spectra of the 13C-labeled complexes to remove the 
resonances associated with the protein. For the reduced FDTS-dUMP complex, the 
flavin was reduced by addition of 10 mM glucose-6-phosphate and catalytic amounts of 
glucose-6-phosphate dehydrogenase and NADPH in an anaerobic chamber. The 
sample was placed in an NMR tube, capped with an anaerobic septum, and removed 
from the anaerobic chamber for data collection. The sample was pale yellow throughout 
the data collection, indicating that the flavin remained reduced. Spectra for the 
uncomplexed ligands were acquired separately. The sample for unbound dUMP at pH 
12 was acquired in 50 mM sodium phosphate buffer, 0.2 % sodium azide, 10% D2O. 
Crystallization and Structure Determination  
Crystals of FDTS were grown under previously reported conditions using the 
sitting drop vapor diffusion method.10  For the R90A FDTS-dUMP, R174A FDTS-dUMP, 
and WT FDTS-dU complexes, crystals were grown by mixing protein-ligand stock 
solution (10 mg/mL FTDS variant, 20 mM dU(MP)) in 10 mM Tris-HCl, pH 7.9 with 40-
50 % PEG 200, 0-150 mM NaCl and 100 mM Tris-HCl, pH 8.0 at a 1:1 ratio.  The 
R174A crystals were grown by streak seeding of WT FDTS-dUMP crystals with an 
eyelash into a pre-equilibrated drop containing R174A FDTS and dUMP in the 
crystallization solution.  Crystals were flash frozen in liquid N2 without additional 
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cryoprotection.  Crystals of the FDTS-dUMS complex (stock solution containing 10 
mg/mL FDTS and 5 mM dUMS in 10 mM Tris-HCl, pH 7.9) were grown in 7 % PEG 4K, 
100 mM NaCl, 100 mM Na/K phosphate, pH 6.6.  The crystals were serially transferred 
to solutions of increasing PEG 4K and glycerol to a final concentration of 24 % PEG 4K, 
10% glycerol, 200 mM NaCl, 100 mM Na/K phosphate, pH 6.6 before being flash frozen 
in liquid N2. 
Diffraction data were collected at the General Medical Sciences and Cancer 
Institutes Structural Biology Facility at the Advanced Photon Source (GM/CA at APS) on 
beamline 23ID-D.  The data were processed in HKL2000,11 XDS12 or MOSFLM13 . A 
single chain of FTDS (PDB ID 4GT9) was used for molecular replacement in MolRep14 
and iterative rounds of model building in Coot15 and refinement in Refmac16 were used 
to generate the final model.  TLS groups were identified using the TLSMD server.17 
Restraints for 2′-deoxyuridine-5′-monosufate were generated using the GRADE 
server.18  An additional copy of FAD was observed near the active site in the FTDS-
dUMS complex, the adenine portion is disordered and crosses a crystallographic 2-fold 
axis so riboflavin was built in place of FAD.  The final models were validated with 
MolProbity.19 
Results 
The mutant enzymes studied here were selected because a mechanism was 
proposed where dUMP is activated as a nucleophile by three charged groups in the 
active site of FDTS oriented around polar ends of the uracil ring – R90, R174, and the 
phosphate of dUMP (Figure 2 - 2).5 These groups enhance the contribution of the 
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enolate resonance form of the uracil ring, increasing nucleophilicity at C5 (Figure 2 - 
1B). Mutagenesis supported this idea; the rate constants for flavin oxidation of the R90A 
mutant and the R174A mutant were 8-fold and 3000-fold smaller, respectively, than 
wild-type FDTS in oxidative half-reactions with dUMP and CH2THF.  
 
Binding  
A large change in the flavin UV/visible absorbance spectrum of oxidized WT 
FDTS occurs upon binding of dUMP (Figure 2 - 3A) – the extinction coefficients for the 
peaks at 375 nm and 450 nm increase and decrease, respectively. This spectral change 
can be used to track dUMP binding in titrations, allowing the dissociation constant of 
Figure 2 - 2. Active site of flavin-dependent thymidylate synthase (PDB code: 1O26). In the 
mechanism shown in Figure 2 - 1B, the arrangement of R90, R174, and the phosphate of dUMP 
(cyan) are proposed to stabilize an alternate resonance form of dUMP with enhanced nucleophilicity at 
C5. Also, note the close proximity of the phosphate oxygens to C5 of the uracil. 
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dUMP for FDTS to be determined. dUMP bound stoichiometrically to WT FDTS, 
providing only an estimate of the Kd of 30 nM (Table 2 - 1). 2’-deoxyuridine (dU) – which 
lacks the 5’ phosphate group – induces a similar change as dUMP in the flavin 
absorbance spectrum of WT FDTS upon binding to the enzyme (Figure 2 - 3B). The 
dissociation constant for dU binding to oxidized WT FDTS was 78 µM (Table 2 - 1). The 
R90A mutant and the R174A mutant bound dUMP with dissociation constants of 14 µM 
and 110 µM, respectively (Table 2 - 1). The flavin spectral change upon binding of 
dUMP to the R90A mutant was similar to dUMP binding to WT FDTS (Figure 2 - 3C). 
However, the spectral change in the flavin of the R174A mutant was clearly different 
from the rest of the mutants tested (Figure 2 - 3D) – the 450 nm peak blue-shifted 
slightly and the extinction coefficient of the 450 nm peak decreased upon binding 
dUMP. 
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Figure 2 - 3. Spectrophotometric titrations of WT FDTS with dUMP (A) and dU (B) and R90A FDTS (C) 
and R174A FDTS (D) with dUMP in 0.1 M Tris-HCl, pH 8 at 25 °C. The insets show the change in 
absorbance as a function of ligand concentration. The spectral change for dUMP binding to R174A FDTS 
was noticeably different from other FDTS variants. Fitting to Eq. 1 gives a Kd of 30 nM for dUMP binding 
to WT FDTS. Fitting to a square hyperbola gives a Kd of 78 µM for dU binding to WT FDTS, and 14 µM 
and 110 µM for dUMP binding to R90A and R174A FDTS, respectively. 
Table 2 - 1: Ligand Binding to WT and Mutant FDTSs 
enzyme + ligand complex Kd (µM)
a 
WT + dUMP 0.03 ± 0.02b 
WT + dU 78 ± 5 
R90A + dUMP 14 ± 2 
R174A + dUMP 110 ± 10 
WT + dUMS 0.17 ± 0.08b 
a0.1 M Tris-HCl, pH 8 at 25 °C. 
bEstimate from Fitting to Equation 1. 
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NMR  
We probed polarization by comparing the 13C-NMR spectra of 13C/15N-labeled 
dUMP in aqueous solution at pH 8 with 13C/15N-labeled dUMP bound to FDTS. Due to 
the size of the enzyme tetramer (110 kDa), we were unable to perform multinuclear 
NMR experiments on the complex. Instead, we collected 1-dimensional 13C-NMR 
spectra of labeled dUMP bound to WT FDTS (Figure 2 - 4). Spectra were recorded at 
45 °C to minimize peak broadening due to chemical shit anisotropy. We used an excess 
of FDTS over dUMP, well above the Kd of dUMP, to ensure that the signals resulted 
from dUMP bound to the enzyme. The resonances associated with the protein were 
subtracted from the 13C-NMR spectra of the 13C-labeled dUMP-FDTS complexes by 
using the spectrum of the unlabeled complex. The peaks associated with dUMP in the 
ligand-protein complex were substantially broadened, confirming binding.  
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Table 2 - 2: Chemical Shifts for Uracil Carbonsa 
  C2 (ppm) C4 (ppm) C5 (ppm) C6 (ppm) 
unbound dUMP pH 8 152.7 167.6 102.8 142.3 
unbound dUMP pH 12 159.7 177.2 103.2 140.7 
dUMP + WT 160.5 176.4 103.9 141.2 
dUMP + R174A 152.6 167.9 103.2 144.4 
dUMP + R90A 160.3 177 103.7 140.7 
dU + WT 160.4 176.6 104.3 138.8 
a45°C, pH 8 unless stated otherwise. 
 
 
Figure 2 - 4. The 
13
C-NMR spectra of uracil carbons of dUMP/dU free in solution or bound to WT and 
mutant FDTSs at 45°C. All of the ligand-FDTS complexes were at pH 8. The C4 andC2 signals for dUMP 
shifted upfield ~8 ppm when bound to WT FDTS, having nearly identical chemical shifts as free dUMP at 
pH 12. Mutation of R174 – which is 2.8 Å from N3 of dUMP in the dUMP-WT FDTS structure – to alanine 
eliminated the changes in chemical shifts of the dUMP-FDTS complex. In contrast, mutation of R90 to 
alanine or removal of the phosphate of dUMP had little effect on the 
13
C-NMR spectrum of the uracil 
carbons in the complex. Highlighted in yellow and blue, respectively, are the chemical shifts of the 
carbonyl carbons of N3-ionized and N3-unionized uracil. 
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Binding of dUMP to WT FDTS produced substantial changes in the 13C chemical 
shifts of the uracil ring (Figure 2 - 4 and Table 2 - 2). Most notably, the 13C-NMR signals 
of the two carbonyl carbons, C2 and C4, shifted downfield by approximately 8 ppm 
each. dUMP bound to WT FDTS had the same 13C spectrum whether the flavin was in 
the oxidized form or the hydroquinone form, indicating that the redox state of the flavin 
does not affect the electrons of the uracil of dUMP. 
We further tested the polarization hypothesis by individually removing the 
charged groups interacting with the uracil ring and obtained chemical shifts. To test the 
importance of the phosphate of dUMP, a 13C-NMR spectrum was collected of dU bound 
to WT FDTS. The 13C chemical shifts of the uracil in unbound dU are identical to the 
chemical shifts of the uracil in unbound dUMP. Surprisingly, the 13C spectrum of dU 
bound to WT FDTS was nearly identical to the 13C spectrum of dUMP bound to WT 
FDTS (Figure 2 - 4); the only notable difference was that the signal for C6 (which is 3.3 
Å away from the phosphate of dUMP in the dUMP-FDTS structure) was ~2 ppm lower 
than the C6 resonance of the dUMP-FDTS complex. Likewise, dUMP bound to R90A 
FDTS also had 13C chemical shifts that were similar to dUMP bound to WT FDTS. 
However, dUMP bound to R174A FDTS had chemical shift values that were similar to 
those of free dUMP at pH 8 (Figure 2 - 4). The peaks were still broadened in the 
complex, indicating that dUMP was bound to the R174A mutant.  
The 13C-NMR spectra at pH 8 of free dUMP and dUMP bound to WT FDTS and 
the various mutants show that R174 is largely responsible for producing the changes in 
the chemical shifts of the uracil of dUMP bound to FDTS. What might R174 be doing to 
cause these changes? The crystal structure of the dUMP-WT FDTS complex shows 
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that R174 is positioned 2.8 Å away from N3 of dUMP (Figure 2 - 2).7 The pKa of N3 is 
normally 9.3 in aqueous solutions.20 We hypothesized that the close proximity of the 
positively charged guanidinium group of R174 to N3 lowers the pKa of N3, ionizing it in 
the complex. To test this, we collected the 13C-NMR spectrum of unbound dUMP at pH 
12, well above the pKa for N3 of dUMP. The 
13C chemical shift values of unbound dUMP 
at pH 12 were nearly identical to those of dUMP bound to WT FDTS, strongly 
suggesting that N3 of dUMP is ionized when bound to FDTS at pH 8 (Figure 2 - 4). 
Structures  
In order to confirm that dUMP and dU bind in a catalytically competent 
conformation in the active site variants of FDTS, we determined the crystal structures of 
dUMP bound complexes of the R90A and R174A FDTS variants and the structure of dU 
bound to WT FDTS (Table 2 - 3). In all three cases the nucleotide/nucleoside bound in 
the same position as in the WT FDTS-dUMP complex (Figure 2 - 5). Most of the protein 
residues were also in the same positions in all of the structures; one notable difference 
in the dU-FDTS structure was that R147 (which forms a salt bridge with the phosphate 
of dUMP) was flipped away from the phosphate binding site. We also observed a 
polyethylene glycol molecule in the dU-FDTS structure in the space occupied by the 
phosphate group and R147 in the dUMP-FTDS complex. 
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Table 2 - 3: Crystallographic Summary 
Crystal Contents FDTS R90A-FAD FDTS R174A-FAD FDTS-FAD FDTS-FAD 
 dUMP dUMP dU dUMS 
Diffraction Data     
Space group P212121 P212121 P212121 I4122 
Cell (Å) 54.1  116.2  141.0 54.1  115.9  141.1 54.2  116.1  141.9 109.7  109.7  119.9 
dmin (Å) 1.9 (1.97-1.90)
a
 2.00 (2.11-2.00) 1.93 (2.02- 1.93) 1.95 (2.06-1.95) 
Average I/σI 22.9 (2.3) 8.7 (2.4) 22.8 (2.5) 20.4 (2.6) 
Rsym 0.073 (0.856) 0.115 (0.682) 0.094 (0.897) 0.118 (1.096) 
CC 1/2    99.9 (82.5) 
Multiplicity 6.6 (5.9) 6.0 (6.1) 7.6 (6.8) 14.6 (14.2) 
Completeness 99.5 (99.6) 90.7 (86.0) 98.1 (96.9) 99.7 (98.1) 
No. of unique reflections 70476 54863 67137 27043 
Refinement     
Data Range (Å) 89.68 -1.90 89.54 - 2.00 89.86 - 1.93 80.92-1.95 
Reflections 66829 52046 62459 25671 
Rwork/ Rfree 0.178 / 0.211 0.183 / 0.217 0.170 / 0.202 0.162 / 0.200 
RMSD bonds (Å) 0.010 0.010 0.010 0.009 
RMSD angles (°) 1.48 1.49 1.46 1.37 
Ramachandran (%)     
Allowed 100 100 100 100 
Outliers 0 0 0 0 
Average B-factors (Å
2
)     
Protein 37.1 34.8 39.3 22.8 
Ligand 25.9 25.6 36.8 32.5 
Water 38.0 37.3 40.4 37.8 
a
Values in parentheses refer to the outermost shell of data. 
Figure 2 - 5. Overlay of WT and mutant structures. dUMP/dU/dUMS bind in the same position and 
orientation in all of the active site variants used in this study. dUMP + WT (PDB code: 1O26), blue; dU + 
WT, green; dUMP + R90A, gray; dUMP + R174A, magenta; dUMS + WT, yellow. 
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Lack of Reactivity of dUMP Analogs  
In addition to the two arginine mutants, dU – which still binds to the WT enzyme 
– failed to support oxidation of WT FDTS containing reduced flavin in the presence of 
CH2THF and could not be converted into 2’-deoxythymidine (dT), indicating that the 
phosphate of dUMP is important for catalysis by FDTS (Figure 2 - 6). However, the 
NMR data show that the phosphate of dUMP does not play a major role in ionizing the 
uracil ring of dUMP since dU was ionized when bound to FDTS.  In addition, the crystal 
structure of the dU-FDTS complex showed that dU binds in a similar manner to dUMP. 
We therefore considered the possibility that the phosphate might be important in 
another step of the reaction catalyzed by FDTS. 
 
 
 
 
 
 
 
 
 
Figure 2 - 6. dU failed to oxidize reduced FDTS in the presence of CH2THF. Anaerobic oxidized FDTS 
(green) in 0.1 M Tris-HCl, pH 8 at 25°C was titrated stoichiometrically with dithionite to reduce the flavin 
(blue). Anaerobic addition of CH2THF perturbed the spectrum, indicating that it formed a complex with the 
enzyme (black). Anaerobic addition of dU to the reduced FDTS-CH2THF complex also perturbed the 
spectrum but failed to oxidize the flavin (orange), indicating that the phosphate of dUMP plays an essential 
role in the FDTS-catalyzed reaction. The flavin could then be reoxidized by air (red). 
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Any mechanism for FDTS requires the involvement of a base to remove the 
proton at C5 of the dUMP-CH2THF bridged intermediate. However, the base in the 
mechanism of FDTS is currently unknown. The base would have to be on the opposite 
face of the uracil ring from the side that reacts with CH2THF; CH2THF is proposed to 
react on the side of the uracil facing the flavin in Figure 2 - 2.10 In the dUMP-WT FDTS 
structure no side-chains are properly positioned to act as a base. However, dUMP is 
bound in an unusual curled conformation where one of the phosphate oxygens of dUMP 
is 3.4 Å away from C5, close enough for the phosphate to act as a general base. 
To test this possibility, we synthesized an analog of dUMP where the 5’-
phosphate is replaced with sulfate – 2’-deoxyuridine-5’-monosulfate (dUMS). Sulfate is 
structurally similar to phosphate, but the pKa1 for sulfate is ~10 units lower than the pKa2 
for phosphate,21 making it a poor general base. dUMS bound to oxidized FDTS with an 
affinity similar to that of dUMP and produced a similar change in the flavin UV/visible 
absorbance spectrum upon binding to FDTS (Table 2 - 1, Figure 2 - 7A). The crystal 
structure of the dUMS-FDTS complex at 1.9 Å resolution showed that dUMS binds in 
the same position as dUMP (Figure 2 - 5), without affecting any protein residues. 
However, dUMS was unable to oxidize reduced FDTS in the presence of CH2THF and 
no 2’-deoxythymidine-5’-monosulfate was detected (Figure 2 - 7B).  
The reaction of dUMS with reduced FDTS and CH2THF should form a dUMS-
CH2THF bridged intermediate, but should be unable to break down the intermediate 
since dUMS cannot remove the C5 proton of the intermediate. We attempted to detect 
the bridged intermediate from the reaction in Figure 2 - 7B by denaturing the enzyme 
using 1 M HCl and analyzing the supernatant by reverse-phase HPLC. No new species 
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were detected in the HPLC chromatogram (only dUMS, CH2THF, FAD, and their 
decomposition products were detected), indicating that either the bridged intermediate 
is unstable when removed from the active site of FDTS or that the equilibrium constant 
for its formation lies to the left. 
 
Discussion 
Our data indicate that N3 of dUMP is ionized upon binding to FDTS. The 13C 
chemical shift values for the uracil carbons of dUMP bound to FDTS at pH 8 are nearly 
identical to those of unbound dUMP at pH 12. R174 in T. maritima FDTS appears to be 
solely responsible for causing this ionization. When dUMP is bound to R174A FDTS the 
chemical shifts of the uracil carbons are nearly identical to those of unbound dUMP at 
pH 8. However, when the other active site groups that directly interact with dUMP are 
removed, the chemical shifts are nearly identical to dUMP bound to WT FDTS. The pKa 
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Figure 2 - 7. Binding and reactivity data for dUMS in 0.1 M Tris-HCl, pH 8 at 25°C. (A) 
spectrophotometric titration of WT FDTS with dUMS. dUMS produced a flavin spectral change similar 
to dUMP. Fitting to Eq. 1 gave a Kd of 170 nM. (B) dUMS failed to oxidize reduced FDTS in the 
presence of CH2THF. Anaerobic oxidized FDTS (green) was titrated stoichiometrically with dithionite to 
reduce the flavin (blue). Anaerobic addition of CH2THF perturbed the spectrum of the flavin (black), 
indicating that it formed a complex with the enzyme. Anaerobic addition of dUMS to the reduced FDTS-
CH2THF complex also perturbed the spectrum (orange), indicating binding, but it failed to oxidize the 
enzyme. The flavin was then reoxidized by exposure to air (red). 
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for N3 of dUMP is 9.3 in water; the positively charged R174 therefore must lower the 
pKa for N3 of dUMP by several units in the active site FDTS in order for it to be ionized 
at pH 8.  
The large change in the flavin absorbance spectrum of WT FDTS upon binding 
dUMP is likely due to the N3-ionized form of the uracil stacking against the isoalloxazine 
of the flavin. Binding of dUMP to WT FDTS causes a large change in the UV/visible 
absorbance spectrum of the flavin. Binding of dU to WT FDTS and binding of dUMP to 
R90A FDTS also produce a similar change in the flavin absorbance spectrum; however, 
the absorbance spectral change upon binding dUMP by R174A FDTS is significantly 
different, indicating that the environment of the flavin is different in the dUMP-R174A 
FDTS complex.  
The three charged groups in the dUMP binding site also play a significant role in 
the binding of dUMP by FDTS – removal of the phosphate and substitution of the two 
arginines with alanine each cause a substantial lowering of the binding affinity of FDTS 
for dUMP/dU. dU binds to WT FDTS 5300-fold weaker than dUMP, corresponding to a 
loss of ~5.2 kcal/mol of binding energy. The phosphate of dUMP forms a salt bridge with 
R147 and hydrogen bonds with S88 and Q75, all of which are lost with dU. dUMP binds 
to R90A FDTS 670-fold weaker than WT, corresponding to a loss of ~4.0 kcal/mol of 
binding energy. R90 would form a partial salt bridge with O4 due to resonance of the 
N3-ionized form of dUMP. Finally, dUMP binds to R174A FDTS 7300-fold weaker than 
WT FDTS, corresponding to a loss of ~5.4 kcal/mol of binding energy. R174 is 
positioned to form a salt bridge with N3 of the ionized form of dUMP – substitution of 
R174 with alanine removes this interaction. 
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We also found evidence consistent with the phosphate of dUMP acting as the 
base that deprotonates C5 of the dUMP-CH2THF adduct during carbon transfer, 
explaining why dU does not support oxidation of the reduced flavin of FDTS in the 
presence of CH2THF even though dU is ionized when bound to the enzyme. This 
finding also provides an explanation for the unusual conformation of dUMP bound to 
FDTS which, to our knowledge, is unique among nucleotide-binding proteins. Binding of 
dUMS to FDTS has similar affinity and produces similar spectral changes compared to 
binding of dUMP, indicating that the same interactions between the nucleotide and 
protein are intact with dUMS, including ionization of N3.  In addition, the crystal structure 
of the dUMS-FDTS complex shows that dUMS binds in the same position as dUMP. 
However, dUMS is unable to support oxidation of the flavin in the presence of CH2THF. 
While sulfate is structurally similar to phosphate, the pKa for sulfate is many units lower 
than that of phosphate, making base catalysis normally performed by phosphate 
inaccessible to dUMS.  
Our findings with dUMS are similar to those observed with 5F-dUMP,4 which also 
blocks deprotonation of C5: 5F-dUMP produces a similar change in the UV/visible 
absorbance spectrum of the reduced FDTS-CH2THF complex, but does not react. 
Curiously, we were unable to detect a dUMS-CH2THF bridged intermediate by HPLC 
after acid-denaturing the enzyme from Figure 2 - 7B. However, past attempts to isolate 
an intermediate using 5F-dUMP were also unsuccessful,3,22,23 indicating that the 
intermediate might be unstable when removed from the active site of the enzyme. 
Ionization of N3 requires a modification of the mechanism shown in Figure 2 - 1B 
since the negative charge of the ionized nitrogen can be delocalized onto O2 and O4, 
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blocking the enolate-containing resonance structure from occurring (Figure 2 - 8A). We 
propose a new mechanism for dUMP activation based on ionization of N3. The C5-C6 
pi-electrons cannot be delocalized onto the C4 carbonyl in the N3-ionized dUMP; this 
stabilizes the resonance structure with a formal negative charge on C5 in N3-ionized 
dUMP relative to unionized dUMP (Figure 2 - 8A). This resonance structure is highly 
nucleophilic at C5; we propose that the C5 carbanion directly attacks CH2THF, initiating 
the oxidative half-reaction of FDTS (Figure 2 - 8B). Ionization of N3 is clearly important 
for chemistry. The rate constant for flavin oxidation in oxidative half-reaction 
experiments for the R174A mutant is 3000-fold slower than that of wild-type,5 and our 
crystal structure shows this is not due to improper positioning of dUMP in the mutant. As 
a possible precedent for this mechanism of activation, dUMP can react with 
formaldehyde under basic conditions to make 5-hydroxymethyl dUMP.24,25  
Following activation of dUMP and formation of the dUMP-CH2THF bridged 
intermediate, the phosphate of dUMP abstracts the proton at C5 to break down the 
intermediate and eliminate THF (Figure 2 - 8B). dTMP is then formed by hydride 
transfer from reduced FAD and the rearrangement proposed previously (Figure 2 - 1B, 
steps 3-5).3  
The findings presented here further establish that FDTS uses a novel mechanism 
to methylate a pyrimidine. Uracil activation by N3 ionization has never been reported, 
but may be used by other uracil-methylating enzymes. However, other mechanisms for 
the enzymatic deprotonation of uracil nitrogens have been identified: the immediate 
product of the reaction catalyzed by uracil DNA glycosylases is a uracil deprotonated at 
N1 that is stabilized by a strong hydrogen bond with O2.26–29 In addition, the phosphate 
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of dUMP appears to be important for catalysis by FDTS, which is not the case with 
classic TS.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 - 8. Proposed mechanism for the reaction of FDTS. (A) the proposed mechanism for activation of 
dUMP by ionization of N3. The negative charge of N3-ionized dUMP would be delocalized onto O4 and O2, 
preventing the enolate-containing resonance structure normally available with unionized dUMP. Destabilization 
of the enolate-containing resonance structure enhances the population of the resonance structure with a formal 
negative charge on C5 (red box), which is a good nucleophile. (B) the proposed mechanistic steps for the 
FDTS-catalyzed reaction following ionization of N3. Steps (3) – (5) in Figure 2 - 1B occur after removal of the 
C5 proton of the dUMP-CH2THF adduct by the phosphate of dUMP. 
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Conclusions 
FDTS ionizes N3 of dUMP, which is largely caused by an active site arginine, 
providing a new mechanism for dUMP activation. The phosphate of dUMP is crucial for 
flavin oxidation, suggesting that it acts as the base that deprotonates C5 of the dUMP-
CH2THF adduct. Notably, both ionization of N3 and acid-base catalysis by the 
phosphate of dUMP are not implicated in the mechanism used by classic TS. 
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Chapter 3 
Nucleotide Binding to Flavin-Dependent Thymidylate Synthase from 
Thermotoga maritima 
Flavin-dependent thymidylate synthases (FDTSs) are tetrameric enzymes that 
use a flavin adenine dinucleotide (FAD) prosthetic group to synthesize the essential 
DNA precursor – 2’-deoxythymidine-5’-monophosphate (dTMP) – from 2’-deoxyuridine-
5’-monophosphate (dUMP), 5, 10-methylenetetrahydrofolate (CH2THF), and NADPH. A 
number of pathogenic microorganisms use FDTS to make dTMP whereas humans use 
classic thymidylate synthase (TS). FDTS has a structure that is unrelated to classic TS, 
and a very different mechanism, making FDTS a potential target for new antimicrobial 
drugs.1–3 Whereas the electrons that reduce the methylene to form dTMP come from 
the reduced folate in classic TS, the electrons come from NADPH in FDTS. Structures 
of FDTS from several organisms have been solved, and all are very similar.4–9 The 
majority of the structures with substrates or analogues bound are of the enzyme from 
Thermotoga maritima. FDTS is a homotetramer with four active sites per tetramer. Each 
active site contains the redox-active isoalloxazine of an FAD and is composed of 
residues from three of the four subunits. dUMP binds in a pocket enclosed by a loop 
(residues 89-94 in T. maritima FDTS), with the uracil stacked against the isoalloxazine. 
In the absence of dUMP, the loop is disordered and the active site is open. A crystal 
structure of FDTS with CH2THF and dUMP showed that CH2THF binds in a pocket on 
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the opposite face of the isoalloxazine from dUMP.10 However, this binding mode was 
proposed to be non-catalytic since dUMP and CH2THF must be adjacent to each other 
in order for methylene transfer to occur. 
Details of the chemical mechanism of FDTS are beginning to be understood.11–14 
However, the timing of substrate binding and product release has not been fully 
characterized. The catalytic cycle of FDTS involves three substrates and three products, 
making for a complex catalytic cycle, and the active site of FDTS is not large enough to 
accommodate all three substrates at the same time. Most work suggests that NADPH 
and CH2THF bind to the same site at different points in the catalytic cycle, and that 
dUMP binds in its own, independent site.5,8,10,15 NADPH binds to oxidized FDTS and 
reduces the flavin in the reductive half-reaction. The resulting NADP+ is then replaced 
by CH2THF, allowing the reductive methylation of dUMP by CH2THF and the reduced 
flavin, making dTMP in the oxidative half-reaction and completing the catalytic cycle. 
While there is some consensus on the timing of NADPH and CH2THF binding and the 
release of their products, the timing of dUMP binding and dTMP release is less clear. 
The presence of dUMP has been shown to stimulate the reduction by NADPH for some 
FDTSs, suggesting that dUMP binds to oxidized FDTS prior to reduction of the flavin by 
NADPH.16,17 However, another study has shown that dUMP does not enhance the 
reduction of oxidized FDTS by NADPH, suggesting that dUMP only participates in the 
oxidative half reaction.18 No studies have directly compared the binding of dUMP or 
dTMP to oxidized and reduced FDTS.  
Here we report that FDTS from T. maritima (TmFDTS) binds dUMP and dTMP 
significantly weaker when the flavin is reduced than when the flavin is oxidized, and the 
84 
difference in affinity is largely due to changes in the rate constant for deoxynucleotide 
dissociation. This finding suggests that the exchange between dTMP and dUMP in the 
catalytic cycle of TmFDTS occurs when the flavin is reduced. We also show that 
TmFDTS behaves as a dimer of dimers with regards to dUMP and dTMP binding at low 
temperatures.  
Experimental Procedures 
Protein Preparations  
Recombinant TmFDTS was purified as previously reported,19 followed by 
formation of apo-protein by treatment with concentrated sodium chloride5 to remove 
dTMP bound to the protein. FAD was then added to the apo-protein and the excess 
FAD removed by desalting. 
Instrumentation   
UV/visible absorbance spectra were recorded on a Shimadzu UV-2501PC 
standard scanning spectrophotometer. Circular dichroism spectra were recorded on a 
Jasco J-810 spectropolarimeter equipped with a Jasco PFD-425S peltier temperature 
controller. Stopped-flow experiments were recorded using a Hi-Tech Scientific 
KinetAsyst SF-61 DX2 stopped-flow spectrophotometer. 
Anaerobic Experiments  
When necessary, enzyme solutions were made anaerobic in glass tonometers or 
anaerobic cuvettes20 by repeated cycles of vacuum and equilibration with anaerobic 
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argon.21 Ligand solutions were made anaerobic by bubbling in syringes with anaerobic 
argon. 
Detection of Bound Nucleotides 
TmFDTS was denatured by adding 1 M HCl and incubating at 70°C for one 
minute. The precipitated protein was removed by centrifugation. The pH of the 
supernatant was raised to ~5 by adding 10 mM ammonium acetate and titrating with 10 
M NaOH. The supernatant was then analyzed on a Shimadzu HPLC with a UV/Vis 
diode array detector at room temperature on a 5 µm, 25 cm x 4.6 mm Supelcosil LC-18-
DB column with 1 mL/min flow rate. A 0 to 10 minute, 0 to 50% methanol gradient was 
used in 10 mM ammonium acetate, pH 5, followed by 15 minutes of isocratic 50% 
methanol in 10 mM ammonium acetate, pH 5. The relative concentrations of bound 
nucleotides within each sample were determined using ε260 = 10000 M
-1cm-1 for dUMP, 
ε267 = 9490 M
-1cm-1 for dTMP, ε271 = 8860 M
-1cm-1 for dCMP, and ε450 = 11300 M
-1cm-1 
for FAD. 
 Reduction Potentials 
Reduction potentials were determined using the xanthine/xanthine oxidase 
method of Massey.22 Experiments were performed in anaerobic cuvettes in 0.1 M Tris-
HCl, pH 8 at 25°C and monitored in a standard scanning spectrophotometer. 1-
hydroxyphenazine (Em = -225 mV at pH 8, 25°C)
23 was used as the indicator dye for 
unbound TmFDTS. Phenosafranine (Em = -274 mV at pH 8, 25°C)
23 was used as the 
indicator dye for dUMP- and dTMP-bound TmFDTS. 
 
86 
Spectrophotometric Titrations 
Spectrophotometric titrations were performed on a scanning spectrophotometer. 
~16 µM enzyme (active sites concentration) was used for titrations with oxidized 
TmFDTS; ~41 µM enzyme (active sites concentration) was used for titrations with 
reduced TmFDTS. Enzyme in 0.1 M Tris-HCl, pH 8 at 25 °C was titrated with ligand in 
the same buffer and absorbance spectra were recorded after each addition. The change 
in flavin absorbance due to ligand binding was plotted against ligand concentration.  
Isothermal Titration Calorimetry 
Isothermal titration calorimetry was performed using a MicroCal VP-ITC. 
Titrations were performed in 0.1 M Tris-HCl, pH 8 (pH determined at 25°C). 50 µM 
TmFDTS (tetramer concentration) was titrated with 2 mM dUMP or dTMP using 5 µL 
injections. Data were analyzed using the Origin software provided by MicroCal and fit to 
either a one site model or a two independent sites model (for more details, see 
Appendix 1). For a one-site model, the total heat content Q of the solution in the active 
cell volume Vo is 
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where n is the number of binding sites, Mt is the bulk concentration of macromolecule, 
ΔH is the molar heat of ligand binding, Lt is the bulk concentration of ligand, and K is the 
binding constant. 
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For two sets of independent binding sites 
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where θ is the fraction of sites occupied by ligand L and [L] is the concentration of free 
ligand. Q in Vo for two independent binding sites is 
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The change in heat after the ith injection {ΔQ(i)} for the one or two-site model is  
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where ΔVi is the change in volume after the ith injection. 
Binding Kinetics 
The kinetics of binding dUMP or dTMP to oxidized TmFDTS was monitored in a 
stopped-flow spectrophotometer. Experiments were performed by mixing ~16 µM 
oxidized TmFDTS (active sites concentration) with 50-200 µM dUMP or dTMP (all 
concentrations are after mixing) in 0.1 M Tris-HCl, pH 8 at 25°C. Traces were monitored 
at 390 and 450 nm. Three traces were averaged for the two wavelengths at each 
nucleotide concentration. The averaged traces at 390 and 450 nm were fit 
simultaneously to a single exponential using PSI-Plot for each nucleotide concentration. 
The concentration dependence of the observed rate for dUMP or dTMP was fit to a line 
in KaleidaGraph, with the slope providing the association rate constant. 
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Competition with dCMP to Measure dUMP or dTMP Dissociation 
The kinetics of dUMP or dTMP dissociation from TmFDTS through competition 
with dCMP was monitored in a stopped-flow spectrophotometer. Experiments were 
performed by mixing the preformed TmFDTS-dUMP or dTMP complex with a vast 
excess of dCMP (0.1-0.2 M after mixing) in 0.1 M Tris-HCl, pH 8 at 25°C. For 
experiments using oxidized enzyme, 21 µM of the TmFDTS-dUMP or dTMP complex 
were used (active sites after mixing); for experiments using reduced enzyme, 83 µM of 
the TmFDTS-dUMP or dTMP complex were used (active sites after mixing). Traces 
were monitored at 390 nm for the oxidized TmFDTS-dUMP complex, 480 nm for the 
oxidized TmFDTS-dTMP complex, and 370 nm for the reduced TmFDTS complexes. 
Traces were fit to sums of exponentials in KaleidaGraph. In all cases, the rate constant 
were the same for 0.1 M and 0.2 M dCMP, indicating that a sufficient amount of dCMP 
was used and that the observed rate constant corresponded to the dissociation rate 
constant for dUMP or dTMP binding to TmFDTS. 
Global Fitting  
The kinetic traces for nucleotide binding to TmFDTS and the competition 
experiments with dCMP were fit globally in Berkeley Madonna using the differential 
equations for the mechanism depicted in Figure 3 - 16 for each nucleotide and flavin 
redox state combination. The script used for the global fitting in Berekely Madonna can 
be found in Appendix 2. For the dUMP and oxidized TmFDTS global fitting, the return to 
baseline of the endothermic event observed by ITC was also included. For the reduced 
TmFDTS global fitting, it was assumed that the association rate constant was the same 
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as oxidized TmFDTS. The spectrophotometric titrations were simulated using the model 
obtained from the global fitting and the experimentally determined change in extinction 
coefficient upon nucleotide binding. 
Results 
Flavin-Dependent Thymidylate Synthase Co-Purifies with dTMP  
For binding studies, it is important to ensure that the protein being used is free of 
bound ligands. FDTS binds deoxynucleotides tightly, so that the enzyme is purified with 
bound dTMP (Mishanina and Kohen, personal communication). We assessed the 
occupancy of TmFDTS purified with affinity chromatography by analyzing the acid-
denatured enzyme using reverse-phase HPLC. Integration of the dTMP peak and the 
FAD peak showed that dTMP was present at approximately half the flavin 
concentration. Since TmFDTS is a tetramer, half of the active sites of TmFDTS likely 
co-purified with dTMP.  
The co-purified dTMP and FAD were removed by making apo-protein using 
previously established methods.5 FAD was then added to apo-TmFDTS to make holo-
TmFDTS, and the excess FAD was removed by desalting. HPLC analysis of the 
resulting TmFDTS confirmed the absence of dTMP. TmFDTS treated in this way was 
able to bind dUMP or dTMP and could convert dUMP into dTMP in the presence of 
CH2THF and reductant. The UV/visible absorbance spectrum of product-free TmFDTS 
had an A450/A375 ratio of 1.4, compared to TmFDTS containing half an equivalent of 
dTMP, which had an A450/A375 ratio of 1.25. The extinction coefficient at 450 nm (ε450) 
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of TmFDTS without bound dTMP was 12000 M-1cm-1. Product-free TmFDTS was used 
in all subsequent experiments in this study. 
Reduction Potentials 
The reduction potentials of the flavin in free TmFDTS and TmFDTS in complex 
with dUMP or dTMP at pH 8, 25 °C were determined using the xanthine/xanthine 
oxidase method of Massey.22 The reduction potential of free TmFDTS was -201 mV 
using 1-hydroxyphenazine as the indicator dye (Figure 3 - 1A). The reduction potential 
of the TmFDTS-dUMP and TmFDTS-dTMP complexes were -262 mV and -264 mV, 
respectively, using phenosafranin as the indicator dye (Figures 3 - 1B and 3 - 1C). 
Nucleotide binding lowers the reduction potential of TmFDTS by ~60 mV. The change in 
reduction potential of TmFDTS upon binding nucleotides indicates that dUMP and 
dTMP bind to reduced FDTS 120- and 140-fold weaker, respectively, than to oxidized 
TmFDTS. The reduction potential for free TmFDTS and the nucleotide-TmFDTS 
complexes are higher than the potential of the NADP+/NADPH couple (-354 mV at pH 
8),17 indicating that hydride transfer from NADPH to FDTS is favorable regardless of 
whether or not dUMP or dTMP are bound to the enzyme. 
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Spectrophotometric Titrations 
A large change in the UV/visible absorbance spectrum of oxidized TmFDTS 
occurs upon binding dUMP or dTMP. This spectral change can be used to track 
nucleotide binding in titration experiments. dUMP bound stoichiometrically to ~16 µM 
active sites oxidized TmFDTS, indicating  that dUMP binds very tightly to oxidized 
TmFDTS (Chapter 2). We performed a similar titration with dTMP, and it also bound 
stoichiometrically to oxidized TmFDTS (Figure 3 - 2A). The point of saturation was 
equal to the concentration of active sites (based on flavin ε450) in the sample. Binding of 
dUMP and dTMP to reduced TmFDTS also produces a change in the absorbance 
spectrum of the flavin, which can be used to monitor binding of either deoxynucleotide 
Figure 3 - 1. Determination of reduction potentials. Reduction potentials were determined using the 
xanthine/xanthine oxidase method of Massey in 0.1 M Tris-HCl, pH 8 at 25°C.
22
 (A), the reduction 
potential of free TmFDTS determined using 1-hydroxyphenazine. (B) and (C), the reduction potential of 
the dUMP- and dTMPcomplexes, respectively, determined using phenosafranine. The insets show the 
Nernst plot for determining the potentials. The reduction potential of unbound TmFDTS was -201 mV. The 
reduction potentials of the dUMP- and dTMP- complexes were -262 mV and -264 mV, respectively. 
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to reduced TmFDTS (Figure 3 - 2B and 3 - 2C). dUMP and dTMP bound to ~41 µM 
reduced TmFDTS (active sites concentration) stoichiometrically, indicating that dUMP 
and dTMP also bind tightly to reduced TmFDTS. 
 
 
 
Figure 3 - 2. Absorbance binding titrations. (A), oxidized TmFDTS (~16 µM active sites) was titrated 
aerobically with dTMP. Reduced FDTS (~41 µM active sites) was titrated anaerobically with dUMP (B) or 
dTMP (C). The insets show the maximum change in absorbance due to dUMP or dTMP binding as a 
function of dUMP or dTMP concentration. dUMP or dTMP bound tightly to both oxidized and reduced 
TmFDTS. 
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Isothermal Titration Calorimetry  
Binding of dUMP or dTMP to oxidized TmFDTS was additionally monitored by 
isothermal titration calorimetry (ITC). Interestingly, ITC thermograms at 25°C in 0.1 M 
Tris-HCl, pH 8 of dUMP or dTMP binding to oxidized TmFDTS indicated two sets of 
binding sites with different enthalpies and binding affinities (Figure 3 - 3A, 3 - 3B). Fitting 
of the binding isotherm to a two-site model (see Methods) using the concentration of 
TmFDTS tetramer (50 µM in the titration) showed that approximately two 
deoxynucleotide molecules bound to each of the two binding sites of the TmFDTS 
tetramer (Table 3 - 1). The higher affinity site bound dUMP or dTMP 17-18-fold tighter 
than the weaker affinity site. The site with lower affinity had ~3 kcal/mol more negative 
enthalpy of binding than the high affinity site for both dUMP and dTMP.  
Table 3 - 1: Thermodynamic Parameters for Deoxynucleotide Binding to TmFDTS
a
 
Nucleotide, 
Temperature 
N1 Kd1 (nM) 
ΔH1 
(kcal/mol) 
ΔS1 
(cal/ 
molK) 
N2 Kd2 (nM) 
ΔH2 
(kcal/mol) 
ΔS2 
(cal/ 
molK) 
dUMP, 25°C 1.90 ± .03 1.4 ± .5 -2.73 ± .06 31.5 1.74 ± .03 25 ± 7 -5.56 ± .07 16 
dUMP, 65°C 3.82 ± .01 83 ± 19 -16.1 ± .1 -15.1 
    
dTMP, 25°C 1.99 ± .02 12 ± 2 -0.02 ± .04 36.2 1.8 ± .02 220 ± 27 -3.6 ± .06 18.4 
dTMP, 65°C 3.66 ± .01 490 ± 50 -14.9 ± .08 -15.3 
    
a
0.1 M Tris-HCl, pH 8 
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Figure 3 - 3. ITC data for the titration of oxidized TmFDTS with dUMP or dTMP at 25°C and 65°C in 0.1 M 
Tris-HCl, pH 8. 50 µM oxidized TmFDTS (tetramer) was titrated with either 2 mM dUMP at 25°C (A) or 
65°C (C) or with 2 mM dTMP at 25°C (B) or 65°C (D). The red line is the best fit of the data using the two 
independent sites model for the titrations at 25°C or the one site model for the titrations at 65°C. The 
thermodynamic parameters from fitting the data can be found in Table 3 - 1. 
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TmFDTS is from a thermophilic organism whose physiological temperature is 
around 80°C, raising the possibility that the observation of asymmetry in the four active 
sites with deoxynucleotide binding might be a result of studying the enzyme at a low 
temperature. To test this, we performed the ITC titrations at 65°C (close to the 
physiological temperature of T. maritima). The ITC titration of dUMP or dTMP binding to 
oxidized TmFDTS at 65°C showed only a single binding event that corresponded to  ~4 
binding sites per enzyme (Figure 3 - 3C and 3 - 3D). One possible explanation for this 
behavior is the change in pH of the buffer caused by the change in temperature, which 
could protonate a group on the enzyme; the pH of Tris decreases by ~1 unit as the 
temperature is increased from 25 to 65°C. However, dUMP binding to oxidized 
TmFDTS at pH 7, 25°C still showed two sites, indicating that the transition between two 
sets of sites to one set when increasing the temperature is not due to changes in the pH 
(Figure 3 - 4). We expanded the temperature dependence by repeating titrations with 
dUMP over a range of temperatures between 5 and 65°C at 10° intervals (Figure 3 - 5 
and Figure 3 - 6). The titrations showed that between 5 and 45°C, two sets of binding 
sites can be distinguished for dUMP binding to oxidized TmFDTS. However, at 55 and 
65°C the titration curves fit to a single set of binding sites. The enthalpy and entropy of 
binding for both sets of sites decreased linearly with increasing temperature (Table 3 - 2 
and Figure 3 - 7A and 3 - 7B). The heat capacity change (ΔCp) of the binding interaction 
can be determined from the slope of the change in enthalpy with temperature. ΔCp is     
-280 ± 30 cal/molK for the high affinity site and -250 ± 20 cal/molK for the low affinity 
site. Van’t Hoff plots for dUMP binding to both sites were non-linear, which also 
indicates that ΔCp is nonzero for the binding interaction (Figure 3 - 7C).
24 From the fits 
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of the titration curves, the affinity of the higher affinity site is ~18-fold higher than the 
lower affinity site for the experiments between 5 and 35°C, but is ~11-fold higher at 
45°C (Table 3 - 2), suggesting that the transition between the TmFDTS tetramer 
behaving as a dimer-of-dimers or having four identical sites for deoxynucleotide binding 
occurs around 45°C. The binding affinities of the single site at 55°C and 65°C were 
similar to the lower affinity site in the titrations at lower temperatures. 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3 - 4.  ITC data for the titration of oxidized TmFDTS with dUMP at 25°C in 0.1 M Tris-HCl, pH 
7. The data were fit using the independent two-sites model. The fit gave N1 = 2.1, Kd1 = 32 nM, ΔH1 
= -3.93 kcal/mol, ΔS1 = 21.1 cal/mol*K, N2 = 1.76, Kd2 = 530 nM, ΔH2 = -5.82 kcal/mol, ΔS2 = 9.19 
cal/mol*K 
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Figure 3 - 5. Temperature dependence of dUMP binding to TmFDTS by ITC in 0.1 M Tris-HCl, pH 8. 
Data for experiments at 5°C (A), 15°C (B), 25°C (C), 35°C (D), and 45°C (E) were fit using a two 
independent-sites model. Data for the experiment at 55°C (F) and 65°C (G) was fit using a one site 
model. In the experiments at 5°C, 15°C, and 25°C an exothermic signal followed by an endothermic 
signal occurred after each addition of dUMP until ~half of the active sites were filled. The thermodynamic 
parameters from fitting the data can be found in Table 3 - 2. 
 
A B C 
D E 
F G 
98 
 
 
 
 
 
 
 
 
 
 
 
Table 3 - 2: Thermodynamic Parameters for dUMP Binding to Oxidized TmFDTS at Different 
Temperaturesa 
Temperature 
(°C) 
N1 
Kd1 
(nM) 
ΔH1 
(kcal/mol) 
ΔS1 
(cal/mol*K) 
N2 
Kd2 
(nM) 
ΔH2 
(kcal/mol) 
ΔS2 
(cal/mol*K) 
5 1.74 8.3 1.73 43.2 1.80 140 -2.51 22.4 
15 1.87 3.6 -0.13 38.2 1.89 71 -3.59 20.3 
25 1.88 1.5 -2.67 31.5 1.75 25 -5.59 16 
35 1.94 2.9 -5.19 22.2 1.68 53 -7.38 9.36 
45 2.10 4.1 -9.77 7.68 1.38 49 -11.5 -2.67 
55 
    
3.51 35 -14.6 -10.4 
65 
    
3.82 83 -16.1 -15.1 
a0.1 M Tris-HCl, pH 8 
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Figure 3 - 6. Overlay of temperature dependence of dUMP binding to TmFDTS by ITC in 0.1 M Tris-HCl, 
pH 8. Top panel, comparison of raw thermograms. Bottom panel, overlay of heats of injection for the 
different temperatures. 
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Curiously, in the ITC experiments between 5 and 25°C, addition of dUMP caused 
an exothermic signal which was followed by an endothermic signal; the amplitude of the 
endothermic signal became less prevalent throughout the course of the titration, 
disappearing when roughly half of the active sites were filled (Figure 3 - 5). The 
endothermic portion was attributed to a slower kinetic event that occurred during binding 
of dUMP to TmFDTS; it is unlikely that the endothermic portion is due to an instrument 
Figure 3 - 7. Temperature dependence of  the thermodynamic parameters for dUMP binding to 
TmFDTS by ITC. (A) Enthalpy change with temperature. The slope provides the change in heat 
capacity (ΔCp) of -280 ± 30 cal/molK for the high affinity site and -250 ± 20 cal/molK for the low 
affinity site. (B) Entropy change plotted against lnT in Kelvin. (C) Van’t Hoff plot. 
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Figure 3 - 8. Kinetics of the return to baseline from the endothermic process detected by ITC when dUMP 
binds to oxidized TmFDTS. 50 µM oxidized TmFDTS (tetramer) was titrated with injections corresponding to 
100 µM additions of dUMP in 0.1 M Tris-HCl, pH 8 at 25°C. The first injection gave an exothermic signal 
which overshot the baseline and peaked in the endothermic direction. The inset shows the decay from the 
endothermic signal back to baseline. Fitting the decay to a single exponential gives kobs of 0.019 s
-1
. 
artifact because it only occurred until half the active sites were filled, and the return to 
baseline from the endothermic event became slower as the temperature decreased. If 
the half time for a binding event in ITC is lower than the instrument recovery time 
(typically 10 – 20 seconds), the rate constant of the binding event dictates the 
exponential for the return to baseline.25 Since the return to baseline from the 
endothermic process was very slow (taking several minutes to complete), and became 
slower as the temperature decreased, the exponential for the recovery from the 
endothermic process corresponds to the actual observed rate constant for that step. 
The amplitude for the recovery from the endothermic process was small at 25°C, 
making it difficult to accurately determine the rate constant for the return to baseline. To 
enhance the amplitude of the endothermic process, we performed the ITC titration at 
25°C with larger injections that corresponded to half the number of binding sites (Figure 
3 - 8). This experiment successfully increased the amplitude of the endothermic 
process; fitting that portion of the ITC thermogram to a single exponential gave an 
observed rate constant (kobs) of 0.019 s
-1. 
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The structure of deoxynucleotide-free TmFDTS shows that histidine-53 (H53) 
exists in two different conformations in the four active sites of the TmFDTS tetramer 
(Figure 3 - 9A), indicating that H53 might be involved in producing the two sets of 
deoxynucleotide binding sites. To test this, an H53A mutant enzyme was titrated with 
dUMP by ITC at pH 8, 25°C (Figure 3 - 9B). The thermogram still showed two sets of 
binding sites; however, the binding affinities of the two sets of sites were very similar, 
such that the Origin software was unable to accurately fit the data to a two-site model 
(or a one-site model), suggesting that H53 is involved in producing the two sets of 
deoxynucleotide binding sites. 
 
 
 
 
 
 
 
 
 
 
A 
Figure 3 - 9. Involvement of H53 in the two sets of TmFDTS deoxynucleotide binding sites. (A) Overlay of 
the four active sites of deoxynucleotide-free TmFDTS (PDB code 1KQ4). H53 (cyan) is in two 
conformations in the four active sites of the TmFDTS homotetramer. Only one FAD (yellow) is shown for 
clarity. (B) dUMP binding to an H53A TmFDTS mutant enzyme by ITC in 0.1 M Tris-HCl, pH 8 at 25°C. The 
data could not be accurately fit to a two-site model, as indicated by the large error bars on the 
parameters of the fit – the fit parameters were N1 = 1.41 ± 1.4, Kd1 = 31 ± 105 nM, ΔH1 = 0.17 ± 5.2 
kcal/mol, ΔS1 = 34.9 cal/molK, N2 = 1.44 ± 1.3, Kd2 = 40 ± 92 nM, ΔH2 = - 4.58 ± 5.23 kcal/mol, ΔS2 = 
18.5 cal/molK. 
B 
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 The ITC titration at pH 8, 25°C was also performed in phosphate buffer and 
PIPES, which have different enthalpies of deprotonation than Tris in an attempt to 
quantify the number of protons released or taken up when dUMP binds to TmFDTS 
(Figure 3 - 10). The enthalpy of deprotonation for the pKa values near 8 of phosphate 
buffer, PIPES, and Tris are 0.86 kcal/mol, 2.68 kcal/mol, and 11.34 kcal/mol, 
respectively.26 If protons are released or absorbed upon ligand binding, the ΔH values 
from the titration should scale with the difference in ionization enthalpy between buffers 
multiplied by the number of protons released or taken up during ligand binding. The 
titrations in the different buffers all fit to a two-site model. The binding enthalpy values of 
the two sites were significantly more negative in Tris buffer than in phosphate buffer or 
PIPES, consistent with protons being released when dUMP binds to TmFDTS (Table 3 - 
3). However, the binding enthalpy values for the two sites did not scale linearly with the 
ionization enthalpy of the different buffers; in fact, the binding enthalpy values in 
phosphate were more negative than in PIPES. The binding affinities for the two sites 
were nearly identical in Tris and PIPES; however, the affinities for the two sites in 
phosphate buffer were significantly higher (Table 3 - 3). This indicates that phosphate 
binds the dUMP binding site of TmFDTS, which would affect the binding enthalpies 
measured in phosphate buffer. 
 Figure 3 – 11 shows the dependence of the binding enthalpy for the two sites 
with the enthalpy of ionization for the two buffers that do not inhibit dUMP binding (Tris 
and PIPES). Linear regression of the data indicates that 0.25 and 0.43 protons are 
released by the complex when dUMP binds to the high affinity site and the low affinity 
site, respectively, with a sum of 0.68 protons released when dUMP binds to the entire 
104 
TmFDTS homotetramer. With these preliminary data (only two buffers examined), a 
fraction of a proton released suggests that an ionizable group is partially ionized in 
unbound dUMP and TmFDTS, in the TmFDTS-dUMP complex, or both; i.e., the pKa of 
the ionizable group is near pH 8 in the complex or when free in solution. It also indicates 
that the pKa of the ionizable group is lowered when dUMP binds to TmFDTS. 
 
 
 
A B 
Figure 3 - 10. Titration of TmFDTS with dUMP in different buffers by ITC. TmFDTS was titrated with dUMP 
at pH 8, 25°C in 0.1 M sodium phosphate (A) or 0.1 M PIPES-Na (B). Both titrations fit to a two-site model. 
The thermodynamic parameters from the fit can be found in Table 3 - 3. 
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Table 3 - 3: Thermodynamic Parameters for dUMP Binding to TmFDTS in Different Buffers at pH8, 25°C
a
 
Buffer N1 Kd1 (nM) 
ΔH1 
(kcal/mol) 
ΔS1 
(cal/ 
molK) 
N2 Kd2 (nM) 
ΔH2 
(kcal/mol) 
ΔS2 
(cal/ 
molK) 
Tris 1.90 ± .03 1.4 ± .5 -2.73 ± .06 31.5 1.74 ± .03 25 ± 7 -5.56 ± .07 16.0 
phosphate 2.18 ± .03 9.9 ± 2.1 -1.49 ± .03 31.6 1.60 ± .03 166 ± 18 -3.13 ± .05 20.5 
PIPES 2.28 ± .03 1.4 ± .5 -0.60 ± .02 38.5 1.68 ± .03 35 ± 9 -1.83 ± .03 28.0 
a
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Figure 3 - 11. Binding enthalpy of the two sets of sites for dUMP binding to TmFDTS at pH 8, 25°C as a 
function of the ionization enthalpy of the reaction buffer. Two buffers were used: Tris (ionization enthalpy of 
11.34 kcal/mol) and PIPES (ionization enthalpy of 2.68 kcal/mol). The slope of the linear regression gives 
the number of protons released from the complex when dUMP binds to TmFDTS. 0.25 protons are 
released when dUMP binds to the high affinity site, 0.43 when dUMP binds to the low affinity site, and 0.68 
protons when all sites are bound. 
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Circular Dichroism 
Enzyme-bound flavins generally have a detectable circular dichroism (CD) signal 
in the visible region that is sensitive to changes in the environment of the flavin. 
Oxidized TmFDTS (50 µM active sites concentration) was titrated with dUMP at 25°C 
and CD spectra were recorded between 300 and 500 nm after each addition. During the 
titration, two isodichroic points were present at different points in the titration – one at 
365 nm that appeared when the first half of the active sites were filled (0-25 µM) and 
one at 372 nm that appeared when the second half of the active sites were filled (25-50 
µM) (Figure 3 - 12A) – consistent with TmFDTS having two sets of sites with different 
affinities for binding of dUMP at 25°C. When the same titration was performed at 65°C, 
only a single isodichroic point at 365 nm was present and the signal change at 372 nm 
had a linear response until all of the active sites were filled (0-50 µM), consistent with all 
sites of the TmFDTS tetramer binding dUMP with the same affinity (Figure 3 - 12B). 
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Figure 3 - 12. CD binding titrations. 50 µM oxidized TmFDTS (active sites) was titrated with dUMP at 
25°C (A) or 65°C (B) in 0.1 M Tris-HCl, pH 8 while monitoring changes in the CD spectrum of the flavin. 
At 25°C, there were two isodichroic points at 365 nm and 372 nm that occurred during different portions 
of the titration. At 65°C, there was a single isodichroic point at 365 nm throughout the entire titration. The 
insets show the change in CD signal at 365 nm and 372 nm as a function of dUMP concentration. (C) 
and (D) zoom in on the isodichroic points for the titration at 25°C and 65°C, respectively. 
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Kinetics of Nucleotide Binding 
Binding of dUMP or dTMP to oxidized TmFDTS causes a significant change in 
the absorbance spectrum of the flavin (Chapter 2 and Figure 3 - 2A). Binding of dUMP 
or dTMP to oxidized TmFDTS (16 µM active sites after mixing) was monitored at 25°C 
using a stopped-flow spectrophotometer. We were unable to perform the experiments at 
high temperatures due to limitations of the instrument. Traces at 390 and 450 nm for 
either deoxynucleotide fit to a single exponential at all concentrations of 
deoxynucleotide (Figures 3 - 13A to 3 - 13D). Traces at 390 nm and 450 nm were fit 
simultaneously using a single kobs for each concentration of dUMP or dTMP. The 
observed rate constant for binding of either deoxynucleotide increased linearly with 
nucleotide concentration, consistent with a one-step bimolecular event (Figure 3 - 13E). 
The observation that only a single exponential is observed in the experiment at 25°C 
suggests that the two sets of sites detected by ITC and CD have similar association rate 
constant (kon) values. The slope from the concentration dependence of the observed 
rate constant provides kon for binding of the nucleotide to oxidized TmFDTS. kon for 
binding of dUMP to oxidized TmFDTS was 4.4 ± 0.1 x 106 M-1s-1 whereas kon for binding 
of dTMP to oxidized TmFDTS was 3.5 ± 0.1 x 106 M-1s-1. The y-intercept from the 
concentration dependence of the observed rate constant theoretically corresponds to 
the dissocation rate constant (koff) for ligand binding in a simple one-step mechanism. 
However, the y-intercepts for binding of dUMP or dTMP to oxidized TmFDTS were too 
small to provide an accurate value for koff, and the presence of two sets of sites 
complicates the interpretation of the y-intercept. We were unable to perform similar 
experiments for nucleotide binding to reduced TmFDTS because the spectral change 
109 
upon binding dUMP or dTMP to reduced TmFDTS was too small to observe by 
stopped-flow. 
 
 
 
 
 
 
 
 
Figure 3 - 13. Deoxynucleotide binding kinetics. Binding was observed at 390 nm and 450 nm when ~16 µM 
oxidized TmFDTS (active sites after mixing) was mixed with 50 – 200 µM dUMP ((A) and (B)) or dTMP (((C) 
and (D)) (after mixing) in 0.1 M Tris-HCl, pH 8 at 25°C. Three traces were collected for each dUMP and 
dTMP concentration at each wavelength. Traces at all concentrations fit to a single exponential. (E) 
Dependence of the observed rate constant as a function of dUMP or dTMP concentration. The observed rate 
constant increased linearly with dUMP or dTMP concentration, giving association rate constants of 4.4 ± 0.1  
x 10
6
 M
-1
s
-1
 and 3.5 ± 0.1   x 10
6
 M
-1
s
-1
, respectively, for dUMP and dTMP. 
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Competition with dCMP 
We were unable to determine koff for dUMP and dTMP from the intercepts in the 
binding kinetics studies. An alternative way to determine koff is to use a competitor that 
has a different UV/visible absorbance spectrum when bound to the enzyme. 2’-
Deoxycytidine-5’-monophosphate (dCMP) fulfills that requirement. The absorbance 
spectrum of the oxidized TmFDTS-dCMP complex is different from both the oxidized 
TmFDTS-dUMP and oxidized TmFDTS-dTMP complexes (Figure 3 - 14A). dCMP binds 
to oxidized TmFDTS with a Kd of 13 µM based on spectrophotometric titrations.  
The dissociation of dTMP from the oxidized TmFDTS-dTMP complex was 
monitored in a stopped-flow spectrophotometer at 480 nm by mixing the pre-formed 
oxidized TmFDTS-dTMP complex against an excess concentration of dCMP. Traces fit 
to two exponentials that each contributed ~50% of the total absorbance change (Figure 
3 - 14B). The observed rate constants for the first and second phase were 0.33 ±  0.06 
s-1 and 0.060 ± 0.010 s-1, respectively. The observed rate constants were identical for 
100 mM dCMP and 200 mM dCMP (after mixing), indicating that the concentration of 
dCMP was high enough to make koff rate-limiting. Two phases with similar amplitudes in 
the dissociation of dTMP from oxidized TmFDTS are consistent with two sets of binding 
sites with different affinities, as was observed by ITC and CD. However, only a single 
exponential was observed when dTMP binds to oxidized TmFDTS. This behavior 
suggests that the two binding sites have identical kon values, but different koff values. 
The two koff values and the single kon give Kd values of 17 ± 3 nM and 94 ± 16 nM for 
the two sites, which are similar to the Kd values for dTMP binding to oxidized TmFDTS 
obtained through the absorbance titration and ITC experiments (Table 3 - 4). 
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Figure 3 - 14. Competition of oxidized TmFDTS complexes with dCMP. (A) Absorbance spectra of oxidized 
TmFDTS in complex with saturating concentrations of different deoxynucleotides in 0.1 M Tris-HCl, pH 8 at 
25°C. Black, dUMP; blue, dTMP; orange, dCMP. (B) Kinetic trace observed at 480 nm when 21 µM oxidized 
TmFDTS-dTMP complex (active sites after mixing) was mixed with 100 – 200 mM dCMP (after mixing). Traces 
were fit to two exponentials, with each exponential contributing ~50% of the total signal change. The red line is 
an attempt to fit the data to a single exponential, which poorly fits the data. The observed rate constants for the 
two phases did not vary between 100 and 200 mM dCMP (inset), indicating that saturating concentrations of 
dCMP were used and that the kobs values correspond to the dissociation rate constants for the two sets of 
binding sites. The koff values for dTMP dissociating from oxidized TmFDTS were 0.33 ± 0.06 s
-1
 and 0.06 ± 0.01 
s
-1
. (C) Kinetic trace observed at 390 nm when 21 µM oxidized TmFDTS-dUMP complex (active sites after 
mixing) was mixed with 100 – 200 mM dCMP (after mixing). Traces fit best to two exponentials (blue line) and 
did not fit as well to a single exponential (red line). A log scale is used for the x-axis to highlight the differences 
between fitting to one and two exponentials. (D) The kobs values did not vary with dCMP concentration. The koff 
values for dUMP dissociating from oxidized TmFDTS were 0.032 ± 0.002 s
-1
 and 0.009 ± 0.005 s
-1
. 
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Table 3 - 4: Rate Constants and Dissociation Constants for Deoxynucleotide Binding to TmFDTS, pH 8 at 25 
°C 
Nucleotide enzyme 
 
kon (M
-1s-1) koff (s
-1) Kd from kinetics Kd from ITC 
dUMP 
oxidized 
site A 
4.4 ± 0.1 x 106 
0.009 ± 0.005 2 ± 1 nM 1.4 ± 0.5 nM 
site B 0.032 ± 0.002 7.3 ± 0.5 nM 25 ± 7 nM 
reduced 
site A 
 
1.2 ± 0.1 270 ± 20 nMa 
 
site B 
 
7.1 ± 0.6 1.6 ± 0.1 µMa 
 
dTMP 
oxidized 
site A 
3.5 ± 0.1 x 106 
0.06 ± 0.01 17 ± 3 nM 12 ± 2 nM 
site B 0.33 ± 0.06 94 ± 17 nM 220 ± 27 nM 
reduced 
site A 
 
14 ± 1 4 ± 0.3 µMa 
 
site B 
 
>80 > 23 µMa 
 
aCalculated using the kon determined for oxidized TmFDTS 
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Analogous competition experiments were performed with the oxidized TmFDTS-
dUMP complex to determine koff for dUMP. Traces were monitored at 390 nm instead of 
480 nm because the signal change between the oxidized TmFDTS-dUMP and the 
oxidized TmFDTS-dCMP complexes was larger at 390 nm compared to 480 nm. Traces 
were fit to two exponentials, with the first phase contributing ~85% of the total signal 
change (Figure 3 - 14C). The observed rate constants for the first and second 
exponentials were 0.032 ± 0.002 s-1 and 0.009 ± 0.005 s-1, respectively, giving Kds of 
7.3 ± 0.5 nM and 2 ± 1 nM when combined with kon,
 which again are similar to the 
values obtained through the absorbance titrations and ITC experiments (Table 3 - 4). 
After completion of the competition reaction with dCMP, the A450/A390 ratio in the 
UV/visible absorbance spectrum was 1.24 ± 0.01, which is not consistent with the 
spectrum of the oxidized TmFDTS-dCMP complex (A450/A390 = 1.41 ± 0.02) expected 
if all of the dUMP in the complex was replaced by dCMP (Figure 3 - 15A). Instead, the 
A450/A390 ratio was approximately half-way between that of the oxidized TmFDTS-
dCMP complex and the oxidized TmFDTS-dUMP complex (A450/A390 = 1.10 ± 0.01), 
suggesting that dUMP in half the active sites of the oxidized TmFDTS-dUMP complex 
failed to dissociate when competed with excess dCMP, causing the amplitude for the 
second phase in the competition reaction to be relatively small. To test this, the 
unbound deoxynucleotides were removed from the enzyme after the competition 
reaction using a desalting column; the resulting enzyme was denatured with HCl to 
release the bound deoxynucleotides, which were then analyzed by HPLC. Integration of 
the HPLC peaks indicated the presence of dUMP at roughly half the concentration of 
flavin, consistent with dUMP not dissociating from half of the active sites in the 
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competition experiment (Figure 3 - 15B). The completed reaction from the TmFDTS-
dTMP competition experiment was also desalted and analyzed for tightly bound 
deoxynucleotides; the A450/A390 ratio was 1.38 and only a trace amount of dTMP 
(10% of the flavin concentration) was detected by HPLC, consistent with the majority of 
dTMP dissociating from both populations of the enzyme (Figure 3 - 15C).  
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Figure 3 - 15. dUMP does not completely dissociate from oxidized TmFDTS in the competition 
experiments with dCMP. (A) the UV/visible absorbance spectrum of oxidized TmFDTS at the end of the 
competition experiment in Figure 8C (green) is halfway between the spectrum of the oxidized TmFDTS-
dUMP complex (black) and the spectrum of the oxidized TmFDTS-dCMP complex (blue). (B) HPLC 
chromatogram of the compounds that were bound to TmFDTS at the end of the experiment in Figure 8C. 
The concentrations of dCMP (4 min) and dUMP (5 min) were ~half the concentration of flavin (15 min), 
indicating that dCMP failed to replace the dUMP in half of the active sites of oxidized TmFDTS. (C) HPLC 
chromatogram of the compounds that were bound to TmFDTS at the end of the experiment in Figure 8B. 
The concentration of dTMP (8 min) was ~10% of the concentration of flavin (15 min), indicating that most 
of the dTMP dissociated from oxidized TmFDTS. The concentration of dCMP (4 min) was ~70% of the 
concentration of flavin. The peak at 9 min in the chromatograms has the same UV/visible spectrum and 
retention time as adenosine-5’-monophosphate. It likely resulted from the hydrolysis of FAD when acid-
denaturing the enzyme. 
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The UV/visible absorbance spectrum of the reduced TmFDTS-dCMP complex 
was also different from the reduced TmFDTS-dUMP and reduced TmFDTS-dTMP 
complexes (Figure 3 - 16A). Competition experiments were performed using excess 
dCMP with the reduced TmFDTS-dUMP and reduced TmFDTS-dTMP complexes to 
obtain koff values for dUMP and dTMP bound to reduced TmFDTS. The UV/visible 
absorbance spectrum of the reduced TmFDTS-dUMP and reduced TmFDTS-dTMP 
complexes were identical. The dissociation of dUMP or dTMP from reduced TmFDTS 
was monitored at 370 nm using a stopped-flow spectrophotometer. Traces for the 
dissociation of dUMP fit to two exponentials, with each contributing half of the total 
signal change, again consistent with two binding sites (Figure 3 - 16B). koff for the first 
phase was 7.1 ± 0.6 s-1 and koff for the second phase was 1.2 ± 0.1 s
-1 – the koff values 
for the two sets of binding sites were ~200-fold faster with reduced TmFDTS than with 
oxidized TmFDTS (Table 3 - 4). For dissociation of dTMP, only one exponential was 
observed due to the speed of the reaction and the presence of a mixing artifact within 
the first 50 msec (Figure 3 - 16C and 3 - 16D). The mixing artifact was the result of the 
large viscosity difference between the enzyme solution and the 100-200 mM dCMP. koff 
for the observable phase was 14 ± 1 s-1. Extrapolation of the observable phase back to 
0 seconds indicates that it accounted for only half of the total signal change between 
reduced TmFDTS-dTMP and reduced TmFDTS-dCMP. The rest of the signal change 
corresponds to a first, faster exponential that ended within the mixing artifact (50 msec). 
This provides a lower limit for koff of ~80 s
-1 for the first unobservable phase. The koff 
values for both sets of dTMP binding sites were ~230-fold faster or more with reduced 
TmFDTS than with oxidized TmFDTS (Table 3 - 4).  
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Figure 3 - 16. Competition of reduced TmFDTS complexes with dCMP. Absorbance spectra of reduced 
TmFDTS in complex with saturating concentrations of different deoxynucleotides in 0.1 M Tris-HCl, pH 8 at 
25°C. Black, dUMP or dTMP; orange, dCMP. (B) Kinetic trace observed at 370 nm when 83 µM reduced 
TmFDTS-dUMP complex (active sites after mixing) was mixed with 100 – 200 mM dCMP (after mixing). 
Traces fit to two exponentials, with each exponential contributing ~50% of the total signal change. The kobs 
values did not vary (inset), indicating that saturating concentrations of dCMP were used and that the kobs 
values correspond to the koff values for the two sets of binding sites. The koff values for dUMP dissociating 
from reduced TmFDTS were 7.1 ± 0.6 s
-1
 and 1.2 ± 0.1 s
-1
 for the two sets of binding sites. (C) Kinetic trace 
observed at 370 nm when 83 µM reduced TmFDTS-dTMP complex (active sites after mixing) was mixed 
with 100 – 200 mM dCMP (after mixing). There was a reproducible mixing artifact within the first 50 msec 
due to the large viscosity difference between the two syringes. (D) The data after 50 msec fit to a single 
exponential with kobs that did not vary between 100 mM and 200 mM dCMP, giving koff of 14 ± 1 s
-1
. 
Extrapolating the exponential to 0 sec indicated that the phase encompassed ~50% of the total absorbance 
change, suggesting that the rest of the absorbance change corresponds to a second exponential that 
occurred within the mixing artifact, with koff > 80 s
-1
. 
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Global Fitting 
The kinetic and thermodynamic data at 25°C suggest that the TmFDTS 
homotetramer binds dUMP and dTMP with two independent sets of binding sites that 
have identical kon values, but different koff values (Figure 3 - 17). The kinetic data for 
deoxynucleotide binding (Figure 3 - 13) and the kinetics for deoxynucleotide 
dissociation from the competition with dCMP (Figures 3 - 14 and 3 - 16) for each 
deoxynucleotide and flavin redox state could be fit globally in Berkeley Madonna using 
the model in Figure 3 - 14 (Figures 3 - 18 to 3 – 21 and Appendix 2). For the global 
fitting with oxidized TmFDTS and dUMP or dTMP, four concentrations of 
deoxynucleotide binding data at 450 nm (50 - 200 µM dUMP or dTMP) and the two 
dCMP concentrations (0.1 and 0.2 M) for the competition experiments were used. The 
kon values from the oxidized TmFDTS global fits were used for the global fitting of the 
reduced TmFDTS competition with dCMP data (Figures 3 - 20A and 3 - 21A). Since the 
absorbance titrations did not show two sets of sites, we forced the change in extinction 
coefficient upon binding dUMP or dTMP to each of the two sites to be identical in the 
global fitting. The refined microscopic rate constants from the global fitting were very 
similar to the rate constants from the primary analysis of the kinetic data, indicating that 
the data are consistent with the two independent binding sites model (Table 3 - 5). The 
absorbance titrations from Figure 3 - 2 were also simulated in Berkeley Madonna using 
the model in Figure 3 - 17 with the refined rate constants from the global fitting and the 
change in extinction coefficient upon deoxynucleotide binding from the experimental 
titrations. The simulated absorbance titrations showed good agreement with the 
experimental titrations (Figures 3 - 18 to 3 - 21). The experimental data from the ITC 
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Figure 3 - 17. Two independent sites mechanism for deoxynucleotide binding to TmFDTS at low 
temperatures. The numbers shown in the figure are the refined numbers from the global fit for oxidized 
TmFDTS and dUMP at pH 8, 25°C. The values in red refer to the high affinity site; the values in blue refer 
to the low affinity site. The extinction coefficients shown refer to the concentration of the FAD prosthetic 
group. 
titrations at 25°C could also be fit using the Kd values calculated from the refined global 
fitting models and identical N-values for the two sets of sites (Figures 3 - 18 to 3 - 21).  
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Figure 3 - 18. Global fitting of dUMP binding to oxidized TmFDTS data. (A) Stopped-flow absorbance data 
for dUMP binding to oxidized TmFDTS at 450 nm (red data), dissociation of dUMP from the oxidized 
TmFDTS-dUMP complex by competition with dCMP (blue data), and the return to baseline of the 
endothermic event by ITC (green data) could be fit globally in Berkeley Madonna to the two independent 
sites model shown in Figure 3 - 17. The black lines show the best fits obtained with Berkeley Madonna. 
The data for the kinetics of dUMP binding to oxidized TmFDTS were increased by 0.03 absorbance units 
for clarity. (B) The experimental absorbance titration from Chapter 2 (black data) with a simulated 
absorbance titration (blue line) made in Berkeley Madonna using the rate constants in Table 3 - 5. (C) The 
ITC titration (black data) fit using the Kd values from the global fitting and identical N-values for the two 
sets of binding sites (red trace). 
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Figure 3 - 19. Global fitting of dTMP binding to oxidized TmFDTS data. (A) Stopped-flow absorbance data for 
dTMP binding to oxidized TmFDTS at 450 nm (red data) and dissociation of dTMP from the oxidized TmFDTS-
dTMP complex by competition with dCMP (blue data) could be fit globally in Berkeley Madonna to the two 
independent sites model shown in Figure 3 - 17. The black lines show the best fits obtained with Berkeley 
Madonna. (B) The experimental absorbance titration of oxidized TmFDTS with dTMP (black data) with a 
simulated absorbance titration (blue line) made in Berkeley Madonna using the rate constants in Table 3 - 5. 
(C) The ITC titration (black data) fit using the Kd values from the global fitting and identical N-values for the two 
sets of binding sites (red trace). 
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Figure 3 - 20. Global fitting of dUMP binding to reduced TmFDTS data. (A) Stopped-flow 
absorbance data for dUMP dissociation from the reduced TmFDTS-dUMP complex by competition 
with dCMP (blue data) could be fit globally in Berkeley Madonna to the two independent sites model 
shown in Figure 3 - 17. The kon obtained from the experiments with oxidized TmFDTS was used for 
the global fitting of reduced TmFDTS. The black lines show the best fits obtained with Berkeley 
Madonna. (B) The experimental absorbance titration of reduced TmFDTS with dUMP (black data) 
with a simulated absorbance titration (blue line) made in Berkeley Madonna using the rate constants 
in Table 3 - 5. 
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Figure 3 - 21. Global fitting of dTMP binding to reduced TmFDTS data. (A) Stopped-flow absorbance 
data for dTMP dissociation from the reduced TmFDTS-dTMP complex by competition with dCMP (blue 
data) could be fit globally in Berkeley Madonna to the two independent sites model shown in Figure 3 - 
17. The data before 50 msec were omitted due to a large mixing artifact within the first 50 msec of data 
collection. The kon obtained from the experiments with oxidized TmFDTS was used for the global fitting 
of reduced TmFDTS. The black lines show the best fits obtained with Berkeley Madonna. (B) The 
experimental absorbance titration of reduced TmFDTS with dTMP (black data) with a simulated 
absorbance titration (blue line) made in Berkeley Madonna using the rate constants in Table 3 - 5.  
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Additional support for the two independent sites model comes from the ITC 
experiments for dUMP binding to oxidized TmFDTS at low temperatures; injections of 
dUMP corresponding to less than half the total number of active sites initially gave off 
heat but then absorbed heat (Figure 3 - 5). When dUMP is first injected, TmFDTS is in 
excess over the concentration of dUMP; the dUMP initially binds to both sets of sites 
equally because they have the same kon, giving rise to a single signal change (Figure 3 - 
22 step 1). The difference between the Kd values of the two sets of sites (due to their 
different koff values) then causes dUMP to dissociate from the low affinity site (step 2), 
producing a signal with the opposite sign of the initial binding event (making it 
endothermic), and to bind to the high affinity site (step 3). Since the enthalpy of dUMP 
binding to the low affinity site of oxidized TmFDTS is much more negative than the 
enthalpy of binding to the high affinity site, the re-distribution of dUMP produces an 
endothermic signal (steps 2 and 3). Halfway through the titration the high affinity site is 
completely filled with dUMP, so no redistribution from the low affinity site to the high 
Table 3 - 5: Comparison of the Rate Constants from Global Fitting and Primary Analysis 
 
Nucleotide Enzyme 
Experimental 
kon (M
-1
s
-1
) 
Global Fitting 
kon (M
-1
s
-1
) 
Experimental 
koff (s
-1
) 
Global Fitting 
koff (s
-1
) 
dUMP 
oxidized 
site A 
4.4 x 10
6
 6.4 x 10
6
 
0.009 0.008 
site B 0.032 0.043 
reduced 
site A 
  
1.2 0.8 
site B 7.1 5 
dTMP 
oxidized 
site A 
3.5 x 10
6
 5.9 x 10
6
 
0.06 0.025 
site B 0.33 0.18 
reduced 
site A 
  
14 8 
site B >80 >80 
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affinity site occurs during the second half of the titration (Figure 3 - 5). The re-
distribution step would primarily be dictated by koff for the low affinity site, which is very 
low for dUMP bound to TmFDTS. The return to baseline from the endothermic process 
during the ITC titration of oxidized TmFDTS with dUMP could be incorporated into the 
global fitting without altering the microscopic rate constants (Figure 3 – 18). 
 
 
 
 
 
 
 
 
 
Discussion 
TmFDTS binds dUMP and dTMP ~200-fold less tightly when the enzyme-bound 
flavin is in the reduced, hydroquinone form compared to when the flavin is oxidized. The 
changes in nucleotide affinity with the flavin redox state are largely manifested through 
Figure 3 - 22. Mechanism causing the baseline overshoots in the ITC titrations at low temperatures. The 
high affinity site is shown in red and the low affinity site is shown in blue. The enthalpy values shown are 
for dUMP binding to oxidized TmFDTS in 0.1 M Tris-HCl pH 8 at 25°C. In the early injections of the ITC 
titrations, the concentration of TmFDTS is much higher than the dUMP concentration; dUMP binds to both 
the high affinity site and low affinity site in equal amounts since kon is the same for both sites, causing 8.3 
kcal/mol of heat to be released (step 1). Since there are still many unoccupied high affinity sites available 
to bind dUMP, the dUMP that bound to the low affinity site dissociates from the low affinity site, 
absorbing 5.7 kcal/mol of heat (step 2), and then binds to the unoccupied high affinity sites, releasing 2.6 
kcal/mol of heat (step 3). Overall, 3.1 kcal/mol of heat is absorbed when dUMP re-equilibrates between 
the low and high affinity sites (steps 2 and 3). The re-equilibration step can be observed by ITC because the 
dissociation of dUMP from the low affinity site is much slower than the dUMP binding steps and the 
instrument recovery time. 
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changes in the dissociation rate constant (Table 3 - 5). Although we could not directly 
determine kon for nucleotide binding to reduced TmFDTS, the changes in koff between 
oxidized and reduced TmFDTS are similar to the changes in affinity predicted by the 
differences in reduction potential of free and bound TmFDTS, suggesting that kon does 
not change with the flavin oxidation state. It is somewhat surprising that TmFDTS binds 
deoxynucleotides less tightly when reduced since the reduced enzyme is the form that 
reacts with dUMP and CH2THF in the oxidative half-reaction. However, doing so also 
lowers the reduction potential of the flavin ~60 mV, which might be necessary to provide 
enough reducing power to reduce the dUMP-methylene intermediate in the oxidative 
half-reaction. Curiously, a recent study on the FDTS from Paramecium bursaria 
Chlorella virus-1 showed that the potential of the flavin in that enzyme does not change 
with dUMP binding,17 indicating that changes in affinity for nucleotides with the flavin 
oxidation state might not apply to all FDTS enzymes. However, it is unclear if the 
enzyme used in that study co-purified with dTMP bound; if dTMP were present the 
potential likely would not change upon adding dUMP. 
The very low koff values provide an explanation for why TmFDTS co-purifies with 
dTMP. Bound dTMP could explain the discrepancies between different studies on the 
stimulating effects of dUMP on the reduction of FDTSs by NADPH since the study 
suggesting that dUMP does not affect reduction of FDTS by NADPH used the enzyme 
from T. maritima, which likely co-purified with dTMP.18 It is unclear if FDTSs from other 
organisms also co-purify with dTMP. However, we have observed that FDTS from the 
mesophile Campylobacter jejuni co-purifies with dTMP in all four active sites 
(unpublished observation). 
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It is unlikely that dTMP release and dUMP binding occurs in the portion of the 
TmFDTS catalytic cycle when the flavin is oxidized, given the very low koff values for 
both deoxynucleotides bound to oxidized TmFDTS. If that were the case, dTMP release 
during turnover would be severely rate-limiting since the rate constants for the chemistry 
steps in the reductive and oxidative half-reactions are much faster than the koff for dTMP 
bound to oxidized TmFDTS reported here.17,19 More likely, the dTMP made during the 
oxidative half-reaction remains bound to the enzyme until the flavin has been reduced 
by NADPH. Upon reducing the flavin, koff for dTMP increases ~200-fold, allowing dTMP 
to dissociate from TmFDTS. dUMP can then bind to reduced TmFDTS to react in the 
oxidative half-reaction. Consistent with this idea, we have seen that dTMP stimulates 
the reduction of oxidized TmFDTS by NADPH to a similar degree as dUMP 
(unpublished observation). 
TmFDTS behaves as a dimer-of-dimers with respect to nucleotide binding at 
temperatures below ~55°C, suggesting that there is asymmetry between the four active 
sites of TmFDTS at low temperatures. TmFDTS is from T. maritima, which normally 
lives at temperatures around 80°C. The dimer-of-dimers behavior of TmFDTS is a result 
of studying the enzyme at temperatures well below the physiologically relevant 
temperature of the organism. However, it is also possible that the dimer-of-dimers 
behavior occurs at physiological temperatures, but is only detectable at sub-
physiological temperatures. It is not known if the dimer-of-dimers behavior affects other 
parts of the catalytic cycle of TmFDTS. Most of the previous studies on TmFDTS were 
done at temperatures below the 55°C threshold, so it is possible that the dimer-of-
dimers behavior of TmFDTS complicated the interpretation of the data in those 
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studies.11,14,18,19,27 One notable example is the lax regiochemistry in incorporating the 
hydride from reduced TmFDTS into dTMP during the oxidative half-reaction – at 37°C 
the hydride was transferred to both C6 and C7 of dTMP in roughly equal proportions 
whereas at 65°C the hydride was only transferred to C7 of dTMP.14 The lax 
regiochemistry in hydride transfer at 37°C could therefore have been due to differences 
between the two sets of active sites of TmFDTS.  
The origin of the dimer-of-dimers behavior of TmFDTS is currently unclear. 
However, an overlay of the four subunits of the deoxynucleotide-free TmFDTS structure 
hints at a potential reason – the isoalloxazine portion of the FADs are not well ordered 
and H53 exists in two different conformations in the four active sites (Figure 3 - 7A).4 
Time-resolved fluorescence spectroscopy has also shown that the active site is highly 
dynamic in the absence of bound deoxynucleotides.28 The conformational flexibility of 
H53 and the isoalloxazine could therefore play a role in causing the asymmetry among 
the four active sites of TmFDTS. Supporting this idea, the two sets of sites had nearly 
identical Kd values in the titration of the H53A TmFDTS mutant enzyme with dUMP 
(Figure 3 – 7B). The active site loop (residues 89-94) could potentially be involved as 
well since it is completely disordered in all four active sites of the deoxynucleotide-free 
structure. In order for the dissociation rate constants to be different between the two 
sets of sites, the asymmetry should also be present in the dUMP-bound structure. 
However, the four subunits adopt a single conformation in the dUMP-bound structure 
(Figure 3 - 23).5 Crystallization artifacts cannot be ruled out since a polyethylene glycol 
molecule from the crystallization solution was bound in the active sites next to H53 in 
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Figure 3 - 23. Active site of dUMP-bound TmFDTS (PDB code 1O26). All four subunits of the TmFDTS 
homotetramer – including H53 – are in the same conformation when dUMP is bound. H53 is shown in 
cyan, dUMP is shown in salmon, FAD is shown in yellow, and polyethylene glycol from the 
crystallization solution is shown in orange.  
the dUMP-bound structure, which could have driven H53 to adopt a single conformation 
in all of the active sites. 
 
 
 
 
 
 
 
Conclusions 
TmFDTS binds dUMP and dTMP less tightly when the enzyme-bound flavin is 
reduced than when it is oxidized, which is largely due to changes in the dissociation rate 
constants. As a result, we propose that the exchange of dTMP and dUMP in the 
catalytic cycle of TmFDTS occurs when the flavin is reduced. The TmFDTS 
homotetramer also acts as a dimer-of-dimers with respect to deoxynucleotide binding at 
low temperatures, which should be taken into consideration in all future studies on 
FDTSs. 
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Chapter 4 
Prior Modifications are not Required for all tRNAs to React Rapidly with 
tRNA-Dihydrouridine Synthase-2 from Yeast 
tRNA molecules contain numerous modifications of the four encoded nucleotides 
that comprise all RNA. Over 100 different modifications have been identified in tRNA,1 
of which at least 25 are present in the budding yeast Saccharomyces cerevisiae.  
Dihydrouridine is one of the most abundant tRNA modifications, occurring in 
nearly all organisms.2 It is formed by the reduction of the carbon-carbon double bond of 
specific uridines in tRNAs by the dihydrouridine synthases (DUSs), a class of 
flavoenzymes (Figure 4 - 1).3 The physiological role for dihydrouridine is still unclear. 
Biophysical studies have shown that dihydrouridine increases the conformational 
flexibility of the RNA backbone.4 Corroborating this is the fact that species adapted to 
cold environments have a greater abundance of dihydrouridine whereas thermophilic 
organisms have much less or even none at all.5 The amount of dihydrouridine in each 
class of organisms could thus optimize the flexibility of the tRNA in their respective 
environments. 
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Other studies have shown that tRNA lacking dihydrouridine in addition to other 
modifications degrades at a substantially increased rate.6 The main function of 
dihydrouridine could therefore be to protect tRNA from degradation within the cell. It has 
long been known that dihydrouridine levels are increased in cancerous tissues,7 
possibly increasing the lifetimes of tRNA in cancerous cells. A recent study has shown 
that the human DUS2 is responsible for the increased dihydrouridine levels in 
pulmonary carcinogenesis, and repression of DUS2 inhibited growth of the cancerous 
cells.8 DUSs might therefore be a novel target for the treatment of cancer. 
Previous work has explored the kinetics of the reaction of S. cerevisiae DUS2 
with yeast tRNALeu-CAA, a species of tRNA known to contain dihydrouridine 
modifications.9 Intriguingly, it was found that the rate constant of the reaction of DUS2 
with a synthetic, in vitro transcribed tRNALeu-CAA was far too slow to account for the 
level of dihydrouridine present in S. cerevisiae cells. However, when tRNALeu-CAA 
isolated from a yeast strain lacking DUS2 was used instead (henceforth called “mature 
tRNALeu-CAA”), the reaction was >600 fold faster. Mature tRNALeu-CAA in S. cerevisiae 
contains 12 other modifications in addition to dihydrouridine.10 One possibility is that one 
Figure 4 - 1. Reaction catalyzed by tRNA-dihydrouridine synthase. 
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or more of the other modifications present in mature tRNALeu-CAA is needed before 
dihydrouridine synthesis can occur.  
Here I show that yeast DUS2 is oxidized rapidly by some tRNAs devoid of 
modifications, indicating additional complexity in the recognition of tRNAs by DUS2. I 
also identify RNA elements that are important for DUS2 to react rapidly with tRNAs and 
show that tRNA reactivity with DUS2 is not regulated by a single modification. 
Unmodified tRNALeu-CAA reacts poorly with DUS2 because it adopts a misfolded 
conformation. 
Experimental Procedures 
Protein Expression and Purification 
BL21 (DE3) cells containing the DUS2 expression plasmid were cultured and the 
enzyme purified as described previously.9 The genes for pseudouridine synthase-4 
(PUS4),11 pseudouridine synthase-8 (PUS8),12 tRNA(m5U54)methyltransferase 
(TRM2),13 a truncated version of tRNA(N2,N2G26)methyltransferase ((Δ1-17)TRM1),
14 
tRNA(N1G37)methyltransferase (TRM5)
15 from S. cerevisiae and the gene for tRNA(2’-
O-mG18)methyltransferase (TrmH)
16 from Thermus thermophilus were cloned from their 
respective genomic DNAs into the pMCSG7 ligation-independent cloning expression 
vector.17 The expression plasmids for PUS4, PUS8, and (Δ1-17)TRM1 were cloned into 
BL21(DE3)Gold competent cells whereas the expression plasmids for TRM2, TRM5, 
and TrmH were cloned into Rosetta2TM(DE3)pLysS competent cells. All cells were 
grown in 1L LB + 100 mg/L ampicillin. The Rosetta2TM(DE3)pLysS cultures were also 
grown in the presence of 34 mg/L chloramphenicol. All of the cultures, except the TrmH 
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cultures, were grown at 37°C until OD600 ≈ 1.0. At that point, the temperature was 
reduced to 28°C and each culture was induced with 0.1 mM IPTG. Four hours after 
induction, the cultures were harvested by centrifugation. The TrmH culture was grown at 
37°C until OD600 ≈ 0.8. After that, the temperature was reduced to 20°C and the culture 
was induced with 0.1 mM IPTG and grown overnight (~20 hours) before harvesting. 
After harvesting, the cultures containing PUS4, PUS8, TrmH, or (Δ1-17)TRM1 were 
resuspended in 50 mM NaPO4, pH 8, 300 mM NaCl, 10% glycerol (Purification Buffer A) 
whereas the cultures containing TRM2 or TRM5 were resuspended in 50 mM Tris-HCl, 
pH 7.5, 100 mM NaCl, 5 mM MgCl2, 10% glycerol (Purification Buffer B). After disrupting 
the cells by sonication and removing the cell debris by centrifugation, the cell extracts 
were loaded on separate 5 mL TALON® resin columns at 4°C that were pre-equilibrated 
in their respective Purification Buffers. The resins were washed with the appropriate 
Purification Buffer with 1 M NaCl and 5 mM imidazole added. The pure proteins were 
eluted with the appropriate Purification Buffer + 200 mM imidazole. Purity was assessed 
by SDS-PAGE. The pure proteins were separately desalted into 100 mM HEPES-
NaOH, pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 mM DTT, 10% glycerol and stored at -
80°C. The concentrations of the tRNA-modifying enzymes were estimated using the ε280 
predicted from the amino acid sequence of the proteins.18 The ε280 values used were as 
follows: PUS4 – 28880 M-1cm-1; PUS8 – 66420 M-1cm-1; TRM2 – 28410 M-1cm-1; (Δ1-
17)TRM1 – 59210 M-1cm-1; TRM5 – 37800 M-1cm-1; TrmH – 23590 M M-1cm-1. 
Construction of tRNA Plasmids 
The inserts for the tRNA plasmids of tRNAAsp, tRNAAla, and tRNALeu-CAA were 
each constructed by PCR using two complementary primers (Invitrogen) with a 20 bp 
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overlap comprising the entire tRNA gene to be transcribed with a T7 promoter 
upstream. The promoter-gene sequences were also flanked by an upstream and 
downstream EcoRI and BamHI restriction site, respectively. The original U1-A72 base-
pair was changed to G1-C72 in the tRNA
Asp sequence to improve the yield of full-length 
tRNA through in vitro transcription.11 The inserts were cloned into the vector pUC118 
using the aforementioned restriction sites. The in vitro transcription plasmid for tRNAHis2 
was a gift from Jane Jackman. 
In Vitro Transcription of tRNAs 
The plasmid templates were linearized by digestion with BstNI (for tRNAAsp, 
tRNAAla, and tRNALeu-CAA) or NsiI (for tRNAHis2). tRNAs were synthesized as run-off 
transcripts by in vitro transcription using the linearized plasmids as templates.19 The 
tRNA was then purified by loading the reactions on a 5 cm x 1.5 cm I.D. DEAE-
Sepharose Fast-flow column pre-equilibrated in 50 mM NaPO4, pH 6.5, 150 mM NaCl, 
0.2 mM EDTA. The column was washed with 50 mM NaPO4, pH 6.5, 400 mM NaCl, 0.2 
mM EDTA until the A260 reading of the eluate was 0. Pure tRNA was then eluted with 50 
mM NaPO4, pH 6.5, 525 mM NaCl, 0.2 mM EDTA, concentrated using 10 kDa Amicon 
centrifugal filter units and desalted into 100 mM HEPES-NaOH, pH 7.5, 100 mM NaCl, 
10 mM MgCl2, 10% glycerol using a PD-10 desalting column. Mature tRNA
Leu-CAA was 
purified as described previously using a resin containing an immobilized oligo with a 
sequence complementary to part of tRNALeu-CAA.9 Prior to use, tRNAs in 100 mM 
HEPES-NaOH, pH 7.5, 100 mM NaCl, 10 mM MgCl2 and 10 % glycerol, were heated to 
65°C for 5 min, and then cooled on ice to allow proper folding. 
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Binding Titrations 
Binding titrations were carried out in quartz fluorescence cuvettes at 4°C in 100 
mM HEPES-NaOH, pH 7.5, 100 mM NaCl, 10 mM MgCl2, 10% glycerol in a Shimadzu 
UV-2501 PC scanning spectrophotometer or a Shimadzu RF-5301PC 
spectrofluorimeter. 15 µM enzyme was titrated with increasing concentrations of ligand. 
For the fluorescence titrations, excitation was at 457 nm, and emission scanned 
between 480 and 600 nm, with a maximum fluorescence change at 517 nm. Plots of the 
signal change with ligand concentration could not be fit to a hyperbolic binding isotherm. 
Instead, plots were fit to Equation 1 for tight binding: 
        
          √(        )
       
 
               
where ΔS is the change in absorbance or fluorescence, ΔSmax is the maximum change 
in extinction coefficient for absorbance or an arbitrary parameter in fluorescence, E0 is 
the initial enzyme concentration, L0 is the added ligand concentration and Kd is the 
dissociation constant. 
Oxidative Half-Reaction Kinetics 
Enzyme solutions were made anaerobic in glass cuvettes or tonometers by 
multiple cycles of evacuation followed by equilibration with purified argon. When 
required, DUS2 was reduced by titrating with one equivalent of dithionite. For stopped-
flow experiments, tRNA solutions were made anaerobic by bubbling with purified argon. 
Reactions were performed at 4°C in 100 mM HEPES-NaOH, pH 7.5, 100 mM NaCl, 10 
mM MgCl2, 10% glycerol. The enzyme concentration for all experiments was 15 µM 
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after mixing. Absorbance spectra were obtained over time using a Shimadzu UV-
2501PC scanning spectrophotometer for slow reactions; rapid reactions were studied 
using a Hi-Tech Scientific SF61DX2 stopped-flow instrument. Reaction traces were fit to 
sums of exponentials.  
Binding Kinetics 
The kinetics of unmodified tRNAAsp binding to DUS2ox were studied using a Hi-
Tech Scientific SF61DX2 stopped-flow unit. Experiments were performed by mixing 15 
µM DUS2ox with 25-400 µM unmodified tRNA
Asp (all concentrations are after mixing) in 
100 mM HEPES-NaOH, pH 7.5, 100 mM NaCl, 100 mM MgCl2, 10% glycerol at 4°C. 
For the absorbance experiments, traces were monitored at 510 nm. For the 
fluorescence experiments, the observation cell was excited at 457 nm and a 500 nm 
cut-off filter was used for detecting the fluorescence emission. 
Partial Modification of tRNALeu-CAA 
tRNALeu-CAA was partially modified by incubating 100 µM unmodified tRNALeu-
CAA with 1 µM PUS4, 1 µM PUS8, 1 µM TRM2, 1 µM TRM5, 1 µM TRM1, 1 µM TrmH, 
2 mM S-adenosyl methionine, 5 mM DTT in 1 mL 100 mM HEPES-NaOH, pH 7.5, 100 
mM NaCl, 10 mM MgCl2, 10% glycerol at 30°C for 90 minutes. The sample was then 
incubated at 50°C for 30 minutes to allow for greater activity of TrmH. The reaction as 
then quenched by phenol-chloroform extraction followed by ethanol-precipitation. The 
tRNA was washed once with 70% ethanol and dissolved in 100 mM HEPES-NaOH, pH 
7.5, 100 mM NaCl, 10 mM MgCl2, 10% glycerol. 
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Electrophoresis 
Electrophoresis was performed using a Bio-Rad Mini PROTEAN® 3 system at 
room temperature. The denaturing PAGE experiments were performed using 9% 
acrylamide, 1X TBE, 8 M urea gels. Native PAGE experiments were performed using 
9% acrylamide, 1X TBE, 12 mM MgCl2 gels. 12 mM MgCl2 was also added to the 1X 
TBE running buffer to ensure that Mg2+ remained in the gels. The gels were stained 
using ethidium bromide. 
Results 
Oxidative Half-Reaction with Unmodified tRNAAsp 
 I investigated the oxidative half-reaction of reduced DUS2 (DUS2red) with 
unmodified yeast tRNAAsp, which when modified contains a dihydrouridine at position 
20. Intriguingly, unmodified tRNAAsp was reduced rapidly by DUS2red (Figure 4 - 2), in 
contrast with previous work showing that tRNA must contain other modifications in order 
to react rapidly with DUS2.9 DUS2red was oxidized at 4°C by mixing with various                                                                     
concentrations of unmodified tRNAAsp in anaerobic stopped-flow experiments. The 
absorbance increases at 450 nm fit to two exponentials, with the first contributing ~90 
percent of the absorbance change. The first phase was attributed to oxidation of the 
enzyme by tRNA. The second was attributed to a small amount of enzyme aggregation 
based on an increase in light-scattering at longer wavelengths that occurred with the 
same kobs as the second exponential at 450 nm. The observed rate constant (kobs) for 
the first exponential did not vary with tRNAAsp concentration, indicating a Kd much lower 
than 20 µM (Figure 4 - 2). The rate constant for the reaction of DUS2red with unmodified 
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Figure 4 – 2. Oxidation of DUS2red by unmodified tRNA
Asp
. Anaerobic reduced DUS2 (15 µM) was oxidized 
by mixing with various concentrations of unmodified tRNA
Asp
, from 25 to 400 µM, in 100 mM HEPES-NaOH 
pH 7.5, 100 mM NaCl, 10 mM MgCl2, 10% glycerol, 4°C in a stopped-flow spectrophotometer. The 
absorbance was monitored at 450 nm and traces were fit to two exponentials. The inset shows the 
concentration dependence of the first exponential, flavin oxidation, by unmodified tRNA
Asp
. kobs1 remained 
constant at 0.045 s
-1
 at all tRNA concentrations used, indicating a Kd much lower than 20 µM. The second 
exponential was attributed to an increase in light-scattering due to the aggregation of a small population of 
enzyme. 
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tRNAAsp was 0.045 ± 8 x 10-4 s-1. This is about 3-fold slower than the rate constant 
obtained with mature tRNALeu-CAA (0.14 ± 0.03 s-1), but is still fast enough to account 
for the amount of dihydrouridylated tRNA in yeast cells.9 Modifications therefore are not 
universally required for rapid reactivity with DUS2. 
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 Previous work has also shown that many tRNAs require Mg2+ for proper 
folding.20,21 In an attempt to determine if DUS2 requires properly folded tRNA, the Mg2+ 
dependence of tRNAAsp reduction by DUS2 was investigated by performing the 
oxidative half-reaction in the absence of Mg2+ with 20 mM EDTA. The kinetics of the 
oxidative half-reaction without Mg2+ were identical to the experiments with Mg2+, 
indicating either that DUS2 does not require properly folded tRNA for recognition or that 
unmodified tRNAAsp folds properly even without Mg2+. Recent crystal structures of a 
DUS-tRNA complex from Thermus thermophilus suggest the latter since DUS in that 
structure makes multiple contacts with the D-, T-, and anticodon arms of a properly 
folded L-shaped tRNA (Figure 4 - 3).22 
 
 
 
 
 
 
 
 
 
Figure 4 - 3. Structure of T. thermophilus DUS in complex with tRNA (PDB 3B0U). The two domains of 
DUS are shown in blue and pink. The tRNA is shown in orange. 
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DUS2 Recognizes More than Just the D-loop of tRNA 
 Several tRNA-modifying enzymes can recognize and modify stem-loop structures 
with appropriate sequences independent of the rest of the tRNA molecule.23,24  The 
Mg2+-dependence experiments prompted us to consider whether DUS2 recognizes the 
full-length tRNA transcript or solely the D-loop. To explore this possibility, the oxidative 
half-reaction of DUS2red was performed with 125 µM of a stem-loop comprised of the D-
loop of tRNAAsp extended by the anticodon arm (Figure 4 - 4). The reaction was 
extremely slow, taking nearly a week to complete. The enzyme slowly aggregated over 
the long reaction-time – the turbidity of the sample steadily increased during the 
experiment – so the observed rate constant was estimated as being 1.2 x 10-4 ± 7 x 10-6 
s-1 using the initial rate before excessive aggregation had occurred.   
 
Figure 4 - 4. Stem loop consisting of the D-loop extended by the anticodon stem of unmodified tRNA
Asp
. 
This stem-loop was a poor substrate for DUS2 in an oxidative half-reaction. 
D-loop 
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Uracil 
Anticodon Stem 
143 
 
The Required Modifications for Rapid tRNA Reduction by DUS2 are not Isolated 
to One Region of tRNA 
 To determine if the essential modifications for rapid reactivity with DUS2 of 
tRNALeu-CAA are isolated to a specific region of the tRNA, chimeric tRNAs were 
designed with the D-loops of tRNAAsp and tRNALeu-CAA interchanged (Figure 4 - 5). If 
the important modifications in tRNALeu-CAA were isolated to regions outside of the D-
loop, a chimeric tRNA containing the D-loop of tRNALeu-CAA and the body of tRNAAsp 
would be reduced rapidly by DUS2. Conversely, if the important modifications in 
tRNALeu-CAA were solely in the D-loop, the opposite chimeric tRNA would be reduced 
rapidly by DUS2.  Reduction of both of these chimeric tRNAs by DUS2 was slow. The 
observed rate constants for tRNA reduction were 1.6 x 10-5 s-1 and 2.6 x 10-5 s-1 for the 
construct in Figure 4 - 5A and Figure 4 - 5B, respectively (Figure 4 - 5C).  
A 
Figure 4 - 5. Cloverleaf structures and reactivity of chimeric tRNAs. (A) and (B) show the cloverleaf 
structures of the two chimeric tRNAs. Regions derived from tRNA
Asp
 are depicted in black; regions derived 
from tRNA
Leu
-CAA are depicted in blue. (C) Oxidative half-reactions of the tRNAs in (A) and (B) with 
DUS2red. The tRNA in (A) reacted with kobs of 1.6 x 10
-5
 s
-1
 (black data). The tRNA in (B) reacted with kobs of 
2.6 x 10
-5
 s
-1
 (blue data). Both constructs reacted poorly with DUS2. 
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The Reaction Rate of DUS2 is not Based on a Single Modification 
 The unmodified tRNAAsp oxidative half-reaction experiments indicate that not all 
tRNAs require additional modifications to react with DUS2. One possible explanation for 
this result is that tRNAAsp does not normally contain the modification that is required for 
tRNALeu-CAA to react rapidly with DUS2. Indeed, tRNALeu-CAA contains 7 modifications 
that are not found in tRNAAsp. I sought to eliminate some of these 7 modifications as 
potential candidates for the modification that enhances the reactivity with DUS2 by 
analyzing the reactivities of additional unmodified tRNAs which contain subsets of those 
7 modifications. If the important modification that enhances reactivity is normally present 
on a given tRNA, that tRNA should react poorly with DUS2 as an unmodified transcript. 
However, if a given tRNA does not normally contain the important modification, it should 
react rapidly with DUS2 even when unmodified. Analyzing enough tRNAs should 
eliminate all but one candidate modification. By examining the Transfer RNA Database,2 
tRNAHis2 and tRNAAla, which contain 4 and 1 of the 7 modifications, respectively (Figure 
4 - 6) were chosen.  
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 The oxidative half-reactions with these two tRNAs were monitored in a stopped-
flow spectrophotometer by anaerobically mixing DUS2red with either unmodified tRNA
His2 
or unmodified tRNAAla. Unmodified tRNAHis2 reacted rapidly in a single phase with an 
observed rate constant of 0.22 ± 0.01 s-1 (Figure 4 - 7A). Unmodified tRNAAla also 
reacted rapidly with DUS2red; traces were biphasic (Figure 4 - 7B). Similar to the 
reaction with unmodified tRNAAsp, the first phase contributed the majority of the signal 
change and was attributed to oxidation of the flavin by unmodified tRNAAla. The second 
phase was attributed to a small amount of enzyme aggregation or multiple populations 
of tRNA. The rate constant for flavin oxidation of DUS2red by unmodified tRNA
Ala was 
0.15 ± 0.01 s-1. Since unmodified tRNAAla and tRNAHis2 reacted rapidly with DUS2red, the 
modifications that they share with tRNALeu-CAA are unlikely to be the modification 
Figure 4 - 6. A comparison of the modification profiles of the four yeast tRNAs used in this study. The uridine 
that reacts with DUS2 is highlighted in red and the other modifications are highlighted in blue. Abbreviations 
used: m
2
G: N
2
-methylguanosine, ac
4
C: N
4
-acetylcytidine, Gm: 2’-O-methylguanosine, D: dihydrouridine, 
m
2
2G: N
2
,N
2
-dimethylguanosine, ψ: pseudouridine, m
5
C: 5-methylcytidine, m
1
G: N
1
-methylguanosine, T: 5-
methyluridine, Am: 2’-O-methyladenosine , I: inosine, m
1
I: 1-methylinosine. 
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required for tRNALeu-CAA to react rapidly with DUS2. Eliminating those modifications 
leaves only N2-methylguanosine at position 10 (m2G10) and N4-acetylcytidine at position 
12 (ac4C12) in tRNA
Leu-CAA as candidates. 
 In the process of incorporating individual modifications into unmodified tRNALeu-
CAA in vitro using recombinant tRNA-modifying enzymes, it was discovered that 
tRNALeu-CAA reacted rapidly with DUS2red if the tRNA had been pre-incubated with the 
enzymes that incorporate 2’-O-methylguanosine at position 18 (Gm18), N
2,N2-
dimethylguanosine at position 26 (m22G26), pseudouridine at position 32 (ψ32) and 55 
(ψ55), N
1-methylguanosine at position 34 (m1G34), and 5-methyluridine at position 54 
(m5U54) (Figure 4 - 8). Notably absent from this partially modified tRNA
Leu-CAA are 
Figure 4 - 7. Oxidation of DUS2red by unmodified tRNA
Ala
 (A) or tRNA
His2
 (B). 15 µM DUS2red was mixed 
with 25-50 µM unmodified tRNA
Ala
 or tRRNA
His2
 after mixing in 100 mM M HEPES-NaOH pH 7.5, 100 mM 
NaCl, 10 mM MgCl2, 10 % glycerol at 4 °C in a stopped-flow spectrophotometer. Traces at 450 nm fit to two 
exponentials for unmodified tRNA
Ala
 and one exponential for unmodified tRNA
His2
. The insets show the rate 
constants for flavin oxidation by the two tRNAs. The rate constants for flavin oxidation by unmodified 
tRNA
Ala
 and unmodified tRNA
His2
 were 0.15 s
-1
 and 0.22 s
-1
, respectively, both of which are comparable to 
the rate constants for flavin oxidation by unmodified tRNA
Asp
 and mature tRNA
Leu
-CAA. 
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Figure 4 - 8. Oxidation of DUS2red by partially modified tRNA
Leu
-CAA. A, cloverleaf structure of 
tRNA
Leu
-CAA containing 6 post-transcriptional modifications incorporated in vitro using recombinant 
tRNA-modifying enzymes. B, Reaction of 15 µM DUS2red with 75 µM of the partially modified tRNA
Leu
-
CAA shown in A. The reaction was performed in 100 mM HEPES-NaOH, pH 7.5, 100 mM NaCl, 10 
mM MgCl2, 10 % glycerol at 4 °C using a standard scanning spectrophotometer with one minute scan 
intervals. Most of the flavin was oxidized after the first scan, indicating that the partially modified 
tRNA
Leu
-CAA reacted rapidly with DUS2red. The data fit to a single exponential with kobs of 6 x 10
-3
 ± 3 x 
10
-4
 s
-1
. The fit did not extrapolate back to the initial absorbance of DUS2red (shown as a blue dot), 
indicating that at least one exponential completed prior to the first data point.  
A 
B 
m2G10 and ac
4C12, indicating that these modifications are also not required for tRNA
Leu-
CAA to react rapidly with DUS2. 
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Unmodified tRNAAsp, tRNALeu-CAA, tRNAAla, and tRNAHis2 Bind to Oxidized DUS2 
with Similar Affinities  
Binding of unmodified tRNAAsp induced a substantial change in the flavin 
absorbance spectrum of DUS2ox (Figure 4 - 9A). This spectral change can be used to 
track unmodified tRNAAsp binding in titration experiments, allowing the dissociation 
constant for unmodified tRNAAsp binding to DUS2ox to be determined. Unmodified 
tRNAAsp bound stoichiometrically to DUS2ox. Fitting to Eq. 1 provided an estimate of the 
Kd of 1.1 ± 0.4 µM. Binding of unmodified tRNA
His2 also produced a similar change in 
the flavin absorbance of DUS2ox as binding of unmodified tRNA
Asp. Curiously, binding of 
unmodified tRNALeu-CAA, mature tRNALeu-CAA, or unmodified tRNAAla did not produce 
a substantial change in the absorbance spectrum of DUS2ox. However, binding of these 
tRNAs to DUS2ox caused significant quenching of the flavin fluorescence (Figure 4 - 
9B). The affinities of unmodified tRNALeu-CAA, tRNAAla, and tRNAHis2 for DUS2ox were 
determined through fluorimetric titrations. Fitting the change in fluorescence against 
tRNA concentration provided estimates of 1.4 ± 0.7 µM, 1.0 ± 0.1 µM, and 1.8 ± 0.2 µM 
for the Kds of binding to DUS2ox for tRNA
Leu-CAA, tRNAAla, and tRNAHis2, respectively 
(Figures 4 - 9C, 4 - 9D,  4 - 9E and Table 4 - 1). The affinities for the four unmodified 
tRNAs are similar to the affinity for mature tRNALeu-CAA, which had a Kd of 0.8 ± 0.5 
µM.9 
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Figure 4 - 9. Titration of DUS2ox with unmodified tRNAs. Titrations were performed in 100 mM HEPES-NaOH, 
pH 7.5, 100 mM NaCl, 10 mM MgCl2, 10 % glycerol at 4 °C. (A) binding of unmodified tRNA
Asp
 to DUS2ox causes 
a significant change in the absorbance spectrum of the flavin. The inset shows ΔA510nm against tRNA
Asp
 
concentration. Fitting to Eq. 1 gives a Kd of 1.1 ± 0.4 µM. (B) binding of unmodified tRNA
Leu
-CAA, tRNA
Ala
 or 
tRNA
His2
 quenched the fluorescence of the flavin of DUS2ox. (C), (D), and (E), the change in DUS2ox 
fluorescence as a function of tRNA concentration for unmodified tRNA
Leu
-CAA, unmodified tRNA
Ala
, and 
unmodified tRNA
His2
, respectively. Fitting to Eq. 1 gives a Kd of 1.4 ± 0.7 µM, 1.0 ± 0.1 µM, and 1.8 ± 0.2 µM for 
unmodified tRNA
Leu
-CAA, unmodified tRNA
Ala
, and unmodified tRNA
His2
, respectively.  
0
0.05
0.1
0.15
0.2
300 400 500 600 700 800
A
 (nm)
0
0.01
0.02
0.03
0.04
0 20 40 60 80 100
A510
[tRNA
Asp
] (µM)
A
0
20
40
60
80
100
500 550 600
F 
(a.u.)
 (nm)
Increasing
tRNA
B
-20
-10
0
0 10 20 30 40 50
F
[tRNA
Leu
-CAA] µM
C
-40
-30
-20
-10
0
0 10 20 30 40 50
F
[tRNA
His2
] µM
E
150 
 
Table 4 - 1: tRNA Binding to DUS2ox
a 
tRNA Kd (µM) 
Unmodified tRNAAsp 1.1 ± 0.4 
Unmodified tRNALeu-CAA 1.4 ± 0.7 
Unmodified tRNAAla 1.0 ± 0.1 
Unmodified tRNAHis2 1.8 ± 0.2 
Mature tRNALeu-CAAb 0.8 ± 0.5 
a0.1 M HEPES-NaOH, pH 7.5, 100 mM NaCl, 10 
mM MgCl2, 10 % glycerol at 4°C. bData from ref. 9 
 
Unmodified tRNALeu-CAA Exists in Multiple Conformations  
A native-PAGE experiment was performed to assess whether unmodified tRNALeu-CAA 
has a tertiary structure similar to mature tRNALeu-CAA (Figure 4 - 10). Interestingly, 1 
µM unmodified tRNALeu-CAA refolded by heating to 65 °C then cooling on ice ran as two 
distinct populations on the native-PAGE, whereas unmodified tRNAAsp, unmodified 
tRNAAla, unmodified tRNAHis2, and mature tRNALeu-CAA ran as a single band. The two 
populations were present when unmodified tRNALeu-CAA was refolded in the presence 
or absence of Mg2+, indicating that Mg2+ does not help stabilize one conformation over 
the other. However, under denaturing conditions all of the tRNAs ran as a single band. 
Refolding the slower-running band that had been gel-purified under native conditions 
produced tRNA containing both populations on a native PAGE gel, indicating that the 
two bands are different conformations of the same molecule (Figure 4 - 11). 
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Figure 4 - 10. Native and denaturing PAGE gels of the tRNAs used in this study. tRNAs at 1 µM were 
refolded by heating to 65 °C for 5 minutes followed by cooling on ice in 10 mM Tris-HCl pH 8, 10 mM 
MgCl2, 10 % glycerol. (1) Unmodified tRNA
Ala
; (2) unmodified tRNA
Asp
; (3) unmodified tRNA
His2
; (4) mature 
tRNA
Leu
-CAA; (5) unmodified tRNA
Leu
-CAA refolded in the presence of Mg
2+
; (6) unmodified tRNA
Leu
-CAA 
refolded in the absence of Mg
2+
 (20 mM EDTA added). Unmodified tRNA
Leu
-CAA ran as two populations 
on the native gel whereas the other tRNAs ran as a single population (left panel). All of the tRNAs – 
including unmodified tRNA
Leu
-CAA – ran as a single population on the denaturing gel (right panel). 
 
 
 
 
 
 
 
1 2 
Figure 4 - 11. Native PAGE gel showing that the two conformations of unmodified tRNA
Leu
-CAA can 
interconvert. The larger band of unmodified tRNA
Leu
-CAA from the native gel in Figure 4 - 9 was gel-
purified under native conditions. (1) the larger band of unmodified tRNA
Leu
-CAA without refolding; (2) 
the larger band of unmodified tRNA
Leu
-CAA refolded by heating to 65 °C for five minutes followed by 
cooling on ice. 
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The oxidative half-reaction experiments required very high concentrations of 
tRNA (>750 µM). Unmodified tRNALeu-CAA refolded at 750 µM tRNA failed to enter the 
gel of a native-PAGE (Figure 4 - 12A), suggesting that unmodified tRNALeu-CAA 
refolded under conditions necessary for the oxidative half-reaction experiments exists 
solely as a large oligomer, explaining why unmodified tRNALeu-CAA reacts poorly with 
DUS2red. A native gel of the in vitro transcription reaction to produce unmodified 
tRNALeu-CAA also showed multiple populations of tRNA (Figure 4 - 12B), indicating that 
unmodified tRNALeu-CAA is not transcribed into a single conformation. 
 
Native 
B 
1 2 
A 
1 2 
Denaturing 
1 2 
Figure 4 - 12. Unmodified tRNA
Leu
-CAA does not fold correctly. (A) native and denaturing gels showing that 
unmodified tRNA
Leu
-CAA refolded under conditions necessary for the oxidative half-reaction experiments 
(750 µM tRNA) is a large oligomer. (1) mature tRNA
Leu
-CAA; (2) unmodified tRNA
Leu
-CAA. The extra bands 
in the mature tRNA
Leu
-CAA lane were attributed to minor degradation of the tRNA due to RNAses. (B) native 
gel showing that unmodified tRNA
Leu
-CAA is not transcribed solely into the correct conformation during in 
vitro transcription reactions. (1) mature tRNA
Leu
-CAA; (2)  the in vitro transcription reaction to make 
unmodified tRNA
Leu
-CAA. 
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Binding Kinetics of Unmodified tRNAAsp to DUS2ox 
 Binding of unmodified tRNAAsp to DUS2ox caused a significant blue-shift in the 
flavin absorbance spectrum (Figure 4 - 9A). The kinetics of binding of unmodified 
tRNAAsp to DUS2ox was investigated by performing stopped-flow experiments, 
monitoring the change in flavin absorbance at 510 nm (Figure 4 - 13A). Traces fit to two 
exponentials. The first contributed the majority (>95%) of the signal change and was 
attributed to binding of unmodified tRNAAsp to DUS2ox. The second, minor phase was 
inconsistent and attributed to minor enzyme aggregation or multiple populations of 
tRNA. The observed rate constant for the first exponential remained constant at 2.0 ± 
0.02 s-1 for all tRNAAsp concentrations used, indicating that binding of unmodified 
tRNAAsp to DUS2ox does not occur in one step. If binding had occurred in a single step, 
the observed rate constant would increase linearly with tRNAAsp concentration. The 
invariant observed rate constant also indicates that the Kd is much less than 20 µM, 
which is consistent with the equilibrium titration and oxidative half-reaction experiments 
using tRNAAsp. 
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 Binding of tRNAAsp to DUS2ox also causes a substantial quench in the 
fluorescence of the flavin prosthetic group of DUS2ox. The binding reaction was 
monitored through stopped-flow fluorescence experiments in an attempt to characterize 
the initial bimolecular interaction of tRNAAsp binding to DUS2ox. Flavin fluorescence was 
quenched in two phases (Figure 4 - 13B). The first observed rate constant appeared to 
remain constant at 150 ± 31 s-1 at all tRNAAsp concentrations used; however, the error 
for the data was relatively high for each tRNA concentration so other data fitting models 
cannot be excluded. The second observed rate constant remained constant at 2.3 ± 
0.02 s-1 at all tRNAAsp concentrations. The second exponential likely reflects the same 
step detected using stopped-flow spectrophotometry. The first exponential cannot 
represent the initial bimolecular binding step since it does not increase linearly with 
Figure 4 - 13. The kinetics of binding unmodified tRNA
Asp
 to DUS2ox. Experiments were performed in 100 mM 
HEPES-NaOH, pH 7.5, 100 mM NaCl, 10 mM MgCl2, 10% glycerol, 4°C. The insets show the concentration 
dependence of the kobs values for each experiment. (A) stopped-flow absorbance trace at 510 nm upon 
binding unmodified tRNA
Asp
 to DUS2ox. Traces fit to a single exponential with kobs of 2.0 ± 0.02 s
-1
 at all tRNA 
concentrations. (B) stopped-flow fluorescence trace of unmodified tRNA
Asp
 binding to DUS2ox. Traces fit to 
two exponentials with kobs1 of 150 ± 31 s
-1
 and kobs2 of 2.3 ± 0.02 s
-1
 at all tRNA concentrations. 
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Figure 4 - 14. Proposed mechanism for unmodified tRNA
Asp
 binding to oxidized DUS2. 
tRNAAsp concentration. The stopped-flow data suggest that binding of unmodified 
tRNAAsp to DUS2ox occurs with at least three steps (Figure 4 - 14). 
Discussion 
 Some tRNAs do not require prior modifications to react rapidly with yeast DUS2 – 
in this study, unmodified tRNAAsp, unmodified tRNAAla, and unmodified tRNAHis2 all 
reacted rapidly with DUS2red. Of the tRNAs tested thus far, only tRNA
Leu-CAA requires 
prior modifications in order to react rapidly with DUS2, suggesting that the incorporation 
of tRNA modifications is not ordered for all tRNAs. It is not known which of the other 
yeast tRNAs also require prior modifications in order to react rapidly with DUS2. One 
notable difference between the cloverleaf structure of tRNALeu-CAA and tRNAAsp, 
tRNAAla, and tRNAHis2 is that tRNALeu-CAA contains an extended variable loop (Figure 4 
- 6). In yeast, the only tRNAs containing an extended variable loop are the tRNALeu and 
tRNASer variants. The requirement for modifications might therefore be isolated to these 
tRNAs.  
 A single modification is not responsible for accelerating the reactivity of all tRNAs 
with DUS2. Hybrid constructs swapping the D-loops of unmodified tRNAAsp and 
unmodified tRNALeu-CAA both reacted poorly with DUS2red, suggesting that 
modifications in both the D-loop and the body of tRNALeu-CAA are required for tRNALeu-
CAA to react rapidly with DUS2; if only one modification in a particular portion of 
tRNALeu-CAA were important for reactivity with DUS2, replacing that portion with the 
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sequence of tRNAAsp should alleviate the requirement for that modification. In addition, 
unmodified tRNAAsp, unmodified tRNAAla, and unmodified tRNAHis2 all react rapidly with 
DUS2red; the modifications they share with tRNA
Leu-CAA therefore cannot be the single 
modification that enhances the reactivity of all tRNAs with DUS2red. The only 
modifications present in tRNALeu-CAA that are also absent in tRNAAsp, tRNAAla, or 
tRNAHis2 are m2G10 and ac
4C12. However, tRNA
Leu-CAA containing Gm18, m
2
2G26, ψ34, 
m1G37, m
5U54, ψ55 reacts rapidly with DUS2red. Therefore, m
2G10 and ac
4C12 cannot be 
the single modification that enhances the reactivity of all tRNAs with DUS2red. 
 Unmodified tRNALeu-CAA folds into multiple conformations – depending on the 
tRNA concentration – providing a potential explanation for the poor reactivity of 
unmodified tRNALeu-CAA with DUS2red. At relatively low concentrations (1 µM), 
unmodified tRNALeu-CAA folds into two populations that migrate differently on a native-
PAGE gel; one of the populations migrates through the native gel similar to mature 
tRNALeu-CAA whereas the other, more highly populated conformation, migrates more 
slowly through the gel. At concentrations used for the oxidative half-reaction 
experiments (750 µM), unmodified tRNALeu-CAA folds into a single population that is too 
large to enter the native gel. One possibility is that unmodified tRNALeu-CAA 
oligomerizes upon refolding, which would be consistent with the apparent dependence 
of the tRNA conformation on the concentration of tRNA used during refolding. tRNALeu-
CAA wouldn’t be unique with this regard, as a number of other tRNAs have been shown 
to form dimers.25–27 Another possibility is that unmodified tRNALeu-CAA folds into a 
conformation that differs from the usual L-shape conformation. tRNALeu-CAA isolated 
from yeast used to be known as the “renaturable” tRNALeu since it could be converted 
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into a misfolded conformation with an atypical secondary structure by refolding in the 
absence of Mg2+.28,29 Regardless, the presence of modifications in mature tRNALeu-CAA 
must help stabilize the properly folded state since only a single conformation of mature 
tRNALeu-CAA was detected by native-PAGE.  
 The misfolded conformation of unmodified tRNALeu-CAA does not have a large 
effect on the binding affinity of DUS2ox for tRNAs; the four unmodified tRNAs used in 
this study bind to DUS2ox with affinities similar to mature tRNA
Leu-CAA. This could 
indicate that binding of tRNAs by DUS2 is dominated by the favorable ionic interactions 
between the positively charged surface of DUS2 and the negatively charged 
phosphates of tRNA. The Kds determined through titrations represent the apparent 
equilibrium constant resulting from the multiple steps that occur with tRNA binding to 
DUS2ox. The kinetic data on unmodified tRNA
Asp binding to DUS2ox indicates that 
binding of unmodified tRNAAsp occurs with at least three steps, one of which is only 
detectable by fluorescence. The steps in addition to the bimolecular step could 
represent conformational changes like base-flipping of the reactive uracil into the active 
site of DUS2, or perhaps a rearrangement of the TIM-barrel and helix-bundle domains 
of DUS2 to accommodate tRNA binding. It is unclear why binding of unmodified tRNAAsp 
or unmodified tRNAHis2 causes a substantial change in the absorbance spectrum of 
DUS2ox whereas binding of unmodified tRNA
Ala, unmodified tRNALeu-CAA, or mature 
tRNALeu-CAA do not produce a similar change in the absorbance spectrum. It does 
suggest, though, that the environment of the flavin is different when bound to tRNAAsp or 
tRNAHis2 compared to the other tRNAs. 
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 One question raised by this work is how tRNALeu-CAA properly folds in vivo. 
tRNALeu-CAA would initially be transcribed without the modifications that stabilize the 
properly folded conformation. However, tRNALeu-CAA is also transcribed with an intron 
between the anticodon loop and the variable loop that is removed during processing. 
The role of the intron is currently unknown. The intron could stabilize the native 
conformation of tRNALeu-CAA, allowing some post-transcriptional modifications to be 
incorporated before removal of the intron. Indeed, studies in Xenopus laevis oocyte 
nuclei have shown that a number of modifications are incorporated into tRNA prior to 
removal of the intron.30 Unmodified tRNALeu-CAA containing the intron is a poor 
substrate of DUS2.9 However, DUS2 might not recognize tRNALeu-CAA until the intron 
has been removed. 
Conclusions 
 All tRNAs do not require prior modifications in order to react rapidly with yeast 
DUS2, and no single modification is responsible for enhancing the reactivity of all tRNAs 
with DUS2. Unmodified tRNALeu-CAA, which is a poor substrate of DUS2, folds into 
different conformations depending on the tRNA concentration used during refolding. At 
concentrations needed for oxidative half-reaction experiments with DUS2, unmodified 
tRNALeu-CAA refolds into a large oligomer, explaining why unmodified tRNALeu-CAA is a 
poor substrate of DUS2. Multiple modifications likely must be present on tRNALeu-CAA 
for it to fold into the conformation that reacts rapidly with DUS2.  
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Chapter 5 
Conclusions and Future Directions 
 This thesis focused on understanding the mechanism of substrate recognition 
and activation of two flavoenzymes involved in pyrimidine metabolism - flavin-
dependent thymidylate synthase (FDTS) and tRNA-dihydrouridine synthase (DUS).  
Flavin-Dependent Thymidylate Synthase 
 Chapter 2 focused on testing a mechanism for FDTS where dUMP is activated 
as a nucleophile by the electrostatically polarizing active site of the enzyme.1 The NMR 
data presented in Chapter 2 show that N3 of dUMP is ionized when bound to FDTS due 
to a specific arginine (R174 in T. maritima FDTS) in the active site of the enzyme. The 
electrostatic polarization is so extreme that the pKa of N3 is lowered by a still-unknown 
value. Therefore, I proposed an alternative mechanism for dUMP activation that 
explicitly includes ionization of N3 (Figure 5 - 1). Ionization of N3 of dUMP is clearly 
important for catalysis since the oxidative half-reaction of a R174A mutant enzyme of 
FDTS, which does not ionize N3 of dUMP,  is ~3000-fold slower than WT.1 
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Figure 5 - 1. Activation of dUMP by FDTS. FDTS ionizes N3 of dUMP, which is proposed to enhance the 
contribution and reactivity of the resonance structure of dUMP with a formal negative charge on C5. 
 
 
 
 
 
 In addition to identifying that FDTS ionizes N3 of dUMP, I also presented 
biochemical data on substrate analogs that suggests that the phosphate of dUMP is the 
base that abstracts the C5 proton of the dUMP-CH2THF bridged intermediate. dU, 
which lacks the phosphate, was still ionized when bound to the enzyme, but failed to 
promote oxidation of the flavin of reduced FDTS in the presence of CH2THF. Likewise, 
dUMS – whose sulfate has a much lower pKa than phosphate – was also unable to 
oxidize the flavin of reduced FDTS in the presence of CH2THF. The crystal structures of 
the dU-FDTS and dUMS-FDTS complexes show that the lack of reactivity of the dUMP 
analogs is not due to improper positioning of the uracil in the active site of the enzyme. 
Presumably, dU and dUMS form the bridged intermediate with CH2THF when reacting 
with FDTS, but cannot abstract the C5 proton necessary to continue to the flavin 
oxidation step. Notably, both ionization and acid-base chemistry by the phosphate of 
dUMP are not implicated in the mechanism used by classic thymidylate synthase,2 
further emphasizing the differences between FDTS and classic thymidylate synthase. 
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 In Chapter 3 I used a battery of equilibrium and kinetic methods to monitor dUMP 
and dTMP binding to Thermotoga maritima FDTS. A number of studies have suggested 
that the dissociation of dTMP and association of dUMP steps occur when the flavin of 
FDTS is oxidized.3,4 However, I discovered that FDTS binds deoxynucleotides with 
~200-fold weaker affinity when the flavin is reduced compared to when it is oxidized, 
and the differences in affinity are largely due to differences in the dissociation rate 
constant. This finding strongly suggests that the exchange of dTMP and dUMP in the 
kinetic mechanism of FDTS occurs when the flavin is reduced.  
I also found that there is, curiously, a temperature-dependent effect on the 
mechanism by which FDTS binds deoxynucleotides – below 45°C the FDTS 
homotetramer behaves as a dimer-of-dimers with regards to deoxynucleotide binding 
while at temperatures above 45°C the four subunits of FDTS bind deoxynucleotides 
identically. The dimer-of-dimers behavior could be active at higher temperatures as well, 
but is only detectable at lower temperatures. The dimer-of-dimers behavior of FDTS for 
deoxynucleotide binding would only be catalytically relevant with the reduced enzyme 
since the dTMP made at the end of the oxidative half-reaction would not have enough 
time to dissociate from the oxidized enzyme (due to the low koff values for dTMP bound 
to oxidized FDTS) before reduction of the flavin by NADPH. Upon reduction of the 
flavin, the koff values for dTMP increase ~200-fold so dTMP could quickly dissociate 
from one or both of the sets of sites to allow dUMP to bind and initiate the oxidative half-
reaction. 
 
165 
 
Future Directions 
 The data I presented in Chapter 2 clearly show that dUMP is ionized in the active 
site of FDTS, which is important for catalysis. However, it would be beneficial to verify 
that C5 of dUMP is more nucleophilic in N3-ionized dUMP than in unionized dUMP. 
Computational methods could be used to compare the molecular orbital energies of 
ionized and unionized dUMP. The reactivity of dUMP could be enhanced in N3-ionized 
dUMP if the highest occupied molecular orbital energy more closely matches the lowest 
unoccupied molecular orbital energy of CH2THF than in unionized dUMP. 
 It would also be interesting to determine if FDTS abstracts the N3 proton of 
dUMP using an active site base or if it simply binds the N3-ionized population of dUMP 
in solution. At pH 8, where the majority of the work on T. maritima FDTS has been 
performed, only 4.8% of the dUMP in solution would be ionized (the pKa of N3 of dUMP 
is ~9.3 in water).5 One way to address this would be to perform ITC titrations of FDTS 
with dUMP in different buffers that have different enthalpies of ionization. If protons are 
released upon binding of dUMP, the enthalpy of binding should correlate with the 
difference in ionization enthalpy of the different buffers. However, if an active site base 
abstracts the N3 proton the enthalpy of dUMP binding should be identical in all buffers. I 
attempted to do these experiments in Chapter 3 but the differences in binding enthalpy 
between buffers were not consistent with the differences in the ionization enthalpies of 
the buffers. The buffers could conceivably bind in the dUMP binding site, which would 
alter the enthalpy of binding measured by ITC; care should be taken in the future to 
avoid buffers that might bind in the dUMP binding site.  
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 All chemical mechanisms proposed for FDTS include the formation of a dUMP-
CH2THF bridged intermediate at some point in the mechanism. However, such an 
intermediate has never been detected. In principle, dU and dUMS should stop at the 
bridged intermediate when reacting with FDTS. Yet, I was unable to detect the 
intermediate with dUMS after denaturing the enzyme, indicating that it might be 
unstable when removed from the active site of the enzyme. The bridged intermediate 
could potentially be detected while bound to the enzyme by NMR using 13C-labeled dU 
or dUMS. Upon formation of the bridged intermediate, the C5 carbon of the uracil would 
go from being sp2 hybridized to being sp3 hybridized, which should coincide with a 
substantial change in the chemical shift of the C5 carbon. Therefore, the 13C C5 
chemical shift of dU or dUMS bound to reduced FDTS in the presence of CH2THF 
(forming the bridged intermediate) should indicate the formation of the intermediate. 
 Another question on FDTS raised by the work presented in this thesis is the 
origin of the dimer-of-dimers behavior of FDTS with regards to deoxynucleotide binding 
at lower temperatures. The only structures of FDTS currently available are those without 
deoxynucleotides bound or with dUMP or its analogs bound in all four active sites of the 
tetramer. A structure of FDTS where half of the active sites have dUMP bound could 
clarify the structural differences between the two sets of binding sites. One potential 
clue comes from the nucleotide-free structure of FDTS – a histidine (H53 in T. maritima) 
is in two different conformations in the four active sites of the tetramer (Figure 5 - 2). 
The histidine might play a role in causing the asymmetry among the active sites of the 
FDTS tetramer (Chapter 3). It would also be interesting to determine if FDTS exhibits 
the dimer-of-dimers behavior at low temperatures in other steps of the catalytic cycle 
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(e.g. CH2THF binding, flavin reduction/oxidation, etc.). It is worth noting that reduction of 
the flavin of dUMP-bound FDTS occurs in two phases with roughly equal amplitudes.6 
 
 
 
 
 
 
 
 
tRNA-Dihydrouridine Synthase 
 In Chapter 4, I examined the reactivity of several unmodified tRNAs with yeast 
DUS2 in oxidative half-reactions. In contrast with tRNALeu-CAA – which requires other 
modifications in order to react rapidly with DUS27 – tRNAAsp, tRNAAla, and tRNAHis2 
reacted rapidly with DUS2 as unmodified transcripts. I also presented evidence 
suggesting that it is unlikely that a single modification is responsible for enhancing the 
reactivity of tRNALeu-CAA with DUS2 – more likely, multiple modifications in different 
regions of the tRNA are necessary to enhance the reactivity of tRNALeu-CAA with DUS2.  
Figure 5 - 2. Overlay of the four subunits in unbound T. maritima FDTS (PDB code 4KQ4). Only one 
FAD (yellow) is shown for clarity. Histidine-53 (cyan) in the active site is in two different conformations in 
the four subunits of the FDTS homotetramer. 
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 Unmodified tRNALeu-CAA folds into an incorrect, possibly oligomeric, 
conformation, explaining why unmodified tRNALeu-CAA is such a poor substrate for 
DUS2. The structure of the DUS-tRNA complex from Thermus thermophilus shows that 
DUS recognizes the majority of a properly folded, L-shaped tRNA (Figure 5 - 3).8 Given 
the mode of tRNA recognition in that structure, it is unlikely that DUS could recognize 
the correct uracil of a tRNA in a different conformation. 
 
 
 
 
 
 
Future Directions 
 The biggest question arising from the work presented in Chapter 4 is why 
tRNALeu-CAA requires modifications to properly fold while other tRNAs do not. This 
question could be addressed by assessing whether or not other unmodified tRNAs fold 
properly. The reactivity of each tRNA with yeast DUS2 could be used as a diagnostic of 
proper folding. If enough unmodified tRNAs are analyzed, patterns might develop that 
could indicate the features that cause certain unmodified tRNAs to misfold. While we 
Figure 5 - 3. Structure of T. thermophilus DUS in complex with tRNA (PDB 3B0U). The two domains of 
DUS are shown in blue and pink. The tRNA is shown in orange. 
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now know that unmodified tRNALeu-CAA misfolds, we still don’t know the structure of the 
misfolded state. NMR could potentially be used to determine the secondary and tertiary 
structures of improperly folded unmodified tRNALeu-CAA, which might also shed light on 
why unmodified tRNALeu-CAA adopts the non-canonical conformation. 
 It is also unclear how tRNALeu-CAA folds properly in vivo. tRNALeu-CAA would 
initially be transcribed as an unmodified transcript, which would misfold. However, it is 
also initially transcribed with an intron that might facilitate the proper folding of tRNALeu-
CAA, allowing some modifications to be incorporated prior to removal of the intron. It 
would be interesting to see if intron-containing unmodified tRNALeu-CAA properly folds – 
native PAGE could be used to initially assess whether unmodified tRNALeu-CAA 
containing the intron oligomerizes. NMR could then be used to determine if intron-
containing unmodified tRNALeu-CAA adopts the correct secondary and tertiary 
structures. 
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Appendix 1 
Equations Used for Fitting ITC Data 
The following is adapted from the VP-ITC MicroCalorimeter User’s Manual (MicroCal, 
2004, Northhampton, MA). 
Single Set of Identical Sites 
For a single set of binding sites 
   
 
(   )   
   (1) 
             (2) 
where K is the binding constant, θ is the fraction of sites occupied by ligand L, [L] is the 
free concentration of ligand, Lt is the bulk concentration of ligand, n is the number of 
binding sites, and Mt is the bulk concentration of macromolecule in the active cell 
volume (Vo) 
Combining equations (1) and (2) gives 
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   (3) 
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The total heat content Q of the solution contained in Vo is 
            (4) 
where ΔH is the molar heat of ligand binding. Solving equation (3) for θ and substituting 
into equation (4) gives 
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]  (5) 
The change in heat after the ith injection {ΔQ(i)} is  
  ( )   ( )  
   
  
[
 ( )  (   )
 
]   (   )   (6) 
where ΔVi is the change in volume after the ith injection. 
The experimental data give ΔQ(i) for each injection. Origin uses a nonlinear least-
squares algorithm to provide the best-fit values for n, K, and ΔH.  
Two Sets of Independent Sites 
For two sets of independent binding sites 
   
  
(    )   
          
  
(    )   
  (7) 
         (         )    (8) 
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Solving equation (7) for θ1 and θ2 and substituting into equation (8) gives 
                       (9) 
where 
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        (10) 
Equations (9) and (10) are solved for [L] numerically in Origin by using Newton’s 
Method to obtain n1, n2, K1,and K2 and to provide θ1 and θ2 from equation (7). These are 
then used with the total heat content Q of the solution contained in Vo   
      (               )   (11) 
and the change in heat content after the ith injection   
  ( )   ( )  
   
  
[
 ( )  (   )
 
]   (   ) (12) 
using a nonlinear least-squares algorithm to provide the best-fit values for n1, n2, K1, K2, 
ΔH1, and ΔH2. 
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Appendix 2 
Global Fitting in Berkeley Madonna 
The global model that describes all of the experiments 
 
Red = high affinity site; blue = low affinity site; the term in parenthesis denotes the 
variable used in the differential equations. 
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Script Used for Global Fitting in Berkeley Madonna 
METHOD Stiff 
 
STARTTIME = 0 
STOPTIME=600 
DTMIN = 1e-6 
DTMAX = 100 
TOLERNACE = 1e-10 
DTOUT = 0 
 
d/dt(CEC[1..7]) = -k6*CEC[i] - k6*CEC[i] + k5*CE[i]*C[i] + k5*EC[i]*C[i] 
d/dt(CE[1..7]) = -k1*CE[i]*U[i] - k6*CE[i] - k5*CE[i]*C[i] + k6*CEC[i] + k5*E[i]*C[i] + 
k2*CEU[i] 
d/dt(EC[1..7]) = -k1*EC[i]*U[i] - k6*EC[i] - k5*EC[i]*C[i] + k6*CEC[i] + k5*E[i]*C[i] + 
k4*UEC[i] 
d/dt(E[1..7]) = -k5*E[i]*C[i] - k5*E[i]*C[i] - k1*E[i]*U[i] - k1*E[i]*U[i] + k6*CE[i] + k6*EC[i] + 
k2*EU[i] + k4*UE[i] 
d/dt(CEU[1..7]) = -k2*CEU[i] - k6*CEU[i] + k1*CE[i]*U[i] + k5*EU[i]*C[i] 
d/dt(UEC[1..7]) = -k4*UEC[i] - k6*UEC[i] + k1*EC[i]*U[i] + k5*UE[i]*C[i] 
d/dt(EU[1..7]) = -k2*EU[i] - k5*EU[i]*C[i] - k1*EU[i]*U[i] + k1*E[i]*U[i] + k6*CEU[i] + 
k4*UEU[i] 
d/dt(UE[1..7]) = -k4*UE[i] - k5*UE[i]*C[i] - k1*UE[i]*U[i] + k1*E[i]*U[i] + k6*UEC[i] + 
k2*UEU[i] 
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d/dt(UEU[1..7]) = -k4*UEU[i] - k2*UEU[i] + k1*EU[i]*U[i] + k1*UE[i]*U[i] 
d/dt(U[1..7]) = -k1*CE[i]*U[i] + k2*CEU[i] - k1*EC[i]*U[i] + k4*UEC[i] - k1*E[i]*U[i] + 
k2*EU[i] - k1*E[i]*U[i] + k4*UE[i] - k1*EU[i]*U[i] + k4*UEU[i] - k1*UE[i]*U[i] + k2*UEU[i] 
d/dt(C[1..7]) = -k5*CE[i]*C[i] + k6*CEC[i] - k5*EC[i]*C[i] + k6*CEC[i] - k5*E[i]*C[i] + 
k6*CE[i] - k5*E[i]*C[i] + k6*EC[i] - k5*EU[i]*C[i] + k6*CEU[i] - k5*UE[i]*C[i] + k6*UEC[i] 
 
{Experiments 1 through 4 correspond to 50 - 200 µM dUMP binding to free TmFDTS} 
 
init E[1..4] = Et 
Et = 8.33e-6 
 
init CEC[1..4] = 0 
init CE[1..4] = 0 
init EC[1..4] = 0 
init CEU[1..4] = 0 
init UEC[1..4] = 0 
init EU[1..4] = 0 
init UE[1..4] = 0 
init UEU[1..4] = 0 
 
init U[1] = U1 
init U[2] = U2 
init U[3] = U3 
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init U[4] = U4 
 
U1 = 5e-5 
U2 = 10e-5 
U3 = 15e-5 
U4 = 20e-5 
 
init C[1..4] = 0 
 
{Experiments 5 and 6 correspond to competition experiments where the TmFDTS-
dUMP complex was competed with 0.1 M or 0.2 M dCMP} 
 
init E[5..6] = 0 
init CE[5..6] = 0 
init EC[5..6] = 0 
init CEU[5..6] = 0 
init UEC[5..6] = 0 
init EU[5..6] = 0 
init UE[5..6] = 0 
 
init UEU[5..6] = UEUt 
UEUt = 10.42e-6 
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init U[5] = U5 
init U[6] = U6 
 
U5 = 0 
U6 = 0 
 
init C[5] = C5 
init C[6] = C6 
 
C5 = 0.1 
C6 = 0.2 
 
{Experiment 7 corresponds to the return to baseline of the endothermic event, Figure 3 - 
8, detected by ITC} 
 
init E[7] = Et7 
Et7 = 0.936e-4 
 
init CEC[7] = 0 
init CE[7] = 0 
init EC[7] = 0 
init CEU[7] = 0 
init UEC[7] = 0 
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init EU[7] = 0 
init UE[7] = 0 
init UEU[7] = 0 
init C[7] = 0 
 
init U[7] = U7 
U7 = 0.936e-4 
 
k1 = 6.4e6 
k2 = 0.043 
k4 = 0.0086 
 
k5 = 1e6 
k6 = 7.17 
 
A1 = A[1] 
A2 = A[2] 
A3 = A[3] 
A4 = A[4] 
A5 = A[5] 
A6 = A[6] 
A7 = A[7] 
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{Different extinction coefficients were used for the binding and competition experiments 
because the experiments were monitored at different wavelengths - 450 nm for dUMP 
binding and 390 nm for competition of the TmFDTS-dUMP complex with dCMP} 
 
A[1..4] = os[i] + Ecec1*CEC[i] + Ece1*CE[i] + Eec1*EC[i] + Ee1*E[i] + Eceu1*CEU[i] + 
Euec1*UEC[i] + Eeu1*EU[i] + Eue1*UE[i] + Eueu1*UEU[i] 
 
Ee1 = 24125 
Eeu1 = 23054 
Eue1 = 23054 
Eueu1 = 21983 
Ecec1 = 23000 
Ece1 = 23000 
Eec1 = 23000 
Eceu1 = 23000 
Euec1 = 23000 
 
A[5..6] = os[i] + Ecec5*CEC[i] + Ece5*CE[i] + Eec5*EC[i] + Ee5*E[i] + Eceu5*CEU[i] + 
Euec5*UEC[i] + Eeu5*EU[i] + Eue5*UE[i] + Eueu5*UEU[i] 
 
 
Ee5 = 20000 
Eeu5 = 20000 
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Eue5 = 20000 
Eueu5 = 22050 
Ecec5 = 19902 
Ece5 = 20000 
Eec5 = 20000 
Eceu5 = 20976 
Euec5 = 20976 
 
{Experiment 7 corresponds to the return to baseline of the endothermic event, Figure 3 - 
8, detected by ITC} 
 
A[7] = os[i] + Ecec7*CEC[i] + Ece7*CE[i] + Eec7*EC[i] + Ee7*E[i] + Eceu7*CEU[i] + 
Euec7*UEC[i] + Eeu7*EU[i] + Eue7*UE[i] + Eueu7*UEU[i] 
 
Ee7 = 0 
Eeu7 = 50000 
Eue7 = -20000 
Eueu7 = 22800 
Ecec7 = 20000 
Ece7 = 20000 
Eec7 = 20000 
Eceu7 = 20000 
Euec7 = 20000 
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os[1] = os1 
os[2] = os2 
os[3] = os3 
os[4] = os4 
os[5] = os5 
os[6] = os6 
os[7] = os7 
 
os1 = 0 
os2 = -3.478e-5 
os3 = -1.41e-4 
os4 = -5.456e-4 
os5 = 0 
os6 = 0.0150869 
os7 = 0 
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Appendix 3 
Flavin-Mediated Dual Oxidation Controls an Enzymatic Favorskii-Type 
Rearrangement 
This published study (Teufel, R.*, Miyanaga, A.*, Michaudel, Q.*, Stull, F.*, Louie, G., 
Noel, J. P., Baran, P. S., Palfey, B., Moore, B.S. Nature, 2013, 503, 552-556), for which 
I am a co-first author, was conducted alongside the work presented in this thesis. The 
Supporting Information can be found at 
http://www.nature.com/nature/journal/v503/n7477/extref/nature12643-s1.pdf 
*Contributed equally to the work. 
The antibiotic enterocin (compound 1, Figure A - 1) is produced by various 
streptomycete bacteria1 and contains a unique tricyclic caged core. Nearly 40 years 
ago, isotope labeling studies suggested the involvement of a rare oxidative Favorskii-
type rearrangement during its biosynthesis.2 More recently, the discovery, expression, 
and biochemical analyses of the Streptomyces maritimus enterocin biosynthetic gene 
cluster including in vitro reconstitution of the metabolic pathway showed further 
involvement of the type II polyketide synthase EncABC and the NADPH-dependent 
reductase, EncD1,3,4 (Figure A - 1). Although type II polyketide synthase pathways 
typically yield polycyclic aromatic products such as the antibiotic tetracycline and the 
anticancer agent doxorubicin,5 aromatic polyketides called wailupemycins are formed 
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only as minor products of the enterocin biosynthetic pathway.1 Remarkably, the FAD-
dependent “favorskiiase” EncM proved to be singly responsible for interruption of the 
more typical polycyclic aromatization of the poly(β-carbonyl) chain to direct generation 
of the rearranged desmethyl-5-deoxyenterocin (2).3,6 Until now, detailed mechanistic 
studies of EncM have been hampered by the inherently high reactivity of the proposed 
EncM substrate, a putative acyl carrier protein (ACP)-bound C7,O4-dihydrooctaketide 
intermediate (EncC-octaketide) (3). To overcome this experimental limitation we 
employed synthetic substrate analogs (for synthesis see Supplementary Information), 
including the untethered C7,O4-dihydrotetraketide (4, Figure A - 1), for structure-
function analyses of recombinant EncM. 
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EncM (C4 dual oxidation and Favorskii-type rearrangement) 
Figure A - 1. Overview of the Streptomyces maritimus enterocin biosynthetic pathway and proposed EncM 
catalysis. The ACP EncC is primed with benzoate by ligase EncN, followed by seven iterative type II polyketide 
synthase (EncAB)-catalysed elongation steps by decarboxylative Claisen condensations with malonyl-CoA. The 
ketoreductase EncD probably forms the (R)-7-hydroxyl group during elongation. The linear ((R)-C7,O4-
dihydrooctaketide (3) can cyclize to various wailupemycins (for example G and F), whereas in the presence of 
EncM it is preferentially converted into desmethyl-5-deoxyenteroxin (2). Final pathway steps leading to 
enterocin (1) are catalyzed by EncR and EncK. EncM catalysis (blue box) involves dual oxidation at C4 (see 
Figure A - 3b) and a Favorskii-type rearrangement, followed by aldol condensations and heterocycle formation 
(dashed lines). Functional studies of EncM were conducted with the substrate analogue 4. 
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Several crystal structures of FAD-bound EncM were determined at resolutions up 
to 1.8 Å by molecular replacement against 6-hydroxy-D-nicotine oxidase (6HDNO) from 
Arthrobacter nicotinivorans7 (Figure A - 1, Supplementary Table 1). Structurally, EncM 
shows greater architectural similarity to flavin dehydrogenases than to oxygenases such 
as 6HDNO (33% sequence identity for 444 equivalent amino acid residues, 2.2 Å root-
mean-square-deviation (rmsd) for Cα-atoms, Z-score =  46.4), glucooligosaccharide 
oxidase8 (31% sequence identity for 415 equivalent residues, 2.3 Å rmsd) and 
aclacinomycin oxidoreductase9 (37% sequence identity for 316 equivalent residues, 2.5 
Å rmsd). In contrast to these monomeric dehydrogenases, EncM exists as a homodimer 
in crystal form and in solution (Figure A - 2a, Supplementary Fig. 1). The monomeric 
subunits of the homodimer show structural similarity (0.19 Å rmsd for Cα atoms), and 
each contains distinct domains for substrate binding (residues 211-418) and FAD-
binding (residues 2-210 and 419-461). The FAD-binding domain sequesters the ADP-
ribosyl of the flavin cofactor, and the reactive isoalloxazine core resides at the interface 
between the substrate and cofactor domains (Figures A - 2a, b). As previously observed 
in 6HDNO, the flavin is covalently linked to EncM via the C8-methyl group of the 
isoalloxazine ring system and a histidine residue (His78) (Figure A - 2b).   
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Structure comparisons with homologous flavin-dependent enzymes emphasized 
the unusually elongated L-shaped EncM ligand-binding tunnel that extends about 30 Å 
from the surface to a hydrophobic pocket at its base. This orthogonally arranged two-
room tunnel is complementary to the shapes of the ACP-derived phosphopantetheine 
Figure A - 2. Crystal structure of EncM. (a) Homodimeric EncM shown as a ribbon diagram (with 
flavin cofactors as colour-coded stick model). Monomeric subunits are coloured in green and blue, 
with darker shades of each highlighting the substrate-binding domains and lighter shades 
emphasizing the flavin-binding domains. The basic patch abutting the active-site tunnel entrance 
(dashed red box) is magnified (blue and red colours indicate positive and negative charges, 
respectively). (b) Sliced-away interior view of the EncM substrate tunnel, showing a covalent link 
between His78 and FAD (shown is the SIGMAA-weighted 2Fo – Fc electron density map contoured at 
2.0σ). The natural substrate 3 is shown below. Approximate lengths of the tunnel and substrate are 
indicated. (c) SIGMAA-weighted Fo – Fc difference map of EncM co-crystallized with 4 calculated with 
the ligand omitted, contoured at 2.0σ around modelled 4. Hydrogen-bonding interactions are indicated 
by blue dashed lines. The red dashed line shows the sitance (in Å) from the site of oxidation to the 
reactive N5 of FAD. Normalized activities of active site mutants are shown (native EncM = 100%). (d) 
X-ray structure of the chemically synthesized substrate analogue 4. 
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arm, the octaketide chain and the terminal benzene moiety of 3 (Figure A - 2b, 
Supplementary Fig. 2). The entrance of the tunnel of EncM sits near the dimer interface 
and adjacent to a surface-exposed basic patch formed by a few positively charged 
residues, including Arg107 and Arg210, from the dyad related monomer (Figure A - 2a). 
This positively charged region of EncM is complementary to the decidedly negative 
surface area of ACPs,10 which is indicative that EncC1 presents elongated polyketide 
intermediates to EncM through protein-protein interactions to limit deleterious side 
reactions of the highly reactive poly(β-carbonyl) chain. Support for the close association 
of EncM and EncC was obtained by protein-protein computational docking simulation 
using an EncC homology model (Supplementary Fig. 3). Moreover, disruption of the 
positive surface area of the EncM dimer with the EncM-R210E mutant resulted in about 
40% of the relative activity of native EncM (Supplementary Fig. 4). 
To explore the interaction of EncM with the polyketide reactant, we co-
crystallized the enzyme with substrate analogues harbouring the benzene moiety of 3 
(Supplementary Table 1). The resulting SIGMAA-weighted Fo-Fc electron-density 
difference maps clearly indicated mimetic binding to the active site, although elevated 
B-factors and incomplete occupancy (for example roughly 33 Å2 and 0.8, respectively 
for substrate 4) caused slightly disordered electron densities (Figure A - 2c, 
Supplementary Fig. 5). Binding occurred with little overall structural perturbation to the 
EncM polypeptide backbone (e.g., 0.14 Å rmsd for 4) and no significant backbone or 
side-chain displacements in the binding region. The terminal benzene group sits at the 
hydrophobic end of a long tunnel and forms aromatic-aromatic interactions with Tyr150 
and Trp152 and van der Waals interactions with Leu357. It is likely that the enol at C1 
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engages in hydrogen bonding with O4 of the flavin (2.3 Å), whereas the C3 ketone 
twists away from the flavin and may accept a hydrogen bond from the side chain of 
Glu355 (3.2 Å) and possibly from Tyr249 (3.5 Å). Mutagenesis of these residues 
confirmed their importance for EncM activity (Figure A - 2c). In particular, the putative 
C7-hydroxyl group of 4 resides at the elbow of the L-shaped two-room tunnel and 
ostensibly serves as the pivot point in the natural substrate 3.  The mutually orthogonal 
sections of the EncM ligand-binding pocket separate the C1–C6 triketide head from the 
C8–C15 pantothenate-linked tetraketide tail to uncouple the reactivity of the entire C1-
C16 poly(β-carbonyl) chain. This chemical and structural disconnection prevents 
kinetically facile but unwanted cyclization-aromatization reactions, and instead favours 
the EncM-mediated oxidative Favorskii-type rearrangement (Figure A - 2b). 
We propose that EncM performs a dual oxidation of 3 at C4 to effectively convert 
a 1,3-diketone to a 1,2,3-triketone. In this mechanistic model, C4 is now set up to 
undergo a facile electrophilic cyclization with C2 to trigger the proposed Favorskii-like 
rearrangement (Figure A - 1). Typical flavin oxygenases are initially reduced with 
NAD(P)H to enable capture of O2 by reduced flavin (Flred), generating the flavin-C4a-
peroxide oxygenating species.11 EncM, however, lacks an NAD(P)H binding domain 
and functions in the absence of a flavin reductase,3 raising questions surrounding the 
oxidative mechanism of EncM. 
To gain further insight into the EncM chemical mechanism, we analysed the in 
vitro reaction of EncM with either racemic or enantiomerically pure 4 by reversed-phase 
high-performance liquid chromatography (HPLC) and ultraviolet-visible spectroscopy. 
We found that 4 was converted in the absence of NAD(P)H into diastereomeric products 
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5 and 5’ without detectable intermediates (Figure A - 3a). Through comprehensive NMR 
and mass spectrometric analyses together with chemical synthesis (see Supplementary 
Information), we identified 5 and 5’ as ring-opened derivatives of the expected 
enterocin-like lactone 6 (Figure A - 3b). Circular dichroism experiments proved that the 
configuration of 4 is maintained during the transformation (see Supplementary 
Information). We reasoned that a facile hydrolytic retro-Claisen ring cleavage12,13 of 6 
occurs after an oxidative Favorskii-type rearrangement and lactonization (Figure A-3b, 
step VII) that is probably responsible for the racemization of C4. This proposed reaction 
was further substantiated by the observation that glycerol also effectuates the ring 
opening to form 7 and 7’ (Figure A - 3a, Supplementary Figs 6, 7). During actual 
enterocin biosynthesis this reaction is probably prevented through aldol condensations 
with the remainder of the ketide chain (Figure A - 1). Notably, the C1 and C5 deoxo-
substrate analogs 8 and 9, respectively, were not transformed by EncM, while the 
dehydroxy-substrate 10 (see Figure A - 3d or Supplementary Fig. 5 for compound 
structures) was converted into multiple unstable products that were not further 
characterized. This series of structure-activity relationships revealed that the triketone 
motif (C1–C6) is essential for catalysis and suggested that the C7-hydroxyl is critical for 
spatial and temporal control of the EncM catalysed reaction.  
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Figure A - 3. Proposed EncM mechanism and spectral features of the flavin cofactor catalytic states. 
(a) Reversed-phase HPLC analysis (absorption detection at 254 nm) of enzymatic assays showing 
substrate analogue 4 (upper lane; control assay without EncM) and diastereomeric product pairs 5/5’ 
and 7/7’ (lower lane; after incubation with EncM). The colour code refers to b.  Products 7/7’ were 
observed only in the presence of glycerol (here 20% v/v). No intermediates could be detected. (b) 
Proposed catalytic mechanism of EncM involving substrate oxygenation by means of a flavin-N5-
oxoammonium species. The resultant electrophilic C4-ketone of 12 triggers the Favorskii-type 
rearrangement and lactone formation (see Figure A - 1 for the detailed analogous reactions during the 
natural biosynthesis of enterocin), while the formed Flred reacts with O2 and restores the N5-oxide. The 
stepwise dual oxidation is supported by anaerobic single-turnover experiments (Supplementary Fig. 
16). The C7-hydroxyl group is shown in green, and oxygen atoms derived from O2 and H2O are colour-
coded red and blue, respectively. Roman numerals indicate reaction steps as discussed in the main 
text. (c) Ultraviolet-visible spectra of the oxidized flavin of EncM as isolated (Flox[O], catalytically active, 
purple curve) and after multiple substrate turnovers (Flox, catalytically inactive, blue curve). Molar 
absorption coefficients were ε450 = 11,900 M
-1
cm
-1
 for EncM-Flox and ε460 = 9,600 M
-1
cm
-1
 for EncM-
Flox[O]. (d) Compounds used for structure-activity relationship analyses. 
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The monooxygenase activity of EncM was evaluated by following the 
incorporation of oxygen atoms from 18O2 into 5/5’ and 7/7’ at C4. In contrast, isotope 
labeling from H2
18O was only associated with the non-enzymatic retro-Claisen cleavage 
of 6 to 5/5’ (Supplementary Figs 8 and 9). These measurements suggest that lactone 
formation during enterocin biosynthesis is controlled by the C7-hydroxyl group by 
means of direct intramolecular attack (Figure A - 1). Further support for this biosynthetic 
model came from the structure analysis of the EncM ligand-binding tunnel that can only 
accommodate the (R)-enantiomer of 3 (Supplementary Fig. 10), which is consistent with 
the observed retention of the C4-hydroxyl configuration in the final product enterocin 
(Figure A - 1).   
EncM became inactivated after several turnovers (Supplementary Fig. 11). 
Moreover, the oxidized flavin cofactor of inactivated EncM (EncM-Flox) showed distinct, 
stable changes in the ultraviolet-visible spectrum (Figure A - 3c). We speculated that 
these spectral perturbations are caused by the loss of an oxygenating species 
maintained in the enzyme’s active state. This species, “EncM-Flox[O]”, is largely restored 
at the end of each catalytic cycle (Figure A - 3b), thereby providing an explanation for 
the innate monooxygenase activity of EncM in the absence of exogenous reductants. 
We excluded the participation of active-site residues in harbouring this oxidant using 
site-directed mutagenesis and by showing that denatured EncM retained the Flox[O] 
spectrum (Supplementary Fig. 12). We therefore focused on the flavin cofactor as the 
carrier of the oxidizing species. On the basis of the spectral features of EncM-Flox[O], 
we ruled out a conventional C4a-peroxide.14,15 Moreover, Flox[O] is extraordinarily stable 
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(no detectable decay for more than 7 d at 4°C) and thus is vastly longer lived than even 
the most stable flavin-C4a-peroxides described so far (t1/2 of ≤30 min at 4°C
16,17).  
To further test the possible intermediacy and catalytic role of EncM-Flox[O], we 
reduced the flavin cofactor anaerobically and showed that only flavin reoxidation with 
molecular oxygen restored the EncM-Flox[O] species. In contrast, anoxic chemical 
reoxidation generated catalytically inactive EncM-Flox (Supplementary Fig. 13a). 
Notably, EncM reoxidized with 18O2 formed EncM-Flox[
18O], which converted 4 to 
[18O]5/5’ with 1:1 stoichiometry of Flox[
18O] to [18O]5/5’ (Supplementary Fig. 13b). The 
collective structure-function analyses reported here currently support the catalytic use of 
a unique flavin-oxygenating species that is consistent with a flavin-N5-oxide. This 
chemical species was introduced over 30 years ago as a possible intermediate in flavin 
monooxygenases18,19 before the conventional C4a-peroxide model was accepted 
experimentally. Crucially, spectrophotometric comparison of chemically synthesized 
flavin-N5-oxide and EncM-Flox[O] revealed many of the same spectral features,
20 and 
both can be chemically converted to oxidized flavin (Supplementary Fig. 12). Moreover, 
consistent with an N-oxide, EncM-Flox[O] required four electrons per flavin cofactor to 
complete reduction in dithionite titrations, whereas EncM-Flox required only two 
(Supplementary Fig. 14). We could not observe this flavin modification 
crystallographically (see Figure A - 2b), presumably as a result of X-radiation-induced 
reduction21 of the flavin-N5-oxide, which is highly prone to reduction.20 
 We propose that during EncM catalysis, the N5-oxide is first protonated by the 
hydroxyl proton of the C5-enol of substrate 4 (Figure A - 3b, step I). Despite the 
generally low basicity of N-oxides, the proton transfer is probably enabled by the high 
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acidity of the C5 enol and its appropriate positioning 3.3 Å from the N5 atom of the flavin 
(Figure A-2c). After protonation, tautomerization of the N5-hydroxylamine would lead to 
the electrophilic oxoammonium (step II). Subsequent oxygenation of substrate enolate 
11 by the oxoammonium species may then occur via one of several possible routes 
(Supplementary Fig. 15), yielding Flox and a C4-hydroxylated intermediate (steps III and 
IV). Flox-mediated dehydrogenation of the introduced alcohol group then produces the 
C4-ketone 12 and Flred (step V). Anaerobic single turnover experiments with 4 support 
this reaction sequence (Supplementary Fig. 16). Finally, 12 would undergo the 
Favorskii-type rearrangement (step VI) and retro-Claisen transformation (step VII) to 
yield the observed products 5/5’ or 7/7’, while the reduced cofactor Flred reacts with O2 
to regenerate EncM-Flox[O] and thus prime the enzyme for the next catalytic cycle (step 
VIII). However, alternative mechanisms are also plausible (Supplementary Fig. 17). This 
extraordinary flavin cofactor-mediated dual oxidation vaguely resembles the role of 
flavins in the scarce “internal monooxygenases” (EC 1.13.12) that also use their 
substrate as an electron donor.22 
  Here we provide the first in-depth investigation of an enzymatic oxidation-induced 
Favorskii-type rearrangement. The exceptionally reactive poly(β-carbonyl) substrate 
requires EncM to direct the reaction along a defined mechanistic trajectory by 
sequestration of reactants from bulk solvent, spatial separation of reactive functional 
groups, rapid “one-step” generation of a new electrophilic centre, and expulsion of 
solvent from the active site to prevent retro-Claisen ring cleavage. The discovery that 
EncM uses a stable flavin-N5-oxide for oxygenation rather than the universally accepted 
flavin peroxide suggests that this species may have been overlooked in the flavin 
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biochemical literature. Further studies are underway to explore the factors that govern 
enzymatic formation of the flavin-N5-oxide. In short, the archetypal dual oxidase EncM 
employs unexpected oxidative flavin biochemistry for the NAD(P)H-independent 
processing of extremely reactive polyketides. 
Methods Summary  
Amino-terminal octahistidine-tagged EncM from S. maritimus was produced 
heterologously in Escherichia coli BL21 (DE3) and purified by means of Ni2+-affinity 
chromatography. For crystallization, the EncM His-tag was removed and the protein 
further purified by ResourceQ anion-exchange chromatography. Substrate analogues 
and flavin-N5-oxide were acquired through chemical synthesis. Site-directed 
mutagenesis was conducted with the QuikChange site-directed mutagenesis kit 
(Stratagene), using self-constructed primers.  
The activities of wild-type EncM and EncM-R210E were assayed using the fully 
reconstituted enzyme set as previously reported6. Other EncM assays were conducted 
at 22°C, pH 7.5 using HEPES-Na+ buffer, 150-300 mM NaCl and at least 10 % (v/v) 
glycerol. Products were separated and purified by reverse-phase HPLC with optical 
detection at 254 nm using a Sync Polar RP column with an ammonium acetate-buffered 
(pH 5.0) acetonitrile gradient. A 6230 Accurate-Mass TOF-MS system (Agilent) was 
used for mass spectrometry measurements. NMR spectra were recorded on Bruker 
DRX-600 and AMX-400 instruments. Ultraviolet-visible spectra were conducted with a 
Cary 50 UV-Vis spectrophotometer (Agilent). A Perkins-Elmer 341 polarimeter and an 
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Aviv circular dichroism spectrometer were used for optical rotation and circular 
dichroism spectroscopy measurements, respectively. 
Crystals of EncM were grown from a 1:1 mixture of protein solution (5 mg/ml in 
10 mM TES-Na+ (pH 7.7) and 10% (v/v) glycerol) and a reservoir solution (2 mM DTT, 
0.1 M HEPES-Na+ pH 7.5, 0.2 M calcium acetate, 20% PEG3350) using hanging-drop 
vapour diffusion method at 4 °C. For co-crystallization the enzyme was incubated with 
the substrate mimic (2 mM) before being mixed with the reservoir solution. The crystals 
were stored in 25% (v/v) glycerol until X-ray data collection at the Advanced Light 
Source (Berkeley, CA, USA). The initial phases were determined by molecular 
replacement with 6HDNO (PDB code 2BVG) as a search model.  
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